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2. RESUMEN / SUMMARY 
 
2.1. RESUMEN 
La neurogénesis, o formación de nuevas neuronas, continúa durante la vida adulta en 
roedores y humanos en dos regiones bien definidas: la región subventricular, que genera 
interneuronas destinadas al bulbo olfativo; y la región subgranular (SGZ) del hipocampo, que 
genera neuronas granulares que se integran en el circuito hipocampal y participan en los 
procesos de memoria y aprendizaje. Múltiples son los factores endógenos que regulan la 
proliferación, supervivencia, diferenciación e integración de las nuevas neuronas en el 
hipocampo adulto. Entre ellos, nuestro grupo ha descrito recientemente el papel de la 
microglía, que se encarga de eliminar mediante fagocitosis el exceso de células recién nacidas 
(neuroprogenitores, neuroblastos, y neuronas) que entran en apoptosis o muerte celular 
programada. La microglía es el macrófago residente del sistema nervioso, y además de 
coordinar la respuesta inflamatoria es el fagocito cerebral profesional. Mientras que la 
respuesta inflamatoria está muy bien descrita, la fagocitosis microglial es una gran 
desconocida. Las prolongaciones microgliales son altamente móviles, lo que permite el 
“escaneado” constante del tejido cerebral en busca de alteraciones de la homeostasis. 
Además, la microglía está equipada con receptores para las señales “find-me” y “eat-me” 
producidas por las células apoptóticas, hacia las que se induce una respuesta quimiotáctica 
positiva que termina en el englobamiento del residuo celular en un fagosoma, que 
posteriormente se fusionará con lisosomas para su completa degradación. En el hipocampo, la 
microglía “en reposo” del nicho neurogénico es capaz de reconocer y eliminar de manera muy 
eficaz las células apoptóticas recién nacidas, en un proceso que dura menos de 1.5h. La 
fagocitosis impide la liberación de contenidos intracelulares y además es activamente anti-
inflamatoria, por lo que es esencial para evitar la alteración del tejido circundante. En este 
estudio, proponemos que la fagocitosis microglial no termina con la eliminación física de las 
células apoptóticas si no que, además, la fagocitosis inicia la producción de factores 
neuromoduladores que contribuyen directamente al correcto mantenimiento de la cascada 
neurogénica hipocampal adulta. 
 
Para demostrar nuestra hipótesis, nuestro Objetivo 1 ha sido poner a punto un modelo 
in vitro de fagocitosis que recopilase el mayor número de características posibles de la 
fagocitosis in vivo. Nos enfocamos especialmente en el tipo de cargo, en un englobamiento 
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temprano y en la presencia de moléculas opsonizadoras clave. La microglía es capaz de 
fagocitar diversos cargos, pero para la presente tesis, nos centramos en concreto en la 
fagocitosis de células apoptóticas. Como diana fisiológica para este estudio se utilizaron líneas 
celulares de ratón (NE-4C) y humanas (SH-SY5Y), a las que inducimos apoptosis. Otra 
característica de la fagocitosis in vivo es que las células apoptóticas son rápidamente 
eliminadas, por lo que para este estudio nos aseguramos que la inducción de apoptosis de las 
líneas celulares fuese corta, de manera que la microglía únicamente fagocitase células 
apoptóticas tempranas y no células que ya estuviesen perdiendo la integridad de su 
membrana (necróticas secundarias). Por último, la presencia o ausencia de moléculas 
opsonizadoras como la molécula del complemento C1q se han descrito como claves para 
determinar la respuesta inmune de la fagocitosis microglial, por lo que analizamos su papel en 
relación a las células apoptóticas y a la microglía antes de llevar a cabo el ensayo de 
fagocitosis. Una vez estudiadas en detalle todas estas características, finalmente pusimos a 
punto un ensayo de fagocitosis in vitro que consistía en alimentar microglía primaria murina 
con líneas celulares (NE-4C o SH-SY5Y) previamente tratadas con estaurosporina para la 
inducción de apoptosis, en presencia de C1q en el suero. Para los siguientes objetivos, 
utilizamos el modelo xenogénico (microglía murina, SH-SY5Y humanas), lo que nos permitió 
detectar de forma específica los transcritos de microglía de ratón en los posteriores análisis 
transcripcionales.  
 
Nuestro Objetivo 2 ha sido el estudio de los cambios transcripcionales de la microglía 
producidos tras la fagocitosis de células apoptóticas. Para ello, utilizamos el modelo de 
fagocitosis in vitro detallado en el párrafo anterior y realizamos un estudio comparativo de la 
transcripción en microglía naïve vs. microglía fagocítica usando matrices de expresión génica 
(“gene arrays”). Tras una serie de filtrados estadísticos, aquellos genes que presentaban 
cambios significativos fueron clasificados acorde a su perfil de expresión: genes con expresión 
incrementada o reducida a lo largo del tiempo, y genes con expresión aumentada o disminuida 
de forma transitoria. A continuación, realizamos un análisis funcional de los patrones de 
expresión utilizando tres plataformas bioinformáticas distintas: DAVID, ClueGO e IPA. Los tres 
análisis revelaron la presencia de diversas funciones relacionadas con la neurogénesis que 
estaban significativamente alteradas en la microglía fagocítica. Asimismo, el análisis funcional 
también mostró cambios en numerosas vías de señalización como las metabólicas por 
ejemplo, que abren las puertas para futuros estudios. Con todo esto, nuestros resultados 
sugerían la existencia de un programa neuromodulador en la microglía iniciado por la 
fagocitosis. 
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Nuestro Objetivo 3 ha sido el estudio de la identidad de aquellas moléculas 
potencialmente neuromoduladoras producidas por la microglía fagocítica. Para esta tarea 
realizamos un primer filtrado de los genes de la base de datos de MANGO (The Mammalian 
Adult Neurogenesis Gene Ontology), separándolos en dos categorías: genes autólogos, cuya 
función es actuar en la misma célula que lo produce; y genes heterólogos, que actúan fuera de 
la célula que los produce. Debido a que la modulación de la neurogénesis por la microglía 
fagocítica sólo se podría llevar a cabo mediante genes heterólogos, nuestro siguiente paso fue 
buscar todos los genes heterólogos en nuestro array relacionados con la neurogénesis con 
ayuda de los identificadores de función (GO terms) obtenidos de MANGO. Finalmente, se 
realizó un filtrado manual para seleccionar aquellos genes que estuviesen posicionados de 
manera extracelular en la microglía. Varios de los genes seleccionados que presentaban 
grandes cambios o que habían sido clásicamente descritos como neuromoduladores fueron 
analizados mediante RT-qPCR para validar su expresión. 
 
Nuestro Objetivo 4 ha consistido en analizar los efectos en la neurogénesis in vitro de 
las moléculas producidas por la microglía fagocítica. Para llevar a cabo este objetivo, pusimos a 
punto un modelo de neurogénesis in vitro utilizando neurosferas. Las neurosferas obtenidas 
de cerebros postnatales de ratón fueron expandidas durante una semana y posteriormente 
disociadas y sembradas sobre cubreobjetos de cristal en los que se les permitió proliferar 
durante 48h. Tras este periodo, los neuroprogenitores se trataron con los medios 
condicionados de microglía control y fagocítica durante 3 y 5 días. Tras el tratamiento 
observamos la presencia de diferentes fenotipos celulares: células estrelladas, que expresaban 
altos niveles de la proteína ácida fibrilar glial (glial fibrillary acidic protein, GFAP); células 
ramificadas, que expresaban altos niveles de doblecortina (DCX) y finalmente células bipolares, 
que expresaban altos niveles de nestina y GFAP. En los cultivos tratados con medio 
condicionado de microglía fagocítica, casi el 90% de las células eran bipolares y no había 
ninguna célula que expresase DCX; mientras que en los cultivos tratados con medio 
condicionado de microglía control, la mayoría de las células eran estrelladas y un pequeño 
porcentaje eran células DCX. Debido a su morfología y expresión de marcadores, clasificamos 
las células estrelladas como astrocitos y las ramificadas como neuroblastos. Sin embargo, la 
clasificación de células bipolares requería mayor caracterización.  
 
Dado que las células bipolares no expresaban DCX y poseían altos niveles de nestina y 
GFAP, concluimos que se podían tratar o bien de astrocitos o bien de células 
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neuroprogenitoras que se mantenían indiferenciadas. Para estudiar la primera posibilidad, 
realizamos una inmunofluorescencia con S100β, marcador de astrocitos maduros, en los 
neuroprogenitores tratados con medio condicionado de microglía control o fagocítica. En los 
cultivos tratados con medio condicionado de microglía control, sólo un pequeño porcentaje de 
células estrelladas presentaba marcaje de S100β, lo que sugería que la mayoría de los 
astrocitos del cultivo aún eran inmaduros. También descubrimos un pequeño porcentaje de 
células que únicamente se marcaban con S100β, y que por su morfología identificamos como 
oligodendrocitos. En los cultivos tratados con medio condicionado de microglía fagocítica, 
cerca de la mitad de las células bipolares presentaban marcaje débil de S100β, lo que podría 
sugerir que las células bipolares pertenecen al linaje astrocitario. Para estudiar la posibilidad 
de que las células bipolares fuesen neuroprogenitores aún sin diferenciar, realizamos un 
ensayo de pluripotencia en el que tras tratar a las células con sus correspondientes medios 
condicionados, el medio fue reemplazado por el medio habitual de diferenciación de las 
neurosferas con objeto de sacar del arresto celular al fenotipo bipolar. Tras 5 y 9d de 
diferenciación, el cultivo tratado con medio de microglía fagocítica presentaba un porcentaje 
invertido entre células bipolares y estrelladas, encontrando un número mayor de estas 
últimas, y nunca presentaba células DCX, lo que, una vez más, sugería que este fenotipo 
pertenece a un linaje astrocitario. Además, para una caracterización más profunda de los 
distintos fenotipos, realizamos estudios de imagen de calcio de los cultivos tratados con 
microglía control y fagocítica. Estos experimentos demostraron que las células bipolares 
compartían características tanto con las células estrelladas como con neuroprogenitores 
indiferenciados recién disociados de las neurosferas, por lo tanto, concluimos que el fenotipo 
bipolar pertenece a células inmaduras adscritas a un linaje astrocitario. 
 
Nuestro Objetivo 5 ha sido estudiar la función en la neurogénesis de las citoquinas 
liberadas por la microglía fagocítica. El análisis transcripcional de la microglía fagocítica de los 
objetivos 2 y 3 reveló la producción de ciertas citoquinas pro-inflammatorias por la microglía 
fagocítica. Para determinar si estas citoquinas eran las causantes de los distintos fenotipos 
observados en el ensayo de neurogénesis (Objetivo 4), realizamos un estudio tratando a la 
microglía primaria con lipolisacáridos bacterianos (LPS) para inducir inflamación y cultivamos 
las células progenitoras con este medio microglía condicionado. Observamos que los fenotipos 
resultantes de este tratamiento eran los mismos que al tratar el cultivo con medio 
condicionado de microglía control, y además, nunca se observó ningún fenotipo bipolar. Estos 
resultados descartan que el efecto de la microglía fagocítica sobre las neuroesferas esté 
mediado por citoquinas. 
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Nuestro Objetivo 6 ha sido la identificación de los factores concretos que promueven los 
efectos en la neurogénesis in vitro. Para ello nos centramos en dos de los factores más 
prometedores que habíamos encontrado en los matrices de expresión génica, VGF y lactato. 
Para validar la expresión proteica de VGF realizamos inmunofluorescencia en cultivos de 
microglía fagocítica usando diversos anticuerpos contra diferentes variantes 
postranscripcionales de VGF. Observamos que tras fagocitar, VGF se expresaba más 
intensamente por toda la célula de microglía, validando la sobreexpresión observada mediante 
RT-qPCR. Por otro lado, para la detección de lactato utilizamos ensayos colorimétricos. No 
observamos diferencias en la producción de lactato entre el medio condicionado de la 
microglía control y el de la fagocítica, pero sí observamos que la microglía tratada con LPS 
producía mayor cantidad de lactato. Estos resultados sugieren que el VGF puede ser uno de los 
mecanismos implicados en el control de la neurogénesis por la microglía fagocítica. 
 
Nuestro Objetivo 7 ha sido la validación in vivo del programa neuromodulador de la 
microglía fagocítica obtenidos en los objetivos 2 y 3. Para ello realizamos un análisis de 
secuenciación de RNA de células individuales (single-cell RNA sequencing) comparando una 
población enriquecida en microglía fagocítica obtenida del giro dentado (región en la que 
existe una neurogénesis continua y por lo tanto también apoptosis), con una población de 
microglía no fagocítica obtenida del CA del hipocampo (región en la que al no haber 
neurogénesis, tampoco hay apoptosis). Desafortunadamente, esta técnica no logró encontrar 
diferencias entre las poblaciones de giro dentado y CA, probablemente debido a que la 
población de giro dentado no está suficientemente enriquecida en microglía fagocítica. Por lo 
tanto, esto conlleva la necesidad de diseñar futuras estrategias en las que poder demostrar la 
implicación de la microglía fagocítica en la neurogénesis. 
 
Nuestro Objetivo 8 ha sido analizar los efectos en la neurogénesis in vivo de los factores 
secretados por la microglía fagocítica. Para ello infundimos el medio condicionado de microglía 
control y fagocítica mediante bombas osmóticas en el hipocampo de ratones adultos durante 6 
días. Tras este periodo, inyectamos BrdU y sacrificamos a los animales 2h y 28d después. A las 
2h observamos no observamos diferencias en la proliferación tras el tratamiento con medio 
condicionado de microglía fagocítica, ni sobre el número de neuroblastos. Sin embargo, a los 
28d observamos un descenso en el porcentaje de neuroblastos más maduros lo que sugiere 
que los factores secretados por la microglía fagocítica alteran la neurogénesis hipocampal 
adulta. 
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Nuestro Objetivo 9 ha sido caracterizar diferentes tipos de receptores que participan en 
la fagocitosis microglial con la intención de poder diseñar futuras estrategias para suprimir la 
expresión de dichos genes y estudiar la neurogénesis en ratones que posean una fagocitosis 
impedida. Para ello estudiamos la expresión de las subunidades de todos los receptores de 
glutamato mediante RT-qPCR en microglía aislada por FACS. Encontramos una expresión 
residual de todas las subunidades en microglía, lo que hace improbable que formen receptores 
funcionales. Además, también analizamos diversos receptores fagocíticos y purinérgicos 
mediante RT-qPCR en microglía aislada por FACS de ratones control y tratados con el análogo 
del neurotrasmisor glutamato, kainato (KA), en los que habíamos demostrado previamente 
que la fagocitosis microglial estaba dañada. Encontramos que el tratamiento con KA reducía la 
expresión de todos los receptores fagocíticos mientras incrementaba la expresión de la 
mayoría de los receptores purinérgicos en la microglía. Estos resultados sugieren que la 
modulación de la expresión o función de los receptores purinérgicos y de reconocimiento 
puede alterar la fagocitosis microglial y por lo tanto, podrían ser utilizados como métodos 
alternativos para poder estudiar el impacto de la fagocitosis microglial sobre la neurogénesis. 
 
En conclusión, nuestros datos demuestran que la microglía fagocítica libera factores que 
controlan la diferenciación y supervivencia de los neuroprogenitores tanto en cultivo como en 
la cascada neurogénica hipocampal adulta. Estos resultados sugieren que la fagocitosis 
microglial es un mecanismo que actúa como el freno de la neurogénesis para mantener la 
homeostasis de la cascada hipocampal adulta. 
 
2.2. SUMMARY 
Neurogenesis, or formation of new neurons, continues throughout adulthood in rodents 
and humans in two well-defined regions: the subventricular region, which generates 
interneurons destined for the olfactory bulb; and the subgranular region (SGZ) of the 
hippocampus, which generates granular neurons that are integrated into the hippocampal 
circuit and participate in memory and learning processes. There are multiple endogenous 
factors that regulate the proliferation, survival, differentiation and integration of the new 
neurons in the adult hippocampus. Among them, our group has recently described the role of 
microglia, which is responsible for eliminating by phagocytosis the excess of newborn cells 
(neuroprogenitors, neuroblasts, and neurons) that undergo apoptosis or programmed cell 
death. Microglia are the resident macrophages of the nervous system, and in addition to 
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coordinating the inflammatory response they are the professional brain phagocytes. While the 
inflammatory response is well described, microglial phagocytosis is largely unknown. The 
microglial branches are highly motile, supporting a constant scanning of brain searching for 
alterations in homeostasis. In addition, microglia are equipped with receptors for the ‘find-me’ 
and ‘eat-me’ signals produced by apoptotic cells, which exert a positive chemotactic response 
that results in the engulfment of the apoptotic cell in a phagosome, which subsequently will 
fuse with lysosomes for its complete degradation. In the adult hippocampus, resting microglia 
present in the niche is capable of recognizing and eliminating newborn apoptotic cells very 
effectively, in a process that lasts less than 1.5 hours. Phagocytosis prevents the release of 
toxic intracellular contents and thus, it is essential to avoid the alteration of the surrounding 
tissue. In this study, we propose that microglial phagocytosis does conclude with the physical 
elimination of apoptotic cells, but in addition, phagocytosis triggers the production of 
neuromodulatory factors that directly contribute to the correct maintenance of the adult 
hipocampal neurogenic cascade. 
 
In order to demonstrate our hypothesis, our Aim 1 was to develop an in vitro model of 
phagocytosis that mimicked the highest possible number of in vivo phagocytosis 
characteristics. We focused especially on the type of cargo, on an early engulfment, and on the 
presence of key opsonizing molecules. Microglia is able to phagocyte a large variety of cargos, 
but for this thesis, we focused specifically on the phagocytosis of apoptotic cells. As a 
physiological target for this study, mouse (NE-4C) and human (SH-SY5Y) cell lines were used to 
induce apoptosis. Another characteristic of in vivo phagocytosis is that apoptotic cells are 
rapidly eliminated, so for this study we ensured a short induction of apoptosis, so that 
microglia would only phagocytose early apoptotic cells and not cells that they were already 
losing their membrane integrity (secondary necrotic cells). Finally, the presence or absence of 
opsonizing molecules such as the complement molecule C1q have been described as key to 
determine the immune response of microglial phagocytosis. We therefore analyzed the role of 
C1q on microglial phagocytosis of apoptotic cells in vivo before performing the in vitro 
phagocytic assay. Once all these characteristics were studied in detail, we finally developed an 
in vitro phagocytosis assay that consisted on feeding murine primary microglia with cell lines 
(NE-4C or SH-SY5Y) previously treated with staurosporine for the induction of apoptosis. For 
the following aims, the xenogeneic model (murine microglia, human SH-SY5Y) was used, which 
allowed us to detect specifically the transcripts of mouse microglia in the subsequent 
transcriptional analyzes. 
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Our Aim 2 was the study of the transcriptional changes produced in microglia after 
phagocytosis of apoptotic cells. We used the in vitro model of phagocytosis detailed in the 
previous paragraph and performed a comparative transcriptional study of naïve vs. phagocytic 
microglia using gene expression arrays. After applying several statistical filters, those genes 
that presented significant changes were classified according to their expression profile: up-
regulated genes over time, down-regulated, and genes transiently up- or down-regulated. 
Next, we performed a functional analysis of the expression patterns using three different 
bioinformatic platforms: DAVID, ClueGO and IPA. All three analyzes revealed the presence of 
various functions related to neurogenesis that were significantly altered in phagocytic 
microglia. In addition, the functional analysis also showed changes in numerous signaling 
pathways such as metabolism, which opened the doors for future studies. Overall, our results 
suggested the existence of a neuromodulatory program in microglia triggered by phagocytosis. 
 
Our Aim 3 was the study of the identity of those potentially neuromodulatory molecules 
produced by phagocytic microglia. For this task we performed a first filtering of the MANGO 
database genes (The Mammalian Adult Neurogenesis Gene Ontology) which we divided into 
two categories: autologous genes, which act in the same cell in which are produced; and 
heterologous genes, which act outside the cell that produced them. Since the modulation of 
neurogenesis by the phagocytic microglia could only be exerted by heterologous genes, our 
next step was to filter all the heterologous genes in our array with the help of the GO terms 
related to the neurogenesis obtained from MANGO heterologous genes. Finally, a manual 
filtering was performed to select those genes that were extracellularly located in microglia. 
Several of the selected genes that showed great changes or that had been classically described 
as neuromodulators were analyzed by RT-qPCR to validate their expression. 
 
Our Aim 4 was to analyze the effects on in vitro neurogenesis of the molecules produced 
by phagocytic microglia. We developed a model of in vitro neurogenesis using neurospheres. 
Neurospheres obtained from mouse postnatal brains were expanded for a week and then 
dissociated and seeded on glass coverslips in which they were allowed to proliferate for 48h. 
After this period, the neuroprogenitors were treated with conditioned media from control and 
phagocytic microglia for 3 and 5 days. After the treatment, we observed the presence of 
different cellular phenotypes: stellate cells, which expressed high levels of glial cell fibrillary 
acidic protein (GFAP); ramified cells, which expressed high levels of doublecortin (DCX), and 
finally bipolar cells, which expressed high levels of nestin and GFAP. In cultures treated with 
conditioned medium from phagocytic microglia, almost 90% of the cells were bipolar and there 
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were no cells expressing DCX. In contrast, in cultures treated with control microglia 
conditioned medium, almost 90% of the cells were stellate and about 10% were DCX cells. Due 
to their morphology and expression of markers, we classified stellate cells as astrocytes and 
ramified cells as neuroblasts. However, the classification of bipolar cells required further 
characterization.  
 
Because bipolar cells did not express DCX and showed high levels of nestin and GFAP, we 
concluded that they could be either astrocytes or neuroprogenitor cells that remained 
undifferentiated. To study the first scenario, we performed immunofluorescence for S100β, a 
marker of mature astrocytes, in neuroprogenitors treated with conditioned medium from 
control or phagocytic microglia. In cultures treated with control microglia conditioned 
medium, only a small percentage of stellated cells showed S100β labeling, which suggested 
that most of the culture astrocytes were still immature. We also discovered a small percentage 
of cells that were only labeled with S100β, and by their morphology we identify them as 
oligodendrocytes. In cultures treated with conditioned medium of phagocytic microglia, about 
half of the bipolar cells had weak S100β labeling, which suggest that bipolar cells belong to an 
astrocytic lineage. To study the possibility that the bipolar cells were neuroprogenitors still to 
be differentiated, we performed a pluripotency test in which after treating the cells with their 
corresponding conditioned media, the medium was replaced by the usual media of 
differentiation of the neurospheres in order to allow bipolar phenotype to differentiate. After 
5 and 9d of differentiation, the culture treated with phagocytic microglia medium presented 
an inverted percentage between bipolar and stellate cells compared to cultures treated with 
control microglia conditioned medium, again suggesting that this phenotype belonged to an 
astrocitary lineage. In addition, for a deeper characterization of the different phenotypes, we 
performed calcium imaging studies of the cultures treated with control and phagocytic 
microglia. These experiments demonstrated that bipolar cells shared characteristics with both 
stellar cells and with undifferentiated neuroprogenitors newly dissociated from neurospheres, 
and therefore, we conclude that the bipolar phenotype belongs to immature cells ascribed to 
an astrocytic lineage. 
 
Our Aim 5 was to study the function of the cytokines released by phagocytic microglia 
on neurogenesis in vitro. The transcriptional analysis of the phagocytic microglia from aims 2 
and 3 revealed the production of certain pro-inflammatory cytokines by phagocytic microglia. 
To determine if these cytokines were responsible for the different phenotypes observed in the 
neurogenesis assay (Aim 4), we treated primary microglia with LPS to induce inflammation and 
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cultured the progenitor cells with this conditioned medium. We observed that the phenotypes 
resulting from this treatment were identical to those resulting from treatment with control 
microglia conditioned medium, and, in addition, bipolar cells were never observed. These 
results suggest that the effect of phagocytic microglia on neurospheres is not mediated by 
cytokines. 
 
Our Aim 6 was the identification of the specific factors that promote the effects in 
neurogenesis in vitro. We focused on two of the most promising factors found in the gene 
arrays, VGF and lactate. To validate the protein expression of VGF, we performed 
immunofluorescence in phagocytic microglia cultures of different antibodies against different 
posttranscriptional variants of VGF. We observed that after phagocytosing, VGF was more 
intensely expressed throughout microglia, validating the overexpression observed by RT-qPCR. 
On the other hand, for the detection of lactate we used colorimetric tests. We found no 
differences between the lactate production in conditioned media from control and phagocytic 
microglia. However, LPS-treated microglia showed a higher production of lactate that control 
or phagocytic microglia. These results suggest that VGF could be one of the factors involved in 
the effects of phagocytic microglia on neurogenesis in vitro. 
 
Our Aim 7 was to validate in vivo the neuromodulatory program of the phagocytic 
microglia obtained in aims 2 and 3. For this purpose, we performed a single-cell RNA 
sequencing analysis in order to compare a population enriched in phagocytic microglia 
obtained from the dentate gyrus (a region in which there is ongoing neurogenesis and 
therefore also apoptosis), with a population of non-phagocytic microglia obtained from the 
hippocampal CA (a region in which there is no neurogenesis and therefore, no apoptosis). 
Unfortunately, this method did not find differences in the expression pattern between the 
microglial populations of the dentate gyrus and CA, probably because the population of 
dentate gyrus is not sufficiently enriched in phagocytic microglia. Therefore, future strategies 
in order to be able to demonstrate the role of phagocytic microglia in neurogenesis must be 
designed. 
 
Our Aim 8 was to analyze the effects on in vivo neurogenesis of the factors secreted by 
phagocytic microglia. For this purpose, we infused the conditioned medium of control and 
phagocytic microglia in the hippocampus of adult mice for 6 days using osmotic pumps. After 
this period, we injected BrdU and sacrificed the animals 2h and 28d later. At 2h we did not 
observe differences in proliferation after treatment with conditioned medium of phagocytic 
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microglia or on the number of neuroblasts. However, at 28d we observed a decrease in the 
percentage of more mature neuroblasts, which suggests that the factors secreted by 
phagocytic microglia alter neurogenesis. 
 
Our Aim 9 was to characterize different types of receptors that participate in microglial 
phagocytosis in order to be able to design future strategies to study the impact of phagocytosis 
on neurogenesis. For this purpose, we analyzed the subunits of all glutamate receptors by RT-
qPCR in microglia isolated by FACS. We found a residual expression of all subunits in microglia, 
which makes it unlikely that they form functional receptors. In addition, we also analyzed 
various phagocytic and purinergic receptors by RT-qPCR in isolated microglia by FACS of 
control mice and treated with the neurotransmitter glutamate analog, kainate (KA), in which 
we had previously shown that microglial phagocytosis was impaired. We found that KA 
treatment reduced the expression of all phagocytic receptors while increasing the expression 
of most purinergic receptors in the microglia. These results suggest that modulation of the 
expression or function of purinergic receptors and recognition can alter microglial 
phagocytosis and therefore, could be used as alternative methods to study the impact of 
microglial phagocytosis on neurogenesis. 
 
In conclusion, our data shows that phagocytic microglia releases factors that control the 
survival and differentiation of neuroprogenitors in vitro and in the adult hippocampal 
neurogenic niches. These results suggest that microglial phagocytosis is a mechanism that acts 
as the brake of neurogenesis in order to maintain the homeostasis of the adult hippocampal 
cascade. 
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3. INTRODUCTION 
 
3.1. INTRODUCTION TO MICROGLIA 
The mammalian central nervous system (CNS) comprises several cell types, which 
include both neurons and glial cells. Of the different types of glia within the CNS, microglia is a 
unique population due to both their origin and function. Microglia are the main resident 
macrophages of the CNS, myeloid cells derived from erythromyeloid progenitor cells 
originating in the yolk sac during mouse embryogenesis (E7.5) (Ginhoux et al., 2010). These 
progenitors give rise to primitive erythrocytes and macrophages, which colonize the 
developing CNS to eventually differentiate into microglia (Bertrand et al., 2005; Casano and 
Peri, 2015; F. Chris Bennett, 2018; Ginhoux and Prinz, 2015).  
 
In both mice and humans, microglia presents a ubiquitous and non-overlapping 
distribution in all regions of the postnatal CNS, and comprise around a 12% of the total brain 
cells (Gomez-Nicola and Perry, 2015). Similar to their peripheral macrophage comrades, 
microglia display a remarkable range in both dynamism and functional behavior, in health as 
well as in disease. Indeed, microglia possess an extraordinary surveillance capacity of their 
environment, responding immediately to the most subtle variations of their surroundings, by 
undergoing modifications in morphology and gene expression (Aguzzi et al., 2013; Kettenmann 
et al., 2013). This surveillance capacity supports the ability of microglia to exert a large range 
of functions within the brain parenchyma. The diverse roles of these functions will be 
summarized in the next section. 
 
3.2. MICROGLIAL FUNCTIONS 
Microglia possess a huge capacity to survey the brain parenchyma. Microglial thin, long, 
and branched processes continuously scan their surroundings to detect different signals 
released from the environment. Environmental changes sensed by microglia comprise invading 
microbes, damaged or dead cells associated with neurodegeneration, as well as alterations in 
the pH of the parenchyma, composition or integrity of the extracellular matrix, or the release 
of different substances such as inflammatory cytokines and chemokines (Hickman et al., 2013; 
Nimmerjahn et al., 2005). Thus, microglia are the most sensitive monitors of changes in the 
brain, which allows them to exert a large variety of functions (Ginhoux et al., 2013; Nayak et 
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al., 2014). Some of these functions include synapse monitoring/pruning, myelination, 
vasculogenesis, and neurogenesis during development and adulthood in physiological and 
pathological conditions. 
 
-Synapse pruning: At postnatal stages, microglial cells contribute to the refinement of 
synaptic circuitries and synapse maturation (Hoshiko et al., 2012; Paolicelli et al., 2011; Schafer 
et al., 2012; Zhan et al., 2014). During CNS development, there is a massive production of 
synaptic contacts and mature synaptic networks are formed through an activity-dependent 
refinement, leading to the elimination of excessive inappropriate synapses and to the 
functional maturation of the remaining appropriate ones (Hua and Smith, 2004). In the adult 
CNS, synapse elimination has been proposed to occur via microglia trogocytosis (partial 
elimination or nibbling) rather than via phagocytosis (Weinhard et al., 2018). However, an 
excessive removal of synapses might aggravate several pathological diseases such as 
Alzheimer's disease (AD), schizophrenia, or aging (Vilalta and Brown, 2017). 
 
-Myelination: Microglia is also implicated in myelination by the release of several 
growth factors that control proliferation and survival of oligodendrocytes and their precursors 
(Pang et al., 2013). In addition, microglia also plays a critical role in remyelination process, 
since the phagocytosis of myelin debris after demyelination is crucial for a subsequent 
recruitment and differentiation of oligodendrocyte precursors (Domingues et al., 2016; Kotter 
et al., 2006). In contrast, microglia might exert a detrimental role in remyelination by the 
release of pro-inflammatory cytokines during pathological conditions including white matter 
damage in premature infants and multiple sclerosis in adults (Bennett and Barres, 2017; Pang 
et al., 2000) 
 
-Vasculogenesis: There are increasing evidences suggesting that microglia may play an 
important role in the formation of new blood vessels or angiogenesis both in health and 
disease, since the lack of microglia results in a decrease in the vasculature during development 
(Kubota et al., 2009). In addition, microglia might contribute to abnormalities in vasculature in 
different neurodegenerative diseases such as AD, Parkinson´s disease (PD), or multiple 
sclerosis (Zhao et al., 2018). Nevertheless, the mechanisms underlying this communication 
between microglia and vasculature are still unknown. 
 
-Neurogenesis: During embryonic development, microglia has been suggested to limit 
cell production in the subventricular zone, as it regulates the neuron production in the 
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prenatal brain directly by phagocytosing neural precursor cells in rats (Cunningham et al., 
2013). In addition, during adulthood, microglia remove apoptotic newborn neurons both in the 
hippocampus (Sierra et al., 2010) and in the subventricular zone (Fourgeaud et al., 2016). In 
addition, microglia can also contribute to the decline of neurogenesis in different pathological 
conditions such as aging or neurodegenerative diseases through the release of pro-
inflammatory cytokines during the inflammatory response (Sierra et al., 2014b). In this thesis 
we will focus on the role of microglia in adult hippocampal neurogenesis, which will be 
introduced in detail in section 3.3.4. 
 
Thus, new roles for microglia in the brain are emerging and will be further studied in the 
future. Most of these functions are related to the two major abilities of microglia: the control 
of the inflammatory response and phagocytosis, which we will review in detail in the next 
section. 
 
3.2.1. Immune response 
Microglia are the innate immune cells of the brain, and thus, one of the principal 
function they exert is the regulation of the inflammatory response. The innate immune system 
represents the first defense of the body from infection by other organisms by launching an 
inflammatory response. Contrary to the adaptive immune system, the innate system 
recognizes pathogens unspecifically and might not provide long-lasting immunity to the body 
(MacLeod and Mansbridge, 2016).  
 
Inflammation is a crucial mechanism triggered in response to stimuli that are recognized 
as noxious, such as pathogens or excessive cell death. In order to counteract these stimuli, 
inflammation triggers swelling, redness, heat, pain and fever in the affected tissue, aimed to 
limit proliferation of pathogens (Lucas et al., 2006). 
 
In the brain, microglia, as the resident immune cells, orchestrate the inflammatory 
response. In addition, inflammatory mediators can also be produced by neurons, astrocytes 
and oligodendrocytes (Camara-Lemarroy et al., 2010; Lucas et al., 2006). In the presence of an 
inflammatory insult, microglia release different inflammatory mediators such as cytokines, 
chemokines, and proteins of the complement cascade (Nayak et al., 2014). Their function in 
the organism is to coordinate the response of the immune system and do so they trigger 
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different responses such as proliferation and differentiation, cell dead, release of other 
cytokines, etc (Zhang et al., 2009). Six main groups have been described: 
 
 Interleukins (ILs) are mainly responsible for regulating the activation of several cells of 
the immune system and for controlling the differentiation and proliferation of some 
subpopulations. They also activate the endothelium and increase vascular permeability, 
facilitating the migration of immunity cells from the bloodstream to the tissue (Brocker et al., 
2010).  
 
 Tumor necrosis factors (TNFs) are important cytokines during the early stages of the 
inflammatory response. They are produced by a large variety of cells and play a central role in 
viral infections, as well as cell proliferation and apoptosis (Sun and Fink, 2007).  
 
 Transforming growth factors (TGFs) attract immune cells toward the site. In addition, 
TGFs play a crucial role in resolution and repair of the injury site (Tisoncik et al., 2012).  
 
 Interferons (IFNs) have an important role in the innate response to viruses or other 
pathogenic microorganisms. They are, therefore, secreted as danger signals: they promote the 
antiviral activity and the response of immune cells (Fensterl and Sen, 2009).  
 
 Colony stimulating factors (CSFs): are growth factors. They stimulate the differentiation 
and proliferation of stem cells to cells of the immune system, for example (Jeannin et al., 
2018). They have functions associated with inflammation and the production of other 
cytokines. 
 
 Chemokines: stimulate the motility of the cells of the immune system, and direct them 
towards the location of inflammation (chemotaxis) (Hughes and Nibbs, 2018). 
 
According to the effects that they exert upon binding to their receptors, cytokines are 
generally classified as pro- and anti-inflammatory. 
 
3.2.1.1. Pro-inflammatory cytokines 
Pro-inflammatory cytokines facilitate the inflammatory response. Although their main 
function is to defend the organism, their excessive and chronic release results in detrimental 
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consequences, which has been demonstrated to contribute to tissue damage in several 
neurodegenerative diseases such as AD, PD, stroke, multiple sclerosis, or epilepsy, among 
others (Amor et al., 2010; Vezzani et al., 2011). The detrimental effects of pro-inflammatory 
cytokines include apoptosis induction in neurons and glial cells, increased blood-brain barrier 
(BBB) permeability, and enhanced migration of peripheral immune cells into the CNS, which 
exacerbates neuron damage. In addition, these cytokines trigger the increase of neurotoxic 
factors such as ROS (reactive oxygen species) or NO (nitric oxide) (Sastre et al., 2006; Smith et 
al., 2012).  
 
Classically studied pro-inflammatory cytokines include interleukin 1 beta (IL-1β), 
interleukin 6 (IL-6), tumor necrosis factor α (TNFα), and interferon gamma (IFN-γ) (Su et al., 
2016). Different studies demonstrated that the levels of these classical pro-inflammatory 
cytokines are elevated in chronic neurodegenerative diseases, significantly aggravating the 
diseases progression (Rocha et al., 2012; Zheng et al., 2016). In addition, several of these 
cytokines are able to exert pleiotropic functions, as we will review in section 3.3.5. 
 
Therefore, an extended pro-inflammatory cytokine release results in harmful effects 
during brain pathologies. 
 
3.2.1.2. Anti-inflammatory cytokines 
Anti-inflammatory cytokines control the pro-inflammatory cytokine response. Their 
physiologic role in inflammation and pathologic role in systemic inflammatory states are 
increasingly recognized. Classically studied anti-inflammatory cytokines include interleukin 4 
(IL-4), interleukin 10 (IL-10), and transforming growth factor β (TGFβ) (Su et al., 2016). There 
are also specific cytokine inhibitors and soluble cytokine receptors that act as anti-
inflammatory (Opal and DePalo, 2000). Anti-inflammatory cytokines facilitate the tissue repair 
and restrain the synthesis of pro-inflammatory cytokines (Loftis et al., 2010). Similar to pro-
inflammatory cytokines, several of these cytokines have dual roles, as we will review in section 
3.3.5. 
 
3.2.2. Phagocytosis 
Phagocytosis is the process by which a cell recognizes, engulfs, and degrades large solid 
particles (>0.5 μm) (Mukherjee et al., 1997). It is an essential element of the innate immune 
response, which functions as a defense mechanism against pathogens during infection and 
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clearance mechanism for cellular debris produced during normal brain development and 
injuries (Fricker et al., 2012; Jones et al., 2013). In the CNS, microglia have been regarded as 
the major phagocytes. In addition, other cells such as astrocytes (Magnus et al., 2002; Sierra et 
al., 2010) and neuroblasts (Lu et al., 2011; Sierra et al., 2010) also present the ability to 
phagocytose and can be recruited when needed, although they are not as efficient as microglia 
and thus, they are referred as non-professional phagocytes (Magnus et al., 2002; Parnaik et al., 
2000). 
 
In addition, microglia can phagocytose different types of cargo during physiological and 
pathological conditions. Those targets include cargos such as synapses, neural debris, 
pathogenic proteins (Aβ for example), microbes and apoptotic cells (Diaz-Aparicio et al., 2016; 
Jana et al., 2008; Meyer-Luehmann et al., 2008; Pomilio et al., 2016; Tahara et al., 2006). 
 
3.2.2.1. Types of cargo 
3.2.2.1.1. Synapses and spines 
As it has been described above, during nervous system development, there is an 
overproduction of synapses that eventually need to be eliminated (synaptic pruning) in order 
to accomplish a correct neuronal network connectivity (Zuchero and Barres, 2015).  
 
Because microglia processes establish both direct and transient connections with 
neuronal synapses (Tremblay et al., 2010; Wake et al., 2009), microglia have been proposed to 
execute remodeling of the neural circuitry though the phagocytosis of synaptic components. In 
addition, there are recent evidences confirming that microglia directly engulf and eliminate 
synaptic material, however no evidences of phagocytosis of entire synapses have been found 
(Paolicelli et al., 2011; Stevens et al., 2007; Tremblay et al., 2010). On the contrary, synapse 
elimination has been proposed to occur via microglia trogocytosis (partial elimination or 
nibbling) (Weinhard et al., 2018). These data provide a new inside in role for microglia in the 
control and remodeling of synapses in the healthy developing brain (Nistico et al., 2017). 
 
Several neurodegenerative diseases present aberrant communications between 
microglia and synapses. In AD mouse models, microglia promotes synapse loss due to an 
excessive elimination triggered by an increase in synapse targeting by the complement protein 
C1q (Hong et al., 2016). In ischemia, while microglial processes interact longer with synapses 
(Wake et al., 2009)(Wake et al., 2009), microglia fails to remove them correctly (Wake et al., 
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2009). Synapse loss has also been reported in Huntington’s disease, neuropathies, glaucoma 
and different neurodegenerative diseases (McGonigal et al., 2016; Perry et al., 2010; Williams 
et al., 2016), however the contribution of microglia to synapse elimination in these diseases is 
yet to be determined. 
 
3.2.2.1.2. Amyloid β 
Several reports suggest that microglia remove amyloid-β (Aβ) deposits through 
phagocytosis. Aβ is a 36-43 amino acid peptide derived from the amyloid precursor protein 
(APP) after cleavage (Hamley, 2012). The accumulation of Aβ in the brain renders a major 
pathological hallmark in AD, which is suggested to trigger a detrimental neurodegenerative set 
of events that ultimately leads to cognitive impairment (Hardy et al., 2014). Several studies 
suggest that AD´s progression is due to a failure in the clearance of Aβ rather than an 
overproduction of the peptide (Mawuenyega et al., 2010). 
 
Microglia are found surrounding amyloid plaques in mouse models of amyloidosis as 
well as in AD patients (Daria et al., 2017); however, their role in plaque clearance is still under 
debate. Several studies proposed microglia to mediate Aβ clearance (Krabbe et al., 2013; Liu et 
al., 2010). Certainly, microglial phagocytosis of Aβ in vitro has been reported in several studies 
(Liu et al., 2012) (Hellwig et al., 2015); nevertheless, a complete degradation of the peptide has 
failed to be proven (Grathwohl et al., 2009; Krabbe et al., 2013; Spangenberg and Green, 
2017). In addition, opposite results have been observed regarding the capacity of microglia to 
limit plaque growth. In some studies no changes in plaque size was observed after microglia 
depletion in AD mouse models (Grathwohl et al., 2009; Prokop et al., 2015); however there are 
more recent results suggesting that upon microglia depletion, plaques grow in size (Zhao et al., 
2017). Since microglial phagocytosis of Aβ has not been detected in vivo yet, microglial 
function in Aβ clearance is still to be unraveled. 
 
3.2.2.1.3. Axonal and myelin debris 
During brain injury, axonal debris represents a barrier for axonal outgrowth and 
therefore must be eliminated in order to allow a correct repair. The removal of this debris has 
been proposed to be executed by microglial phagocytosis; however, few studies do actually 
report phagocytosed myelin debris within microglia (Rawji et al., 2018). Different in vitro 
studies show beneficial roles of microglial phagocytosis of axonal debris both in rat explants 
with sectioned neurites (Jin and Yamashita, 2016; Tanaka et al., 2009) or in axonal 
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degeneration co-culture models (Hosmane et al., 2012), in which axonal debris was eliminated 
by microglia, allowing axonal regeneration. In addition, ex vivo live multiphoton imaging has 
shown a decrease motility, surveillance, and phagocytic activity in microglia from 
demyelinated lesions in aging mice, suggesting that a microglial impairment could contribute 
to a decline in remyelination efficiency in aged mice (Rawji et al., 2018).  
 
In addition, microglia have also shown positive consequences in the clearance of myelin 
debris (Rawji and Yong, 2013). In physiological conditions, microglia is responsible for 
eliminating myelin fragments that increasingly split from myelin sheaths with age (Safaiyan et 
al., 2016). The highly lipidic nature of myelin represents a challenge to microglia to digest and 
eventually in aging, myelin forms lysosomal inclusions in microglia filled with insoluble 
materials (Safaiyan et al., 2016), which contributes to microglial impairment. Moreover, in a 
CX3CR1 KO model, microglial inefficient clearance of myelin debris results in the impairment of 
remyelinating processes (Lampron et al., 2015). Thus, correct debris elimination is crucial, 
especially in demyelinating diseases such as MS or EAE or in spinal and nerve lesions. In these 
CNS autoimmunity models microglia has been proposed as the major orchestrator of myelin 
removal via the production of interferon beta (IFNβ), which enhances myelin debris uptake by 
microglia (Kocur et al., 2015). Thus, a correct elimination of myelin debris is essential for an 
efficient remyelination of demyelinating sites. 
 
3.2.2.1.4. Apoptotic cells 
In this Thesis project, we will focus on the apoptotic cells and their phagocytosis, and we 
will further detail this mechanism in the next sections. 
 
Apoptosis, or programmed cell death, is a widespread phenomenon that occurs 
regularly in the brain in both physiological (during development or homeostasis) and 
pathological conditions (Henson, 2005). Whether apoptotic cells come from physiological or 
pathological consequences, efficient clearance of these cells by microglia must occur.  
 
Apoptosis is particularly crucial in long-lived mammals (Danial and Korsmeyer, 2004) as 
it plays a critical function in physiological conditions during both development and adulthood 
(Hassan et al., 2014). It is a mechanism to remove any unnecessary or undesired cell in an 
extremely regulated process. Apoptotic pathways can be triggered by either intracellular or 
extracellular signals, leading to the initiation of the intrinsic (or mitochondrial) or the extrinsic 
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(or death receptor) apoptotic pathways, respectively. Intracellular signals that induce 
apoptosis include DNA damage and growth factor and cytokine deprivation (Zaman et al., 
2014), whereas extracellular signals include stimuli produced by cytotoxic immune cells after 
cell damage or infection in order to promote death (Zaman et al., 2014). Both pathways 
present common downstream executioner caspases (3, 6 and 7), which eventually trigger the 
characteristic cellular changes of apoptosis (Taylor et al., 2008). These changes include 
activation of caspases, which cleave cellular components required for normal cellular function, 
such as cytoskeletal and nuclear proteins. As a result of caspase activity, cells shrink and 
condense their cytoplasm; they also undergo nuclear fragmentation (karyorrhexis) and 
chromatin condensation (pyknosis). Eventually, the cytoskeleton breaks up and causes 
membrane blebs that separate from the cell, taking a portion of cytoplasm with them, forming 
apoptotic bodies (Eidet et al., 2014; Krysko et al., 2008; Poon et al., 2014). One important 
feature of apoptosis is that the integrity of the plasma membrane is preserved until the final 
stages of the apoptotic process (Ren and Savill, 1998). This feature of apoptosis is highly 
relevant since it allows the clearance of dead cells without any contact of toxic intracellular 
contents of the cells with the surrounding tissue. Failure to sustain efficient clearance results in 
secondary necrosis in which the membrane integrity is lost and intracellular toxic contents are 
released to the surrounding, which can lead to exacerbated inflammation and autoimmune 
diseases (Nagata et al., 2010). For these reasons both the dying cell and the phagocyte 
communicate and engage each other to ensure successful removal of apoptotic cells. In the 
next section, we will further detail the communication between apoptotic cells and microglia 
in the process of phagocytosis. 
 
3.2.2.2. Phagocytosis of apoptotic cells 
As stated above, the rapid elimination of the apoptotic cells is crucial to maintain tissue 
homeostasis. Thus, the process to eliminate dead cells must be complex and highly regulated 
as we will detail in this section. 
 
The process of phagocytosis comprises three steps (‘find-me’, ‘eat-me’ and ‘digest-me’) 
(Figure 1). First, apoptotic cells release ‘find-me’ signals which act as chemoattractants for 
microglia (Peter et al., 2010). Microglia then specifically engage the apoptotic cells, via ‘eat-
me’ signals on apoptotic cells and receptors for ‘eat-me’ signals on microglia (Gardai et al., 
2006). Microglia then physically engulf apoptotic cells through signaling induced by 
engulfment receptors and cytoskeletal reorganization of the microglia membrane 
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(Arandjelovic and Ravichandran, 2015; Sierra et al., 2013). Lastly, the corpse contents are 
degraded within microglia through phagolysosomal processing (Kinchen et al., 2008; Kinchen 
and Ravichandran, 2008; Park et al., 2011). Each step is highly regulated by a plethora of 
molecules, specially ligands and receptors from the apoptotic cell and microglia respectively, 
which ensure a correct functioning of the phagocytic process (Figure 2). 
 
 
Figure 1. Phagocytosis of apoptotic cells. Phagocytosis comprises three different phases: ‘find-me’, the 
stage in which microglial processes find the phagocytic target; ‘eat-me’, the stage where a direct 
microglia-target contact is established via a receptor-ligand interaction and recognition and engulfment 
take place; and ‘digest-me’, the stage in which the internalized apoptotic cells are degraded within 
microglia through phagolysosomal processing. 
 
3.2.2.2.1. ‘Find-me’ stage 
Cells undergoing apoptosis release molecules termed ‘find-me’ signals to attract 
microglia towards them. These include the lipids lysophosphatidylcholine (LPC) and 
sphingosine-1-phosphate (S1P), the chemokine fractalkine, and extracellular nucleotides (ATP, 
UTP) (Arandjelovic and Ravichandran, 2015; Elliott et al., 2009; Gude et al., 2008; Lauber et al., 
2003; Sierra et al., 2013; Truman et al., 2008). 
 
LPC is released from apoptotic cells and binds to G2A receptor on microglia, which 
promotes the recruitment of phagocytes to apoptotic cells (Peter et al., 2008; Xu et al., 2016). 
In apoptotic cells, phospholipase A2 (iPLA2) mediates the conversion of phosphatidylcholine 
into LPC (Lauber et al., 2003). 
 
S1P is produced from sphingosine by sphingosine kinase. Apoptotic cells release S1P, 
which binds to S1P receptors expressed on phagocytes, resulting in the migration of 
phagocytes toward apoptotic cells (Gude et al., 2008; O'Sullivan et al., 2018). Although the 
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presence of S1PR on microglia has been demonstrated (O'Sullivan et al., 2018), the role of 
S1P/S1PR signaling on microglia as a ‘find-me’ signal has not been studied yet. 
 
Fractalkine (CX3CL1) protein also plays a role as a ‘find-me’ signal (Truman et al., 2008). 
Fractalkine is produced as a membrane anchor protein, which needs to be proteolitically 
cleaved in order to be released from apoptotic cells. The resulting soluble fragment of the 
protein binds to the microglial-specific CX3C motif chemokine receptor 1 (CX3CR1) and 
promotes the migration of the phagocyte (Eyo et al., 2016; Jung et al., 2000; Mizutani et al., 
2012). 
 
Finally, apoptotic cells release nucleotides such as ATP and UTP, which bind to 
purinergic receptors on phagocytes, facilitating the recruitment of microglia to apoptotic cells 
(Elliott et al., 2009). Pannexin 1 channels allow nucleotide release from apoptotic cells in a 
caspase-3-dependent manner (Chekeni et al., 2010). Nucleotides are in turn recognized by the 
plethora of purinergic receptors present in microglia (Domercq et al., 2013) 
 
After microglia has approached to the apoptotic cell, the second stage of phagocytosis is 
initiated, so called ‘eat-me’ stage, in which physical contact between microglia a target cell 
occurs in order to perform recognition and tethering of the apoptotic cell (Sierra et al., 2013).  
 
3.2.2.2.2. ‘Eat-me’ stage 
After finding the apoptotic cell, microglia must recognize the apoptotic cell in order to 
engulf the correct target (Sierra et al., 2013). Microglia displays a plethora of surface receptors 
that bind to the ‘eat-me’ signals expressed by apoptotic cells. Similarly, apoptotic cells express 
a variety of ligands in their membrane that are recognized as ‘eat-me’ signals by phagocytes. 
 
3.2.2.2.2.1. Apoptotic ‘eat-me’ ligands 
Apoptotic cells display ‘eat-me’ signals on their surface to reflect that they should be 
engulfed by microglia. Although different ‘eat-me’ signals have been suggested, the most 
studied ‘eat-me’ signal is the expression of phosphatidylserine (PS) on the cell surface. PS is a 
phospholipid localized on the inner membrane leaflet of the plasma membrane in healthy cells 
and undergoes externalization to the cell surface upon apoptotic stimuli (Fadok et al., 1992). 
Due to activation of the Xk-related protein 8 (Xkr8), a phosphatidylserine scramblase, PS is 
irreversibly exposed on apoptotic cells (Suzuki et al., 2016). In addition, asymmetry of the 
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membrane is maintained via flip-flop of aminophospholipids from the outer leaflet to the inner 
leaflet of the membrane through the ATP11C ATPase. In cells undergoing apoptosis, it is 
inactivated by caspase-3-mediated cleavage, permitting phosphatidylserine externalization 
(Segawa et al., 2014). 
 
Calreticulin (CRT) is another potential ‘eat-me’ signal. It is usually confined to the 
endoplasmic reticulum (ER), and both ER stress and apoptosis signaling can result in its 
exposure on the surface of non-neuronal cells, where it can present a dual role as an `eat-me´ 
signal or opsonin (Gardai et al., 2005). On neurons, surface CRT binds to microglial LRP (low-
density lipoprotein receptor related protein) and triggers their phagocytosis in vitro (Fricker et 
al., 2012). During cell death induced by ER stress, CRT is translocated from the ER to the Golgi 
and SNARE (Soluble NSF Attachment Protein Receptor)-mediated exocytosis (Panaretakis et 
al., 2009). CRT on the apoptotic cell surface is sensed by LRP on microglia to promote 
engulfment (Gardai et al., 2005). Recently, CRT has been described to associate to PS, which 
leads to apoptotic cell phagocytosis in vitro (Wijeyesakere et al., 2016).  
 
3.2.2.2.2.2. Phagocyte ‘eat-me’ receptors 
Recognition and engulfment are mediated by phagocytic receptors localized in the 
surface of the phagocytes and are able to bind different `eat-me´ ligands and opsonins (see 
next section) in the apoptotic cell. 
 
One of the receptors that mediates apoptotic engulfment is Triggering receptor 
expressed on myeloid cells-2 (TREM2), an immunoglobulin-like receptor expressed on 
macrophages, dendritic cells, and microglia (Neumann and Takahashi, 2007). TREM2 associates 
with adapter protein named DNAX-activation protein of 12 kD (DAP12) (Paloneva et al., 2002), 
and disruption in the function of these two molecules leads to an impairment in the uptake of 
apoptotic cells by microglia in vitro (Hsieh et al., 2009). Apolipoprotein E has been suggested 
as the ligand that directly binds TREM2, and could also present a double role as opsonin by 
connecting PS with LRP in vitro (Atagi et al., 2015). 
 
Another receptor related to apoptotic cell recognition is GPR34 (G protein-coupled 
receptor 34), a P2Y family member receptor (Sugo et al., 2006). GPR34 is activated by 
lysophosphatidylserine (LysoPS), a deacylated form of phosphatidylserine produced by 
phospholipases (PLA) (Makide et al., 2014). LysoPS is known to induce several cellular 
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responses both in vitro and in vivo such as increasing degranulation of mast cells and neurite 
growth; inhibiting T cell proliferation; promoting fibroblast migration; and increasing apoptotic 
uptake by macrophages (Makide et al., 2014). GPR34 is highly expressed in microglia (Bedard 
et al., 2007; Butovsky et al., 2014; Hickman et al., 2013), however its relevance in microglial 
function is beginning to be unraveled. GPR34 deficient microglia presents a decreased capacity 
for clearance in vitro, strongly suggesting that GPR34 plays an important role in phagocytosis 
(Preissler et al., 2015). 
 
Another important phagocytic receptor is Mer tyrosine kinase (MerTK), which is the 
most extensively studied TAM (Tyro3, Axl, and Mer) receptor and is known to play a role in 
apoptotic cell engulfment both in vivo and in vitro (Scott et al., 2001). Microglial MerTK binds 
to the opsonins growth arrest-specific protein 6 (GAS6) or protein S, which in addition bind to 
PS on dead cells in vitro (Wu et al., 2005). Galectin-3 (Gal-3) has also been implicated in MerTK 
mediated apoptotic cell removal in vitro (Caberoy et al., 2012). Recently, the TAM receptor 
tyrosine kinases MerTK and Axl were shown to function as phagocytic receptors under 
different environments. MerTK is mainly involved in the maintenance of the immune balance 
in vitro, whereas the expression of Axl is promoted upon pro-inflammatory stimuli in order to 
inhibit immune responses in vivo (Zagorska et al., 2014). MerTK has been involved in 
regulation of phagocytosis via its receptor ligands GAS6 and protein S (Fourgeaud et al., 2016). 
 
Similarly, vitronectin receptor (VNR) mediates phagocytosis of apoptotic cells by binding 
to the opsonin MFG-E8 (milk fat globule EGF factor 8) both in vitro and in vivo (Hanayama et 
al., 2002). The activation of VNR triggers the reshaping of microglial cytoskeleton and 
promotes phagocytosis. Crosstalk between VNR and MERTK signaling pathways has been 
observed in cell lines, which leads to a synergistic increase in phagocytosis in vitro (Wu et al., 
2005). 
 
Moreover, the complement receptor 3 (CR3), which binds to different molecules of the 
complement cascade such as C1q or C3b (Linnartz et al., 2012), is also well established to 
enable cellular adhesion and phagocytosis of pathogen and apoptotic cells on microglia in vitro 
(Trouw et al., 2008). However, depending on the level of expression and the possibly different 
signaling partners, their participation in phagocytosis varies among cell types. CR3 was shown 
to induce an anti-inflammatory response in microglia, contributing to the maintenance of 
immune tolerance in vitro (Ehirchiou et al., 2007; Fraser et al., 2010; Veldhoen et al., 2007). 
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3.2.2.2.2.3. Opsonins and bridge molecules 
Opsonins are soluble proteins that target cells in order to facilitate their phagocytosis. 
The most described classic opsonins are complement components C1q and C3b. In addition, 
different molecules that act as a bridge between PS in the apoptotic cells and phagocytic 
receptors are also considered as opsonins.  
 
One of these bridge molecules is MFG-E8 (milk fat globule EGF factor 8). Produced by 
macrophages and dendritic cells, MFG-E8 binds to PS on apoptotic cells leading to their 
phagocytosis both in vitro and in vivo in macrophages (Akakura et al., 2004; Hanayama et al., 
2002) and in microglia in vitro (Fuller and Van Eldik, 2008). Gas6 and protein S present similar 
domains and both recognize PS on apoptotic cells to promote the internalization of the cargo 
in vitro (Anderson et al., 2003; Ishimoto et al., 2000). 
 
Another potential bridging molecule is C1q, a complement component. C1q exerts 
crucial functions in the innate immune system. It recognizes the component of the 
macromolecular complex (C1), which in turn induces the classical complement pathway. In the 
immune system, upon binding to apoptotic cell membrane, C1q promotes a proteolytic 
cleavage of C3, resulting in opsonin C3b deposition of the surface of target cells and 
consequent phagocytosis by microglia expressing complement receptors (Bialas and Stevens, 
2013). Activation of C1 is usually triggered by binding of C1q to Fc portions of antibodies in 
immune complexes; however, C1 can also be activated in the absence of antibodies (Fraser 
and Tenner, 2008). In addition to phagocytosis of apoptotic cells, C1q also participates in 
phagocytosis of synapses. In the developing visual thalamus, both C1q and C3 tag a subset of 
immature synapses that are engulfed by microglia through the C3-CR3 signaling pathway 
(Schafer et al., 2012; Stevens et al., 2007). In addition, C1q is emerging as an important 
molecule in the clearance of apoptotic cells, since it has been shown to bind dead cells in vitro 
(Korb and Ahearn, 1997; Nauta et al., 2002; Trouw et al., 2008). C1q directly opsonizes target 
cells by binding to PS on the apoptotic cell surface, which contributes to cell clearance (Fraser 
et al., 2009; Ogden et al., 2001; Paidassi et al., 2008). Similar to synapse opsonization, C1q 
triggers C3b deposition and consequently enhances phagocytosis of apoptotic cells through 
CR3 and/or receptors for C1q (Ogden and Elkon, 2006; Takizawa et al., 1996). In addition, C1q 
can play opsonin role when binding to PS, CRT or a desialylated surface, or it can directly bind 
to the phagocytic receptor CR3 (CD11b) on microglia (Linnartz et al., 2012) or multiple 
epidermal growth factor-like domains protein 10 (MEGF10) on astrocytes (Iram et al., 2016).  
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3.2.2.2.3. ‘Digest-me’ stage 
After recognition and engulfment, the process of apoptotic cell clearance has not 
concluded. After internalization, phagosomes undergo a process of maturation in which they 
fuse sequentially with early and late endosomes, and lysosomes, to form phagolysosomes 
(Desjardins et al., 1994). Inside phagolysosomes, vacuolar ATPases (vATPases) maintain an 
acidic environment (pH ≤ 5) in order to ensure the correct functions of the different hydrolases 
within (Garin et al., 2001; Peri and Nusslein-Volhard, 2008). Several studies have proposed that 
the signaling cascade triggered after internalization might regulate the phagocytic ability of 
phagocytes to engulf additional targets (Park et al., 2011; Wu et al., 2000). However, the 
process of phagosome formation and cargo degradation has been barely addressed in 
microglia and thus, further research is necessary to unravel the mechanisms of degradation of 
apoptotic cells by microglia. 
 
 
Figure 2. Molecules implicated in the phagocytosis of apoptotic cells. Phagocytosis of apoptotic cells 
comprises different steps (‘find-me’, ‘eat-me’ and ‘digest-me’), all of which are highly regulated by a 
plethora of molecules, specially ligands and receptors from the apoptotic cell and microglia respectively, 
which ensure a correct functioning of the phagocytic process. 
 
3.2.3.3. Functional consequences of microglial phagocytosis of apoptotic 
cells 
The clearance of apoptotic cells is a crucial process to maintain tissue homeostasis. It is 
critical that the clearance of the apoptotic cells occurs before they lose the membrane 
integrity, otherwise, apoptotic cells would evolved into secondary necrotic, which are 
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characterized by membrane disruption. The spillover of toxic intracellular content might exert 
the triggering of an inflammatory response or autoimmune diseases (Nagata et al., 2010; Poon 
et al., 2014) and thus, failure to properly remove apoptotic cells presents deleterious 
consequences for the brain parenchyma. 
 
The importance of phagocytosis in maintaining tissue homeostasis is highlighted by 
observing the plethora of redundant phagocytic receptor present in phagocytes, since the 
overlapping function of different phagocytic receptors could compensate to some extent the 
expression decrease of any phagocytic receptor in order to ensure the correct mechanism of 
phagocytosis. In fact, it is well known that inhibitors of individual receptor–ligand pairs only 
show small and partial effects, often not translated to in vivo, which evidences the critical role 
of the phagocytic function (Gordon and Pluddemann, 2018). 
 
Importantly, recent data suggests that the uptake of apoptotic cells has more complex 
benefits than simple removal of noxious substances (Gordon and Pluddemann, 2018). In 
addition, it has become clearer that phagocytosis of apoptotic cells by phagocytes is not 
immunologically silent, and several evidences have emerged suggesting that it is indeed anti-
inflammatory, at least in vitro (Fadok et al., 1998; Stern et al., 1996; Voll et al., 1997). This anti-
inflammatory feature is mainly characterized by the production of TGFβ; however, the 
mechanism underlying TFGβ release upon phagocytosis of apoptotic cells is yet to be 
determined (Lucas et al., 2006). Moreover, phagocytosis of myelin has also been described to 
be anti-inflammatory (Liu et al., 2006). On the contrary, phagocytosis of microbes through toll-
like-receptor (TLR) signaling as well as the engulfment of necrotic cells, has been described to 
be pro-inflammatory in macrophages (Erdman et al., 2009) during infection or as a result of 
accidental injury (Henson and Bratton, 2013).  
 
The anti-inflammatory response to phagocytosis of apoptotic cells has also been 
reported in microglia. After phagocytosis, microglial release of TNFα is reduced and TGFβ is 
increased in vitro compared to microglia challenged with LPS (bacterial lipopolisaccharides) 
(De Simone et al., 2003; Magnus et al., 2001). The immunosuppressive effect induced by 
phagocytosis of apoptotic cells have been recently proposed to depend on the presence of the 
complement protein C1q bound to apoptotic cells. The presence or absence of C1q results in a 
completely different outcome in the process of phagocytosis, determining the anti- or pro- 
inflammatory nature of the process respectively (Fraser et al., 2010). However, whether C1q is 
produced in the brain and mediates the elimination of apoptotic cells by microglia in vivo is yet 
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to be determined. Moreover, since research focused on understanding the type of 
inflammatory response triggered by phagocytosis have been mostly performed in vitro, further 
study is needed to determine the microglial phagocytosis immune response in vivo (Abiega et 
al., 2016). 
 
In addition to the immunomodulatory nature of phagocytosis, there are also increasing 
evidences suggesting that microglia are able to produce different trophic factors after 
apoptotic cell phagocytosis. Phagocytic microglia in culture is capable of producing TGFβ as 
well as NGF (neuronal growth factor) (De Simone et al., 2003). Similarly, hepatic macrophages 
produce VEGF (vascular endothelial growth factor) upon phagocytosis (Golpon et al., 2004). 
These three factors are potent positive (NGF and VEGF) and negative (TGFβ) regulators of 
hippocampal neurogenesis in vivo (Buckwalter et al., 2006; Cao et al., 2004). Microglia are 
further able to produce trophic factors in vitro. After IL-4 or IFNγ treatment, cultured microglia 
decrease levels of TNFα and produce insulin-like growth factor1 (IGF-1), which help to 
maintain critical functions such as neurogenesis or oligodendrogenesis (Butovsky et al., 2006). 
Thus, trophic factors released from phagocytic microglia may mediate the functional recovery 
of the damaged tissue during brain diseases (Diaz-Aparicio et al., 2016). 
 
The concept that microglial phagocytosis of apoptotic cells induces the release of 
different trophic factors could be particularly relevant in the neurogenic niches. For example, 
in the subgranular zone of the adult hippocampus microglia are in direct contact with all 
components of the adult hippocampal neurogenic cascade, which allows them to efficiently 
phagocytose the apoptotic newborn cells (Sierra et al., 2010). In this context, microglial 
phagocytosis could not only exert its beneficial effects by the physical clearance of the 
apoptotic cells but, in addition, it may release different neurotrophic factors that could also 
help to maintain the homeostasis of the cascade. As stated above, there are scarce evidences 
suggesting that phagocytic microglia produce several factors known to act on different stages 
of adult neurogenesis (Sierra et al., 2014b). However, it has to be taken into account that most 
of these observations were obtained in culture and that further research is needed in order to 
elucidate whether those factors are also secreted and have the same regulatory responses in 
vivo.  
 
Due to the scarce information on this matter, and especially on microglia, the goal of 
this Thesis project is to perform a systematic analysis of the molecules released after microglial 
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phagocytosis of apoptotic cells in order to obtain a more complex picture of the inflammatory 
and trophic factors signature of phagocytic microglia and test their role on adult neurogenesis.  
 
Therefore, in order to obtain a deeper knowledge in the matter, in the next section we 
will review in detail the process of adult neurogenesis, its different stages and its tight 
relationship to microglia.  
 
3.3. ADULT HIPPOCAMPAL NEUROGENESIS 
Neurogenesis, or the formation of new neurons, is a complex process that extends 
throughout adulthood in two brain regions of the mammalian brain, the subventricular zone, 
which gives rise to olfactory bulb interneurons, and the subgranular zone (SGZ) of the 
hippocampus, which generates granule cells (Ehninger and Kempermann, 2008). This process 
comprises different steps in which neural stem cell proliferate, differentiate and migrate until 
they eventually integrate into the existing circuitry and gradually acquire physiological 
neuronal properties (Kempermann et al., 2004). For this study, we will focus on adult 
hippocampus, where our group has reported that microglia present in the SGZ efficiently 
phagocytose the excess of newborn cells that undergo apoptosis (Sierra et al., 2010). 
 
In many species of mammals, hippocampal proliferating neuroprogenitors have been 
directly or indirectly demonstrated to produce a significant amount of functional new neurons. 
However, human data on this matter is still scarce and its functional role in humans is currently 
under discussion. Adult human neurogenesis was first assessed two decades ago when BrdU 
positive cells were found both in subventricular and subgranular zone (Eriksson et al., 1998). 
More recently, 14C analyses by Frisen’s group assessed that there is a turning over rate of 700 
new neurons in each hippocampi per day in middle aged humans, a rate that undergoes a 
small decline with age (Spalding et al., 2013). Nevertheless, the persistence of hippocampal 
neurogenesis in the adult human is still controversial. Recently, opposite results have been 
published regarding this matter. On one hand, (Sorrells et al., 2018) suggest that the number 
of proliferating progenitors and new neurons in the dentate gyrus is dramatically reduced 
after the first year and is completely undetectable in the adulthood. On the other hand, 
(Boldrini et al., 2018) suggest that adult neurogenesis continues in the human dentate gyrus 
into the eighth decade of life. Thus, there are still many questions unanswered regarding 
human adult neurogenesis, which might be unraveled in the future with more complete 
analyses. 
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Adult hippocampal neurogenesis process encompasses several stages. Neural stem cells 
(NSCs) reside within the hippocampal neurogenic niche in the SGZ of the dentate gyrus (DG). 
These cells are normally maintained in quiescence, however, upon activation, they undergo 
asymmetric division from which an NSC and an amplifying neuroprogenitor (ANP) are 
produced (Encinas et al., 2011). The highly proliferative nature of the ANPs expands the 
progenitor cell population and eventually, they differentiate into neuroblasts (Encinas and 
Sierra, 2012). Afterwards, neuroblasts migrate a short distance to arrive to their definite 
location into the granular cell layer while differentiating into neurons. During the process of 
neurogenesis, many newborn cells naturally undergo apoptosis (up to 60% in physiological 
conditions) during their first life days, while they transit from amplifying neuroprogenitors to 
neuroblasts, and are rapidly phagocytosed by microglia (Sierra et al., 2010). The surviving cells 
will mature and integrate into the circuitry. By two months, surviving neurons are completely 
integrated into the neuronal network and are electrophysiologically indistinguishable from 
mature neurons (Ge et al., 2008; Piatti et al., 2006; van Praag et al., 2002). Hence, only a small 
proportion of newborn neurons eventually develop into mature neurons after a month 
(Encinas and Enikolopov, 2008; Goncalves et al., 2016b; Kempermann et al., 2004; Sierra et al., 
2010) (Figure 3). 
 
Figure 3. Adult hippocampal neurogenic cascade. In the adult hippocampal neurogenic cascade rNSC 
cells proliferate and differentiate, eventually producing newborn neuroblasts. During this process the 
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majority of the newborn cells die by apoptosis and are rapidly phagocytosed by microglia. Adapted from 
(Sierra et al., 2010).  
 
In the next sections we will review the different cells that comprise the adult neurogenic 
cascade and their characteristics; the functions of the adult neurogenic cascade; the in vitro 
and the in vivo methods used to study it; and the role of microglia. 
 
3.3.1 Characteristics of the cells of the neurogenic cascade 
The different steps of adult neurogenesis occur in parallel with each other within the 
hippocampal adult neurogenesis, where quiescent NPCs and immature neurons coexist as 
immediate neighbors (Braun and Jessberger, 2014), and they will be further detailed in this 
section.  
 
Neural stem cells (NSCs). The neurogenic cascade initiates with NSCs located within the 
hilus and the granule cell layer, in an area characterized by its loose extracellular matrix: the 
SGZ (Kempermann et al., 2004). NSCs present a single apical process that spans towards the 
molecular layer, and for this reason they are also named radial stem cells (rNSCs). In addition, 
these cells share patterns of protein expression with astrocytes, such as glial fibrillary acidic 
protein (GFAP), vimentin, and brain lipid binding protein (BLBP); they also present 
morphological and electrophysiological similarities, such as presence of vascular end-feet and 
low input resistance. In addition, they express neuroepithelial stem cell lineage markers such 
as nestin and Sox2 (Kempermann et al., 2004; Seri et al., 2004). At population level they are 
considered to be primarily quiescent, since NSCs present a very low rate of division (Encinas et 
al., 2006; Kronenberg et al., 2003). NSCs divide mainly asymmetrically, giving birth to a 
daughter cell termed amplifying neural progenitor cells (ANP), which differ from NSCs both 
functional and anatomically. 
 
Amplifying neural progenitor cells (ANPs) are born from NSCs and present short thin 
processes. They have also been named type 2a cells or transient amplifying progenitors. They 
lack, or express at low levels, the majority of the typical markers of NSCs mentioned above 
(GFAP, vimentin, nestin), and they do not express advance neuroblast markers such as prox1, 
doublecortin (DCX) and PSA-NCAM (polysialated neural cell adhesion protein) either. However, 
ANPs still maintain BLBP and Sox2 expression (Kempermann et al., 2004). The ANPs act as 
transient amplifying progenitors (Seri et al., 2004) and divide symmetrically several times 
(Encinas et al., 2011), before they differentiate into neuroblast. Therefore, in contrast to NSCs, 
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ANPs have a highly proliferative nature; however, up to 60% die by apoptosis and are 
phagocytosed by microglia (Sierra et al., 2010). The remaining third of the newborn cells 
continue their maturation into granule cells. 
 
Neuroblasts. One week after birth, ANPs stop proliferating and become neuroblasts 
(Kempermann et al., 2004). They begin to express immature neuron markers and also start to 
extend neurites into the granule cell layer, which will eventually become dendrites. These 
newly generated cells begin to express DCX and PSA-NCAM (Couillard-Despres et al., 2005). On 
average, DCX is expressed approximately for 3 weeks (Brandt et al., 2003; Steiner et al., 2004). 
During this period, the morphology of neuroblast changes into marked polarized cells. The 
presence and morphology of the apical process of DCX cells have allowed the sequential 
categorization of neuroblast cells (Plumpe et al., 2006). Six DCX cell categories have been 
proposed: category A and B comprises cells with no or very short processes parallel to the 
major axis of the granular cell layer; C and D cells present intermediate length processes and 
rather an immature morphology; and E and F cells are characterized for displaying a more 
mature appearance with a thick dendrite that ramifies in the molecular layer (Plumpe et al., 
2006). Later on, while DCX expression is lost, cells mature into neurons that integrate into the 
hippocampal circuitry where they are involved in memory and learning as well as mood control 
in mice (Goncalves et al., 2016a; Tashiro et al., 2007). With time, the surviving newly generated 
neurons will be indistinguishable from pre-existent neurons (van Praag et al., 2002). 
 
Astrocytes. In the neurogenic niche of the SGZ, newborn astrocytes are directly 
generated from NSCs after undergoing several asymmetric divisions (Bonaguidi et al., 2011; 
Encinas et al., 2011). While the young niche produces mostly neurons, the aging niche 
produces equal amounts of neurons and astrocytes (Beccari et al., 2017). Little is known about 
the function of new astrocytes and their contribution to the hippocampus in physiological 
conditions is still not understood (Goncalves et al., 2016a). 
 
3.3.2. Function of adult hippocampal neurogenesis 
Because the hippocampus is strongly associated with learning and memory, many 
efforts have been made to understand whether adult neurogenesis could play functional roles 
in cognition. It is unlikely that newborn neurons participate in behavior prior to integrating into 
the circuitry, generating action potentials or establishing synapses. However, newborn 
neurons are suggested to exert an important role especially between four-six weeks after 
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mitosis, because at this point, their excitability and plasticity is increased (Goncalves et al., 
2016b). In addition, different hypothesis have emerged from computational modeling 
suggesting the functions of newborn neurons, such as the codification of temporal information 
into memory (Aimone et al., 2006; Becker and Wojtowicz, 2007), cognitive plasticity during 
learning of new tasks (Chambers et al., 2004), and pattern separation (Aimone et al., 2009). 
Moreover, recent studies confirm several of these functions and therefore, nowadays newly 
generated neurons are strongly suggested to contribute to hippocampus-dependent learning 
and memory (Deng et al., 2010). These studies confirmed a role for hippocampal neurogenesis 
in spatial and object recognition memory (Jessberger et al., 2009), fear conditioning and 
synaptic plasticity (Saxe et al., 2006) and pattern separation (Nakashiba et al., 2012; Sahay et 
al., 2011).  
 
In addition, the roles of the newborn neurons in the DG might also differ depending on 
the exposure to different environmental inputs and cognitive demands during maturation, 
since integration and connectivity can be experience-dependent during the early maturation 
periods (Bergami et al., 2015; Piatti et al., 2011; Zhao et al., 2006). Moreover, newborn 
neurons might also participate in avoiding the interference between memories obtained at 
different time points (Rangel et al., 2014). However, the mechanism by which newborn 
neurons could execute these functions are yet to be unraveled. There are several evidences in 
the literature suggesting that the decrease of neurogenesis results in a reduction in the 
inhibition of the DG, while an enhancement of neurogenesis allows an increase in the 
activation of interneurons (Drew et al., 2016; Singer et al., 2011). Therefore, immature 
neurons might modulate the feedback inhibitory circuits in the DG, which would result in a 
decrease in the number of granule cells responding to incoming stimuli (Goncalves et al., 
2016b). However, further research should be performed in order to understand how immature 
neurons are associated to inhibitory networks. In addition, in the most recent years, an 
enhancement in neurogenesis has been associated with the elimination of older memories, by 
inhibition of mature granule neurons or competitive rewiring of DG outputs (Akers et al., 
2014).  
 
Importantly, disruptions in the hippocampal neurogenic cascade have been related to 
different neurodegenerative diseases such as PD, AD or Huntington's disease (HD) (Goncalves 
et al., 2016a). 
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3.3.3. In vitro methods to study neurogenesis 
In vitro cultures of adult hippocampal neuroprogenitor cells and their differentiation 
into granule cell-like neurons present a key tool for understanding the cellular and molecular 
mechanisms of adult neurogenesis. In vitro experiments of neuroprogenitor cells facilitate the 
analysis of the cells isolated from any signal produced in the neurogenic niche; however, 
culture settings must ensure the correct maintenance (proliferation and survival) of the 
neuroprogenitor cells. Although several procedures have been proposed to successfully extract 
and culture neuroprogenitor cells, preserving their intrinsic properties is a complex task. 
Generally, adult neuroprogenitor cells have been studied in vitro using two different culture 
methods: as neurospheres, non-adherent spherical clusters of cells; and as adherent 
monolayer cultures. Both models have their individual advantages and disadvantages that will 
be discussed in this section (Figure 4). 
 
 
Figure 4. In vitro methods to study neurogenesis. Left panel. Representative confocal z-stack of neural 
precursor cells from Nestin-GFP mice grown in vitro as neurospheres. Right panel. Representative 
confocal z-stack of neural precursor cells from Nestin-GFP mice grown in vitro as an adherent monolayer. 
Intrinsic nestin-GFP is labeled in green, nestin in cyan, GFAP in magenta and nuclei were stained with 
DAPI (white). Scale bars = 20μm  
 
Neurospheres: Neural stem cells (NSC) in vitro have the ability to proliferate, self-renew, 
and generate multipotential offspring (Rietze and Reynolds, 2006). NSCs expand giving rise to 
floating clusters termed neurospheres. This in vitro system allows the analysis of different NSC 
features such as the proliferative, renewal and differentiation potential (Jensen and Parmar, 
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2006). Because neurospheres are preserved in well-defined culture conditions, the only 
external signals that they might encounter are those produced by their neighbor cells. In 
addition, the manipulation of the extrinsic signaling is an easy task that can be achieved by 
varying different factors of interest in the media or co-culturing with other cells (Campos, 
2004). In addition to the many advantages that the neurosphere culture provides, there are 
also some limitations of their use that need to be considered. Neurosphere cultures might 
present rather a high variability due to their sensitivity to their environment. Small changes is 
cell density, number and frequency of passages, or concentration of media factors can result in 
different proliferative rates or even changes in the properties of the cells within the 
neurosphere (Arsenijevic et al., 2001; Caldwell et al., 2001; Irvin et al., 2003; Morshead et al., 
2002; Tropepe et al., 1999). Due to these variations in culture method, it is often difficult to 
compare studies from different groups (Hack et al., 2004; Parmar et al., 2002) in order to 
achieve conclusions on the neuroprogenitor cell properties. Nevertheless, neurospheres have 
proven useful for neurogenesis-related biological studies (Klein et al., 2005). 
 
Adherent monolayer: Adherent monolayer cultures overcome some of the 
disadvantages related to neurospheres as they are a less heterogeneous population of 
precursor cells. Single cells grow as a monolayer and therefore, each cell is equally exposed to 
culture media growth factor. This setting prevents any spontaneous differentiation and allows 
uniform proliferation of the cells (Conti and Cattaneo, 2005). Additionally, monolayer cultures 
facilitate the follow-up of individual cells, in which space between cells allow the analysis of 
variations in different features such as morphology or cell size. 
 
Nevertheless, it must be highlighted that both neurospheres and monolayer culture 
represent a reductionist approach since neuroprecursor cells are always surrounded and in 
close contact to neighbor cells in vivo. Therefore, the advantages and disadvantages of the in 
vitro cultures must be carefully considered when interpreting the results obtained in this 
culture conditions. 
 
3.3.4. In vivo methods to study neurogenesis 
A complete analysis of neurogenesis in vivo is based on the characterization of the cell 
types and their tracking through the cascade from the NSC step until the differentiation into 
neurons. Several strategies have been developed over time in order to perform a systematic 
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analysis of the different steps of neurogenic cascade in vivo (Kuhn et al., 2016), and we will 
detailed them in this section. 
 
The most classical strategy utilized to study the different steps of the neurogenic 
cascade is the tracking of proliferating cells by thymidine analogues such as 5-bromo-2´-
deoxyuridine (BrdU), 5-chloro-2’-deoxyuridine (CldU), or 5-iodo-2’deoxyuridine (IdU) (Burns 
and Kuan, 2005; Encinas and Enikolopov, 2008; Kempermann et al., 2004; Vega and Peterson, 
2005). Their main advantages are that they can be administered systemically and that the label 
is retained in the long term, allowing lineage analysis of the newborn cells. The combination of 
this approach with cell-specific markers and morphology of the different cells from the 
cascade, results in a precise tool to study neurogenesis by immunofluorescence. However, one 
of the limitations that this techniques present is that the analysis of neurogenesis can only be 
performed in fixed tissue, and therefore, it does not allow the study of electrophysiological 
properties of the cells of interest. 
 
In order to overcome this limitation, in the recent years the use of viral vectors 
(retroviral and lentiviral vectors) has been validated as an experimental approach to study 
neurogenesis. Retroviral vectors that carry fluorescent transgenes have been used to label 
dividing cells and their progeny (Enikolopov et al., 2015). The infected cells are permanently 
labeled, which allows long-term analysis and, in addition, there is no need of fixing the tissue, 
which is advantageous in order to perform electrophysiological analysis (Laplagne et al., 2006). 
However, retroviral vectors only infect dividing cells and its efficiency is rather low. On the 
other hand, lentiviral vectors can infect both dividing and non-dividing cells efficiently (Sarno 
and Robison, 2018) and therefore, they can be used for long-term in vivo tracking of the adult 
NSC during proliferation, migration and differentiation (Consiglio et al., 2004; Geraerts et al., 
2006). In addition, low doses of lentiviral vectors have been used to perform clonal analysis in 
vivo, allowing a more precise lineage analysis (Bonaguidi et al., 2011). 
 
Another strategy that has been utilized in order to study neurogenesis are transgenic 
mice. The use of constitutive reporter mice in which fluorescent reporter genes are under the 
control of cell type-specific promoters such as nestin, GFAP, or DCX have arisen as useful tools 
that allows the visualization, characterization and isolation of newborn cells in the adult brain 
(Dhaliwal and Lagace, 2011; Kuhn et al., 2016). An innovative approach of the recent years has 
been the development of inducible transgenic mice. This technique is based on the targeted 
expression of the Cre-recombinase fused with a mutated form of the estrogen receptor (e.g., 
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CreERT2), which presents a high affinity for tamoxifen, an exogenous estrogen (Rotheneichner 
et al., 2017). After tamoxifen administration, the fusion protein translocates to the nucleus and 
excises genomic segments comprised between loxP sequences. In many cases, the loxP sites 
floxed a reporter protein that has a stop codon, which allows the expression of the reporter 
protein after recombination. One of the most popular promoters in the CreER/lox system to 
study adult neurogenesis has been nestin (Nestin-CreERT2) (Lagace et al., 2007), although 
recently more CreER/lox systems under different promoters such as GLAST (Glutamate 
aspartate transporer; specific of astrocytes) (Mori et al., 2006), Sox2 (Sex determining region Y 
box 2; expressed in NSCs and ANPs) (Favaro et al., 2009) or Tlx (Nuclear receptor subfamily 2 
group E; specific of B cells of SVZ) (Liu et al., 2008) have been generated in order to study adult 
neurogenesis. One of the greatest advantages of this approach is that upon tamoxifen 
administration, the recombination will be permanent in both the desired cells and their 
progeny, which will allow the specific visualization and characterization of the cells in a long-
term (Dhaliwal and Lagace, 2011). In addition, the tamoxifen system is very useful in loss-of-
function studies, since the desired gene will only be excised upon tamoxifen administration, 
which ensures a normal development of the mice. 
 
3.3.5. The role of microglia in adult hippocampal neurogenesis 
Microglia are crucial elements in the adult hippocampal neurogenic niche. The most 
characterized function of microglia in neurogenesis is inflammation and the detrimental 
consequences that pro-inflammatory cytokines exert on the adult hippocampal neurogenesis. 
A persistent neuroinflammation is harmful for the brain. The cytokines released by immune 
cells provoke behavioral changes in the brain in animals undergoing inflammation, which is 
termed sickness behavior (Dantzer and Kelley, 2007). The major cytokines, IL-1, TNF-α, and 
others, act on the hypothalamus to cause alterations in the homeostasis, such as elevated 
body temperature, increased sleep, and loss of appetite as well as major alterations in lipid 
and protein metabolism leading to significant weight loss (Tizard, 2008). In addition, 
inflammation impairs different hippocampal functions such as novel place recognition, spatial 
learning, and memory formation (Belarbi et al., 2012) and some of these effects have been 
related to the detrimental consequences of inflammation on neurogenesis. Newborn neuron 
formation is declined after both systemic or intrahippocampal administration of LPS, likely 
because it reduces newborn cell survival of (Ekdahl et al., 2003; Monje et al., 2003). In 
addition, in vitro experiments performed with conditioned media from LPS-treated microglia 
showed induction in apoptosis of neuroblasts (Monje et al., 2003). However, in addition to 
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microglia other brain immune cells such as meningeal macrophages, perivascular 
macrophages, and mast cells (Lopez-Atalaya et al., 2017), are also able to respond to LPS and 
contribute to the inflammatory response. Therefore, although the negative role of 
inflammation on neurogenesis is well characterized, the contribution of microglia and the rest 
of the inflammatory cells in the brain need to be delimited. 
 
In addition to the role of inflammation on neurogenesis, several studies suggest that 
microglia could produce factors that might modulate proliferation or survival of different cells 
of the neuronal lineage, which suggests a much less studied beneficial role of microglia. In vitro 
studies demonstrate that cultured microglia promotes differentiation of precursor cells 
(Aarum et al., 2003). In addition, microglia conditioned media enhances survival of neurons 
and neuroblast production (Morgan et al., 2004; Walton et al., 2006). Throughout the 
literature, a limited number of growth factors, such as FGF-2 (Fibroblast growth factor-2) or 
IGF-1, have been described to be produced by microglia (Sierra et al., 2014a). These molecules 
produced by microglia that could potentially affect neurogenesis will be further detailed in 
section 3.3.6. On the other hand, neuroprogenitor cells are known to be influenced by 
surrounding signals such as different trophic factor. However, direct evidence of neurogenesis 
regulation by microglia-derived factors is still missing both in vitro and especially in vivo (Sierra 
et al., 2014b). 
 
3.3.6. Regulation of neurogenesis by phagocytic microglia 
As mentioned above, microglia can play an essential role in neurogenesis and its 
regulation through the release of different trophic factors or the phagocytosis of apoptotic 
newborn cells. However, little is known about the role of the trophic factors released by 
phagocytic microglia. One of the goals of the present study is to systematically identify 
different molecules that were described to be implicated in the regulation of neurogenesis and 
that have emerged as neuromodulatory factors secreted by microglia in the course of this 
study. In this section we will review in detail the already described role in neurogenesis of 
some of those molecules and their potential release by microglia. 
 
 
 
 
 
INTRODUCTION 
56 
 
3.3.6.1. Neuropeptides  
 
3.3.6.1.1. Cart: Cocaine- and amphetamine-regulated transcript (CART) is a highly 
conserved neuropeptide across mammalian species (Douglass and Daoud, 1996; Kristensen et 
al., 1998). 
-Expression. CART is largely expressed in stomach and endocrine glands as well as in 
both CNS and PNS (Rogge et al., 2008; Wierup et al., 2005). In the brain, CART is mainly 
observed in nerve terminal vesicles, indicating its role in neurosecretory pathway (Rogge et al., 
2008). In addition, its high expression in appetite associated regions in the brain suggests a 
role for CART in energy balance. 
-Microglial production. There are very few studies regarding microglia and CART and 
they mainly address the anorexigenic effects of CART on metabolism and the link between fat-
rich diets and microglial inflammation in vivo (Barreto-Vianna et al., 2016; Geloneze et al., 
2017), but direct connections between CART and microglia have not been studied. 
-Receptors. Although binding to A G protein-couple receptor have been proposed, CART 
target receptor is still unknown (Lakatos et al., 2005).  
-Functions. CART participates in a variety of physiological processes, such as energy 
balance, reward or neuroprotection (Rogge et al., 2008). This neuropeptide promotes the 
production of different neurotrophic factors that enhance neural differentiation of stem cells 
(Zhang et al., 2012). CART is early expressed at P12 and maintains the same expression pattern 
throughout adulthood, suggesting a role in synapse and spine formation (Abraham et al., 
2007). However, further studies are needed to unravel CART function in the development of 
the central nervous system.  
 
 3.3.6.1.2. VGF: VGF (non-acronymic) is a 68kDa polypeptide with a secretory sequence 
of 22 amino acids at the N-terminal, which promotes translocation to the endoplasmic 
reticulum (ER) (Jethwa and Ebling, 2008). After proteolytic post-translational processing, a 
variety of VGF peptides are produced (Bernay et al., 2009; Trani et al., 2002). Bioactive VGF-
derived peptides include TLQP-62, TLQP-21, HHPD-41, AQEE-30, AQEE-11, LQEQ-19, and NERP-
1 and -2 (Trani et al., 2002; Yamaguchi et al., 2007). 
-Expression. VGF mRNA is broadly distributed throughout CNS (Lewis et al., 2015). In 
adult mice, VGF mRNA is highly expressed in hypothalamus and cerebellum, and in addition it 
can also be found in olfactory bulbs, hippocampus, cortex, basal ganglia, thalamus, amygdala, 
midbrain, and the brainstem. In the hippocampus, VGF peptides are mainly located in axons of 
the mossy fibers and synaptic terminals in the CA3 (Hunsberger et al., 2007). 
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-Microglial production. In terms of microglia, there are very few studies in which 
microglia and VGF are linked (Chen et al., 2013; Riedl et al., 2009). Different studies have been 
performed in order to show that both macrophage and microglia cells express the VGF 
receptor gC1qR both in vitro and in vivo (Chen et al., 2013); however, whether microglia 
produce VGF peptides have not been previously studied. 
-Receptors. Of all the VGF derived peptides, TLQP-21 has been the most studied. Two 
receptors have recently been proposed for TLQP-21. First, gC1qR, which is activated in rat 
macrophages after TLQP-21 binding and in addition, it is also expressed in both brain and 
spinal cord derived microglia (Chen et al., 2013). Second, the complement receptor C3A 
receptor-1 (C3AR1), which not only does mediate immune response, but also it has been 
associated with cancer, neurogenesis and hormone release (Francis et al., 2003; Opstal-van 
Winden et al., 2012). 
-Functions. VGF is implicated in metabolism, and different pathologies such as 
neurodegeneration (AD and PD) or psychiatric disorders (depression) (Cocco et al., 2010; 
Foglesong et al., 2016; Razzoli et al., 2012). In addition, VGF peptides enhance adult 
hippocampal neurogenesis both in vitro and vivo (Thakker-Varia et al., 2014; Thakker-Varia et 
al., 2007; Yang et al., 2016) and promote neuron survival upon injury in vitro (Severini et al., 
2008).  
 
3.3.6.2. Trophic factors 
 
3.3.6.2.1. EGF: EGF (Epidermal Growth Factor) is a polypeptide synthesized as a 
precursor that is proteolytically cleaved to maturation (Yamada et al., 1997). There are 
additional growth factors that share structural features with EGF and are also able to bind EGF 
receptor (EGFR), such as TGFα, Amphiregulin, Epiregulin, Betacellulin, Heparin-binding 
epidermal growth factor-like growth factor and Epigen (Singh et al., 2006). All these molecules 
exert combined effects when bind to the receptor in order to achieve a large range of 
biological responses. 
-Expression. EGF is widely express in different tissues. In the brain the highest 
expression is found in cerebellum, cortex, hippocampus or olfactory bulb among other (Wong 
and Guillaud, 2004).  
-Microglial production. The release of EGF by microglia has been specially studied in cell 
cultures and ischemic conditions, where it shows a neuroprotective role by enhancing the 
survival of neurons (Villalonga 2008). In addition, EGF is also released by microglia after 
ischemia in vivo (Lee et al., 2005). 
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-Receptors. The epidermal growth factor receptor belongs to ErbB family of receptors, 
which comprises four receptor tyrosine kinases: EGFR (ErbB-1), HER2/neu (ErbB-2), Her 
3 (ErbB-3) and Her 4 (ErbB-4), EGFR immunoreactivity is widely distributed throughout the 
brain during both development and adulthood (Bodey et al., 2005). 
-Functions. EGF promotes proliferation and regulates the fate of neural stem and 
progenitor cells in the developing and adult CNS. In addition, EGF can promote the migration 
and proliferation of newborn cells in the SVZ. EGF enhances the differentiation, maturation 
and survival of a variety of neurons (Wong and Guillaud, 2004). 
 
3.3.6.2.2. FGF-2: Fibroblast growth factor-2 (FGF-2) is a trophic factor that belongs to 
the superfamily of proteins Fibroblast growth factor (FGFs), which can bind heparin and 
extracellular heparin sulfate proteoglycans (HSPGs) (Burgess and Maciag, 1989). 
-Expression. FGF-2, like some other members of the FGF family, is expressed in the CNS 
both during development and postnatally (Chadi et al., 1993; Eckenstein, 1994; Emoto et al., 
1989). Within the CNS, FGF-2 has been widely found not only in neurons but also in glial cells 
(Eckenstein et al., 1991). In detail, FGF-2 mRNA has been detected in the olfactory bulb, cortex, 
hippocampus, striatum, thalamus, substantia nigra, pons, medulla oblongata, motor and 
sensory nuclei, as well as in the pituitary (Bean et al., 1991; Ernfors et al., 1990; Gomez-Pinilla 
et al., 1994; Grothe et al., 1991). 
-Microglial production. Regarding microglia, microglia is able to both secrete and 
respond to FGF-2 in vivo (Liu et al., 1998). In addition, the production of FGF-2 by microglia and 
its possible contribution to the regulation of neuronal development and regeneration has been 
proposed for almost 30 years (Shimojo et al., 1991). 
-Receptors. FGF-2 binds with high-affinity to four different tyrosine kinase receptors 
(FGFR1-4) (Jaye et al., 1992). FGFR1 and FGFR4 are mainly produced in adult CNS neurons, 
while oligodendrocytes and astrocytes express large levels of FGFR2 and FGFR3 respectively 
(Asai et al., 1993; Miyake and Itoh, 1996). FGF-2 displays the highest affinity for FGFR-1 in the 
CNS (Woodbury and Ikezu, 2014). 
-Functions. In the adult CNS, FGF-2 is expressed in the neurogenic niches, SVZ and SGZ, 
and has been associated with adult neurogenesis regulation because it promotes proliferation 
and differentiation of adult neural stem and progenitor cells (Rai et al., 2007; Werner et al., 
2011). In addition, during development, FGF-2 controls fate, migration and differentiation of 
neuronal progenitors (Dono et al., 1998).  
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3.3.6.2.3. GDNF: The glial cell line–derived neurotrophic factor (GDNF) belongs to GDNF 
family ligands (GFL) which includes different related factors: GDNF, neurturin (NRTN), artemin 
(ARTN), and persephin (PSPN) (Airaksinen et al., 2006). Each ligand is produced as pre-pro-
precursor protein which is cleaved afterwards to produce the bioactive forms of the protein 
(Lin et al., 1993; Masure et al., 1999). 
-Expression. GDNF is mainly produced in hippocampus, cerebellum and cortex (Cortes et 
al., 2017). Neurons are the main source of GDNF in the brain; however, its expression has been 
also found in glial cells at much lower rates (Carnicella and Ron, 2009). 
-Microglial production. Similar to EGF, microglia also produces GDNF which is enhanced 
after ischemia in vivo (Lee et al., 2004)  
-Receptors. GDNF preferentially binds to GFRα1, NRTN to GFRα2, ARTN to GFRα3, and 
PSPN to GFRα4, all of which are GFL family receptors (Airaksinen et al., 2006). 
-Functions. GDNF acts in the support of CNS and PNS neurons by promoting their 
survival and differentiation (Fielder et al., 2018). In addition, GDNF is implicated in the process 
of neuronal networking and synapse plasticity (Hibi et al., 2009). Moreover, GDNF also have a 
role in progenitor cell differentiation into astrocytes (Boku et al., 2013). Furthermore, GDNF 
plays neuroprotective functions in the survival of neurons from substantia nigra in PD (Kirik et 
al., 2004). 
 
3.3.6.2.4. IGF-1: IGF-1 (Insulin Growth Factor-1) is a 70-amino-acid polypeptide hormone 
which shares structural features with insulin (Laron, 2001). 
-Expression. IGF-1 is produced in many tissues including the brain (Sell, 2015; Wrigley et 
al., 2017). In addition, in developmental brain, mRNA for IGF-1 is expressed in many regions of 
the adult brain, such as the hippocampus, olfactory bulbs and cerebellum (Bondy and Lee, 
1993; Werther et al., 1990). However, adult expression of IGF-1 is mainly limited to the 
neurogenic niches (Wrigley et al., 2017). In addition, circulating IGF-1 can cross the BBB and 
influence the brain (Ozdemir et al., 2012). 
-Microglial production. Cultured microglia express IGF1 mRNA and produce IGF1 protein 
at ranges of pg/ml (Suh et al., 2013). In addition, microglia cells have also shown to produce 
IGF-1 in vivo (Ziv and Schwartz, 2008). 
-Receptors. IGF-1 binds to the type 1 IGF receptor, although it also presents affinity for 
the insulin receptor (Werner and LeRoith, 2014). The IGF-1 receptor is found throughout the 
body, consistent with its diverse range of actions. In the brain, IGF-1 receptors are expressed in 
the hippocampus, olfactory bulbs, hypothalamic areas, and in ependymal and epithelial cells of 
the choroids plexus (Richardson et al., 2017). 
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-Functions. IGFs is a trophic factor that enhances proliferation of CNS neuroprogenitors 
(Arsenijevic et al., 2001; Learish et al., 2000). Moreover, IGF-1 affects neuronal maturation at 
different steps, including neurotransmitter production and electrical activity (Torres-Aleman, 
1999). IGF-1 exerts a large variety of actions on neural linage cells, which includes a reduction 
of the neuroprogenitors cell cycle or even an enhancement in the proliferation of neural cell 
types (Ye and D'Ercole, 2006). In the adult brain, IGF1 modulates the activity of neural 
circuitries and the strength of the synapses (Llorens-Martin et al., 2009). In addition, IGF-1 has 
been proposed as one of the mediators of the effect of physical exercise in adult neurogenesis 
(Ziv and Schwartz, 2008). 
 
3.3.6.2.5. PDGF-a: Platelet-derived growth factor (PDGF) family comprises four 
polypeptide chain isoforms that are encoded by different genes (PDGF-A, -B, -C and –D) and 
form both homo and heterodimers (Heldin, 2012).  
-Expression. PDGF is produced by a wide range of cells such as platelets, macrophages, 
muscle cells, etc. In addition, expression of the four chains is found within the nervous system 
(Andrae et al., 2008; Ishii et al., 2008; Zheng et al., 2010). 
-Microglial production. Microglial have been shown to release PDGF and its production 
is enhanced after ischemic stroke in vivo (Su et al., 2017). 
-Receptors. Two PDGF receptors have been described (PDGFR-α, -β), which bind to 
different chains (Heldin, 2012). Both PDGFR-α and PDGFR-β are expressed in neurons from 
cortex, retina or substantia nigra among others (Nait Oumesmar et al., 1997). 
-Functions. Role of PDGF and its receptors vascularization is essential for a correct 
development of CNS (Sil et al., 2018). Besides its well-known role in angiogenesis, PDGF-A 
plays an essential function in neuronal survival, especially in damaged brain areas (Krupinski et 
al., 1997). In addition, PDGFs can induce neural precursor cell differentiation into 
oligodendrocytes, neurons and astrocytes (Chojnacki et al., 2008; Chojnacki and Weiss, 2004). 
 
3.3.6.2.6. VEGF: Vascular endothelial growth factor (VEGF) is a heterodimeric 
glycoprotein which presents alternative posttranslational modifications, leading to the 
production of biochemically different proteins (Azam et al., 2010; Cursiefen et al., 2004; 
Ferrara, 2009). 
-Expression. VEGF is produced in a large variety of cell types such as platelets, 
keratinocytes, smooth muscle cells, etc. In the CNS VEGF is released by astrocytes, microglia 
and neuronal stem cells (Jin et al., 2016; Nowacka and Obuchowicz, 2012). 
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-Microglial production. Along with other glial cells, microglia produce VEGF in vivo (Jin 
et al., 2016; Krause et al., 2014). 
-Receptors. VEGF binds three receptor subtypes, VEGFR1, VEGFR2 and VEGFR3; 
however, in the nervous system, VEGFR2 is the mainly expressed receptor (Nowacka and 
Obuchowicz, 2012). 
-Functions. VEGF promotes proliferation and survival of endothelial cells and stimulates 
nitric oxidedependent vasodilation. It influences vasculature formation and increases vascular 
permeability (Azam et al., 2010; Carmeliet and Storkebaum, 2002). In the brain, VEGF 
participates in angiogenesis both in embryonic and postnatal development (Carmeliet and 
Storkebaum, 2002). Importantly, VEGF has emerged as a neuronal and glial trophic factor 
(Brockington et al., 2004). In the nervous system, VEGF participates in the induction of 
proliferation and migration of neural stem cells and neuroblast, as well as survival and 
maturation of neurons and axonal outgrowth (Fournier and Duman, 2012; Nowacka and 
Obuchowicz, 2012). VEGF can also influence a variety of complex processes in adult mice such 
as learning and memory (Cao et al., 2004). 
 
3.3.6.3. Matrix proteins 
 
 3.3.6.3.1. MMP-3: Matrix metalloproteinases (MMPs) are proteolytic enzymes that 
reshape of the extracellular matrix (ECM) (Seiki, 2002; Stamenkovic, 2003). MMP-3 is able to 
degrade a broad range of ECM proteins. Apart from this role, MMP-3 also activates different 
growth factors by cleavage, such as cytokes, chemokines or adhesion molecules (Van Hove et 
al., 2012).  
-Microglial production. Microglia is one of the few brain cells that express MMP-3, and 
this expression has been shown to be enhanced in AD in vivo (Brkic et al., 2015). 
-Expression. In the adult CNS, the level of MMP3 mRNA and protein are almost 
inexistent (Li et al., 2009) and MMP-3 expression is restricted to neurons and microglia in 
physiological conditions (Van Hove et al., 2012). 
-Functions. MMP-3 has been related to metastatic processes due to its degradatory 
nature; however, it also exerts multiple physiological roles during development and adulthood. 
In development, MMP-3 is implicated in migration, apoptosis and axonal growth in the 
remodeling process of the cerebellum (Vaillant et al., 2003) as well as in the formation and 
remodeling of synapses (Ethell and Ethell, 2007). In the adult, MMP-3 is associated to 
neuroprogenitor differentiation and migration (Barkho et al., 2008).  
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3.3.6.4. Membrane ligands 
 
3.3.6.4.1. Jag1: Jagged1 (Jag1) is a surface ligand that binds to Notch receptor (Zhou et 
al., 2010). 
-Expression. Jag1 is widely expressed in the brain, especially in the cortex, hippocampus 
and cerebellum (Stump et al., 2002). 
-Microglial production. There are very few reports studying Jag1 expression on 
microglia; however, those studies suggest a very limited Jag1 expression on these cells in vitro 
(Xing et al., 2013)  
-Receptors. A total of four Notch receptors have been described (Notch 1-4) in 
mammals that trigger their signaling after the direct cell-to-cell binding of different 
transmembrane ligands (Jagged1 and 2; Delta-like1, 3 and 4) (Zhou et al., 2010). 
-Functions. Jag1 promotes the differentiation of neuroprogenitor cells into astrocytes 
(Grandbarbe et al., 2003; Morrison et al., 2000). In addition, it limits neuron premature 
differentiation through the inhibition of proneural genes and increase of neuroprogenitor cell 
survival (Gaiano and Fishell, 2002; Lutolf et al., 2002). Jag1 is also implicated in the regulation 
of dendrite and axon growth and morphology (Mathieu et al., 2013). 
 
3.3.6.5. Cytokines  
 
3.3.6.5.1. Csf3: Colony stimulating factor 3 (Csf3), also termed granule-colony 
stimulating factor (G-CSF), is a small glycoprotein formed by several α helices (Wells et al., 
1996). 
-Microglial production. Along with the rest of the immune system cells, microglia also 
release Csf3 at least in vitro (Spanos et al., 2015). 
-Expression. Csf3 is released by wide range of cells such as bone marrow cells, 
fibroblasts or macrophages, upon different stimuli (Aloisi et al., 1992; Demetri and Griffin, 
1991). Importantly, Csf3 and its receptor (G-CSFR) are expressed in both the SVZ and the DG 
(Schneider et al., 2005). 
-Receptors. G-CSFR is expressed hematopoietic cells and also on neurons, endothelial 
cells, and glial cells (Boneberg et al., 2000; Schabitz et al., 2003). 
-Functions. Csf3 is a neuroprotective cytokine in the brain (Wallner et al., 2015). It has 
been shown to trigger anti-apoptotic pathways (Komine-Kobayashi et al., 2006) and 
proliferation in bone marrow stem cells (Jung et al., 2006). In addition, Csf3 promotes the 
differentiation of neural stem cells both in vitro and in vivo (Schneider et al., 2005). Moreover, 
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Csf3 exerts an anti-inflammatory role since it reduces levels of TNF-α (tumour necrosis factor 
α), the inhibition of iNOS (inducible nitric oxide synthase) activity or the decrease of IL-1β (Lu 
and Xiao, 2006).  
 
3.3.6.5.2. IL-1β: Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that belongs to the 
IL-1 family. 
-Expression. In the brain, IL-1β is released mainly by microglia, although astrocytes can 
also produce this cytokine; and the level of this cytokine are increase upon different stimuli 
such as injury or disease (Arguello et al., 2009; Pitossi et al., 1997). 
-Microglial production. The microglial IL-1β release is mainly documented in conditions 
of neuroinflammation both in vivo and in vitro (Smith et al., 2012).  
-Receptors. IL-1β binds to type I IL-1 receptor (IL-1RI). This receptor is activated upon 
the interaction with both cytokines IL-1α and IL-1β. In addition, a third ligand called Interleukin 
1 receptor antagonist (IL-1Ra) can also bind IL-1RI, but no signaling cascade is triggered 
afterwards, acting as an inhibitor (Dinarello, 2011; Weber et al., 2010). 
-Functions. An overproduction of IL-1β in the hippocampus during neuroinflammatory 
conditions contributes to decline hippocampal neurogenesis in many neurodegenerative and 
psychiatric disorders (Ye et al., 2013). In addition, IL-1β prevents neuron differentiation in the 
hippocampus (Mathieu et al., 2010). In physiological conditions the role of IL-1β is still not 
well understood and contradictory results have emerged regarding its implication in the 
induction of proliferation (Koo and Duman, 2008; Spulber et al., 2008). Moreover, there is 
some evidence suggesting that IL-1β is necessary for hippocampal dependent learning and 
memory (Goshen et al., 2007). Thus, additional studies are needed in order to understand the 
role of IL-1β in physiological conditions. 
 
3.3.6.5.3. IL-6: Interleukin-6 (IL-6) is a pleiotropic cytokine that can exert its function 
through two signaling pathways. In classical signaling, IL-6 binds to the α-receptor IL-6R, which 
triggers the dimerization with β-receptor gp130, promoting the downstream signaling pathway 
(Hibi et al., 1990). On the contrary, IL-6R can be cleaved and released as a soluble fraction (sIL-
6R) which will bind to IL-6. This complex can trigger the alternative pathway in cells that lack 
IL-6R but express gp130 (trans-signaling) (Rose-John and Heinrich, 1994). 
-Expression. IL-6 is produced by different immune cells such as T-, B-cells or 
macrophages and microglia, especially under neuroinflammatory conditions; and also by 
fibroblast, adipocytes or even neurons (Rothaug et al., 2016).  
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-Microglial production. Similar to IL-1β production, IL-6 released from microglia has 
been mainly studied in the context of inflammation and microglia activation in vivo and in vitro 
(Smith et al., 2012)  
-Receptors. In the brain, IL-6R is expressed in very limited cell types (immune cells 
mainly), but is not found on oligodendrocytes or astrocytes (Hsu et al., 2015; Lin and Levison, 
2009). On the other hand, gp130 is ubiquitously expressed on almost all cell types including 
glia and neurons (Rothaug et al., 2016). 
-Functions. The two signaling pathways result in both positive and negative effects in 
the brain. Classical signaling mainly plays a regenerative role in the tissue, whereas trans-
signaling mediates most of the traditionally studied detrimental consequences of this cytokine. 
IL-6 can both trigger neuronal degeneration (Campbell et al., 2005) as well as regeneration by 
promoting oligodendrocyte differentiation and acting as neurotrophic factor (Yang et al., 
2012). In addition, the lack of IL-6 signaling has also been implicated in both inflammation and 
neuroprotection (Klein et al., 1997; Penkowa et al., 1999). 
 
3.3.6.5.4. TGF-β: The human transforming growth factor-beta (TGF-β) family includes a 
large group of secreted proteins: TGF-βs themselves, activins, nodal, bone morphogenetic 
proteins and growth and differentiation factors (Morikawa et al., 2016). TGF-βs are 
synthesized as inactivated pre-pro-proteins that upon secretion are proteolytically activated 
(ten Dijke and Arthur, 2007). 
-Expression. In the CNS, TGF-β2 and TGF-β3 are found in the NSCs, mature astrocytes 
and numerous neuron populations. TGF-β1 is expressed in the meninges and the choroid 
plexus as in astrocytes and microglia (Wachs et al., 2006). Moreover, after traumatic spinal 
cord injury, TGF-β1 and TGF-β2 are up-regulated in neurons (Buss et al., 2008). 
-Microglial production. Similar to other cytokines, microglia release TGF-β, especially 
under inflammatory stimuli, lesions or pathology in vitro and in vivo (Wachs et al., 2006). 
-Receptors. There are three different TGF-β receptors, TGFBRI, TGFBRII and TGFBRIII. 
TGF-β can bind to either TGFBRII directly or TGBRIII, which will result in the presentation of 
TGF-β to TGFBRII. Afterwards, TGFBRII recruits TGFBRI in order to trigger the downstream 
signaling pathway (Blobe et al., 2001). In the normal CNS, TGF-β receptors are expressed by 
neurons, astrocytes and microglia (Lane et al., 2007). 
-Functions. TGF-β can exert dual functions in the CNS. During hippocampal 
neurogenesis, TGF-β promotes cell cycle exit of the neuroprogenitor cells and neuronal 
differentiation (Vogel et al., 2010). Nevertheless, TGF-β also plays negative effects on 
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neurogenesis, since an overexpression can result in a decreased proliferation of 
neuroprogenitor cells (Buckwalter et al., 2006; Wachs et al., 2006).  
 
3.3.6.5.5. TNF-α: Tumor necrosis factor alpha (TNF-α) belongs to the large TNF ligand 
superfamily and is generally produced a precursor transmembrane-associated TNF-α protein 
that is proteolytically cleaved into a soluble TNF-α homotrimer (Wajant et al., 2003). Both 
transmembrane and soluble forms are biologically active (Montgomery and Bowers, 2012). 
-Expression. TNF-α is synthesized in many cell types, including immune cells and non-
immune cells such as endothelial cells, fibroblasts, etc. Within the CNS, microglia, astrocytes 
and neurons can release TNF-α (Hanisch, 2002; Klintworth et al., 2009; Lau and Yu, 2001). 
-Microglial production. In the CNS, microglia is one of the cell sources of TNF-α, and its 
production is enhanced upon an immunological stimulus in vitro and in vivo (Garden and 
Moller, 2006; Klintworth et al., 2009).   
-Receptors. Two transmembrane glycoprotein receptors have been reported: TNF-
receptor 1 (TNF-RI) and TNF-receptor 2 (TNF-RII). Both receptors are differentially expressed 
and controlled (Montgomery and Bowers, 2012). TNF-RI is constitutively expressed on the 
majority of the cells, except for erythrocytes. On the other hand, TNF-RII expression is 
triggered after an inflammatory stimulus on hematopoietic lineage cells (McCoy and Tansey, 
2008).  
-Functions. Classically, TNF-α binding to TNF-RI has been related to an increase of 
apoptosis and cytotoxicity, whereas binding to TNF-RII has mostly been associated with 
survival and proliferation. This dual role of TNF-α is also observed in adult neurogenesis. Upon 
binding to TNF-RI, hippocampal NSC proliferation is decreased and cell death is enhanced, 
which results in an inhibition of adult neurogenesis (Cacci et al., 2005). On the contrary, when 
TNF-α is bound to TNF-RII, it triggers the increase in proliferation and survival of NSCs, leading 
to a maintenance of neurogenesis (Iosif et al., 2006). Thus, TNF-α can exert both beneficial and 
detrimental effects in adult hippocampal neurogenesis, which result upon the binding to 
different receptors. 
 
3.3.6.6. Metabolic products 
 
3.3.6.6.1. Lactate: L-lactate is the monosaccharide compound that result from the 
fermentation of pyruvate during both normal metabolism and exercise. 
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-Production. Different cell types produce lactate in basal conditions, such as 
erythrocytes, hepatocytes or skeletal myocytes (Phypers et al., 2006). In the physiological CNS, 
astrocytes are the main lactate source (Bonvento et al., 2005; Choi et al., 2012). 
-Microglial production. Both microglia and macrophages can release lactate; however, it 
has only been studied in the context of inflammation associated activation in vitro (Kelly et al., 
2015; Tsukada et al., 2014). 
-Receptors. Lactate can enter a cell via different monosaccharide transporters in order 
to be used as fuel (Choi et al., 2012). In addition, in the recent years, a specific receptor for 
lactate have been describe, the G protein coupled receptor 81 (GPR81), which is especially 
localized in hippocampus, cortex and cerebellum and it has been mainly reported to be 
expressed by neurons (Morland et al., 2015). 
-Functions. Lactate had classically been considered just a waste product of metabolism, 
however, it is currently considered an important source of energy for many cells. In addition, 
lactate does not only play a role in metabolism, but it also exerts hormone functions and it has 
been related to memory formation and neuroprotection (Proia et al., 2016). Lactate supports 
synaptic function and promotes long-term potentiation (Cater et al., 2001; Skriver et al., 2014). 
Moreover, upon glucose deprivation, lactate protects tissue integrity and reestablishes neuron 
excitability (Ainscow et al., 2002; Cater et al., 2001). In addition, lactate might also support 
neurogenesis in vivo (Alvarez et al., 2014), however, further research is required. 
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4. HYPOTHESIS AND OBJECTIVES  
 
During adult hippocampal neurogenesis, the majority of the newborn cells die by 
apoptosis and are rapidly and efficiently eliminated by microglia in the process termed 
phagocytosis (Sierra et al., 2010). In this study, we hypothesize that microglial phagocytosis is 
not merely the end point of the elimination of apoptotic cells, but has an active role in 
maintaining homeostasis of the neurogenic cascade by triggering a coordinated 
neuromodulatory program in microglia, which contributes to the maintenance and correct 
regulation of the neurogenic niche. 
 
Aim 1. To develop an in vitro model of phagocytosis of apoptotic cells that mimics 
phagocytosis in vivo. For this purpose we will first study the phagocytosis cargo identity; early 
engulfment; and presence of key opsonizing molecules in physiological conditions in order to 
translate this information to an in vitro model of phagocytosis. Afterwards we will set up our in 
vitro model of phagocytosis in which primary microglia will be fed with different (mouse or 
human) neuronal lines that have been previously treated with staurosporine to induce 
apoptosis. Microglial phagocytosis of apoptotic cells will be quantified by immunofluorescence 
by confocal microscopy.  
 
Aim 2. To study the transcriptional changes induced by phagocytosis of apoptotic cells 
in microglia in vitro. For this purpose we will perform a full genome wide transcriptomic 
analysis of naïve and phagocytic microglia using the in vitro model of phagocytosis set up in 
Aim 1. We will perform a functional analysis of the phagocytic microglia transcriptome by using 
three different bioinformatic platforms (DAVID, ClueGO, and IPA). 
 
Aim 3. To identify the molecules expressed by phagocytic microglia that could 
potentially modulate neurogenesis. For this purpose we will use the information obtained 
from the transcriptomic analysis performed in Aim2. We will perform an initial filtering by 
differentiating those genes whose protein would exert their function outside the expressing 
cell (heterologous) and genes that would act directly on the cell expressing them (autologous) 
in the MANGO database (The Mammalian Adult Neurogenesis Gene Ontology). Then, GO 
terms related to neurogenesis will be selected for the heterologous MANGO genes. 
Afterwards, we will search back in the array in order to find the molecules that present the 
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neurogenic GO terms. Finally, the genes will be filtered only to select those that appeared 
extracellularly (heterologous genes). 
 
Aim 4. To analyze the effects of the factors secreted by phagocytic microglia on 
neurogenesis in vitro. For this purpose we will collect conditioned media from naïve and 
phagocytic microglia using the model from Aim 1 and we will test its effects in vitro on 
neuroprogenitor cells obtained from disaggregated neurospheres. Neuroprogenitor cells will 
be treated with naïve or phagocytic microglia conditioned media and the cell marker 
expression and morphology of the resulting cells will be analyzed by immunofluorescence and 
confocal microscopy. In addition, the resulting cells will be also subjected to calcium imaging 
under different stimuli in order to perform a further characterization of these cells. 
 
Aim 5. To discriminate the role of cytokines released by phagocytic microglia on 
neurogenesis in vitro. For this purpose we will collect the conditioned media of LPS-treated 
primary microglia and we will compared the cell phenotypes produced by the LPS-treated 
conditioned media with the ones observed in phagocytic microglial conditioned media in the 
model of neurogenesis in vitro from Aim 4. 
 
Aim 6. To identify the specific factors secreted by phagocytic microglia that trigger the 
effects on neurogenesis in vitro. For this purpose we will focus in the two most promising 
neuromodulatory molecules expressed by phagocytic microglia obtained in Aim 3, VGF and 
lactate. We will validate their production and secretion by inmunofluoresce and/or ELISA and 
in order to test whether these molecules could be responsible of the cell phenotypes obtained 
with microglial conditioned media (Aim 4). 
 
Aim 7. To validate the neuromodulatory program of phagocytic microglia in vivo. For 
this purpose we will perform single-cell RNA sequencing in order to compare a population 
enriched in phagocytic microglia isolated from the dentate gyrus, where there is ongoing 
neurogenesis and therefore apoptosis, with non-phagocytic microglia isolated from the CA 
region of the hippocampus, where there is no neurogenesis and therefore no apoptosis. 
 
Aim 8. To analyze the effects of the factors secreted by phagocytic microglia on 
neurogenesis in vivo. For this purpose we will infuse the conditioned media obtained for Aim 4 
into the hippocampus of 1 month old mice using osmotic pumps in order to analyze the effects 
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of the factors secreted by phagocytic microglia. All parameters regarding neurogenesis will be 
quantified by immunofluorescence in mouse tissue sections imaged by confocal microscopy.  
 
Aim 9. To develop new strategies in order to validate the relevance of phagocytic 
microglia in neurogenesis in vivo. For this purpose we will characterize several phagocytic and 
purinergic receptors in a microglia impaired model (via administration of the glutamate agonist 
kainic acid) in FACS-sorted microglia by RT-qPCR. In addition, glutamatergic receptor subunits 
will also be characterized in order to unravel the mechanism of communication between 
microglia and the neurogenic niche. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. EXPERIMENTAL PROCEDURES 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  EXPERIMENTAL PROCEDURES 
75 
 
5. EXPERIMENTAL PROCEDURES 
 
5.1. ANIMALS 
All experiments were performed in fms-EGFP (MacGreen) mice, except for some of the 
experiments involving administration of microglial conditioned media, which were performed 
in Nestin-GFP (Encinas et al., 2006; Mignone et al., 2004) and single-cell RNA sequencing 
experiments, which were performed in CX3CR1GFP/+ mice, respectively. In both fms-EGFP 
(Sasmono et al., 2003; Sierra et al., 2007) and CX3CR1GFP/+ mice (Jung et al., 2000), all 
microglia express the fluorescent reporter. All mice used were in a C57BL/6 background. Mice 
were housed in 12:12h light cycle with ad libitum access to food and water. All procedures 
followed the European Directive 2010/63/EU and NIH guidelines, and were approved by the 
Ethics Committees of the University of the Basque Country EHU/UPV (Leioa, Spain; 
CEBA/205/2011, CEBA/206/2011, CEIAB/82/2011, CEIAB/105/2012). 
 
5.2. CELL CULTURES 
 
5.2.1. NE-4C cell line 
NE-4C (American Type Culture Collection), a mouse neural stem cell line derived from 
the cortex of 9 day old (P9) tumor protein 53 (p53, a tumor suppressor gene) knock-out 
embryos was used for phagocytic assay experiments. NE-4C cells were grown as an adherent 
culture in Poly-L-lysine-coated (15µl/ml, Sigma) culture flasks covered with 10-15ml of 
medium. The medium consisted on Minimum Essential Medium (MEM, Gibco), supplemented 
with 1% Glutamax, 2,5% Fetal Bovine Serum (FBS) and 1% antibiotic/antimycotic (all from 
Gibco). When confluency was reached, cells were trypsinized and replated at 1:4.  
 
5.2.2. SH-SY5Y cell line 
SH-SY5Y (American Type Culture Collection), a human neuroblastoma cell line derived 
from the bone marrow of 4 year-old female was used for phagocytic assay experiments. SH-
SY5Y cells were grown as an adherent culture in non-coated culture flasks covered with 10-
15ml of medium. The medium consisted on Dulbecco's Modified Eagle Medium (DMEM, 
Gibco), supplemented with 10% Fetal Bovine Serum (FBS) and 1% antibiotic/antimycotic (all 
from Gibco). When confluency was reached, cells were trypsinized and replated at 1:4.  
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5.2.3. BV2 cell line 
BV2 (Interlab Cell Line Collection San Martino-Instituto Scientifico Tumori-Instituto 
Nazionale per la Ricerca sul Cancro), a cell line derived from raf/myc-immortalized murine 
neonatal microglia was used to obtain LPS induced condition media. BV2 cells were grown as 
an adherent culture in non-coated culture flasks covered with 10-15ml of medium. The 
medium consisted on Dulbecco's Modified Eagle Medium (DMEM, Gibco), supplemented with 
10% Fetal Bovine Serum (FBS) and 1% antibiotic/antimycotic (all from Gibco). When confluency 
was reached, cells were trypsinized and replated at 1:4.  
 
5.2.4. Primary Microglia Cultures 
Primary microglia cultures were performed as previously described (Abiega et al., 2016; 
Beccari et al., 2018). Postnatal day 0-1 (P0-P1) fms-EGFP mice pup brains were extracted and 
the meninges were peeled off. The olfactory bulb and cerebellum were discarded and the rest 
of the brain was then mechanically homogenized by careful pipetting and enzymatically 
digested with papain (20U/ml, Sigma), a cysteine protease enzyme, and deoxyribonuclease 
(DNAse; 150U/µl, Invitrogen) for 15min at 37ºC. The resulting cell suspension was then filtered 
through a 40μm nylon cell strainer (Fisher) and transferred to a 50 ml Falcon tube quenched by 
5 ml of 20% Fetal Bovine Serum (FBS; Gibco) in HBSS. Afterwards, the cell suspension was 
centrifuged at 200 g for 5 min, the pellet was resuspended in 1ml Dulbecco’s Modified Eagle’s 
Medium (DMEM, Gibco) complemented with 10% FBS and 1% Antibiotic/Antimycotic (Gibco), 
and seeded in Poly L-Lysine-coated (15μl/ml, Sigma) culture flasks with a density of two brains 
per flask. Medium was changed the day after and then every 3–4 days, always enriched with 
granulocyte-macrophage colony stimulating factor (5 ng/ml GM-CSF, Sigma), which promotes 
microglial proliferation. After confluence (at 37°C, 5% CO2 for approximately 14 days), 
microglia cells were harvested by shaking at 100-150 rpm, 37°C, 4 h. Isolated cells were 
counted and plated in a density of 80.000 cell/well on poly-l-lysine-coated glass coverslips in 
24-well plates for immunofluoresce purposes or 1.000.000 cell/dish on coated Petri dishes for 
RT-qPCR and Western Blot. Microglia were allowed to settle for at least 24h before any 
experiment.  
 
5.2.5. Neurospheres cell culture 
Neurospheres cultures were performed as previously described (Babu et al., 2011) with 
some modifications. Briefly, P0-P1 fms-EGFP pups were decapitated and the brains extracted 
and placed in cold HBSS. The homogenization process was performed as detailed in section 
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5.2.4, except that no FBS was used in any step in order to avoid undesired neurosphere 
adhesion and differentiation. Afterwards, the cell suspension was centrifuged at 200 g for 5 
min, the pellet was resuspended in 1ml DMEM/F12 with Glutamax (Gibco) supplemented with 
1% Penicillin/Streptomycin, 1% B27, EGF (12,5 ng/ml), FGF-2 (5 ng/ml) (Xapelli et al., 2013). 
Cells were plated on uncoated Petri dishes (P60 aprox. 28 cm2), each brain was plated in 4 
Petri dishes with supplemented DMEM/F12. After six days, neurospheres were then 
disaggregated into a single cell suspension using NeuroCult chemical dissociation kit following 
manufacturer’s instructions and each Petri dish was plated in two 6-multiwell plates. In order 
to maintain replicability through the experiments, neurospheres were frozen until their use at 
-80ºC in 15% DMSO after the first passage.  
 
5.3. IN VITRO PHAGOCYTOSIS ASSAY  
Microglia were allowed to rest and settle for at least 24h before phagocytosis 
experiments. Primary microglia cells were fed for different time points with NE-4C or with SH-
SY5Y. Both cell lines were previously labeled with the membrane marker CM-DiI (5μM; 10 min 
at 37°C, 15 min at 4°C; Invitrogen) and treated with staurosporine (1μM for NE-4C or 1,5uM for 
SH-SY5Y, 4h; Sigma) to induce apoptosis. Apoptotic cells were added to the microglial cultures 
in a proportion 10:1 approximately. Apoptotic cells were visualized and quantified by trypan 
blue in a Neubauer chamber. Because cell membrane integrity is still maintained in early 
induced apoptotic cells, cells not labeled with trypan blue were considered apoptotic. The 
media of naïve and phagocytic (24h) microglia was immediately stored at -80ºC until its use as 
conditioned media for neuroprogenitor cells. 
 
For the physiological phagocytosis assay, apoptosis of SH-SY5Y was induced with 3µM 
STP (4h) and only the floating dead cell fraction was collected from the supernatant and added 
to the primary microglia cultures in a proportion of 1:1 approximately. As in 10:1 paradigm, 
apoptotic cells were quantified by trypan blue staining in a Neubauer chamber and non-
labeled cells were considered apoptotic. 
 
In some experiments, control and phagocytic microglia were treated with LPS. Three 
different LPS paradigms were used. In the low LPS concentration paradigm, media was 
removed and fresh medium with 150 ng/ml LPS or vehicle (PBS) was added for 18 hours to 
primary microglia (Fraser et al., 2010). In the high LPS concentration paradigm, media was 
removed and fresh medium with 1 µg/ml LPS or vehicle (PBS) was added for 24h to primary or 
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BV2 cells (Monje et al., 2003). In order to control for LPS presence in the phagocytic media, a 
third paradigm was performed in which primary microglia was treated with 1 µg/ml LPS or 
vehicle (PBS) for 6h, then media was changed into fresh media for another 18h. All 
supernatants were collected and stored at -80ºC until its use as conditioned media for 
neuroprogenitor cells, and all of them were filter-sterilized prior to adding to the 
neuroprogenitor cell culture. 
 
5.4. DETECTION OF DIFFERENT MOLECULES IN THE MICROGLIAL 
CONDITIONED MEDIA 
 
5.4.1. VGF protein detection 
VGF protein levels in microglia conditioned media were detected by a quantitative 
sandwich enzyme-linked immunosorbent assay (ELISA) kit following manufacturer’s 
instructions (Cloud-Clone). Briefly, plates were pre-coated with an antibody specific to VGF. 
Standards and samples were added to a microplate and detected with a biotin-conjugated 
antibody specific to VGF. Next, Avidin conjugated to Horseradish Peroxidase (HRP) was added 
to each well and incubated. After TMB substrate solution was added, only wells containing 
VGF, biotin-conjugated antibody and enzyme-conjugated Avidin exhibited a change in color. 
The enzyme-substrate reaction was terminated by the addition of sulphuric acid solution and 
the color change was measured spectrophotometrically at a wavelength of 450nm. The 
concentration of VGF in the samples was then determined by comparing the optical density of 
the samples to the standard curve. Cortex and serum were used as positive and negative 
controls respectively. Different sample dilutions were tested prior to the experiment. 
 
5.4.2. Lactate levels detection 
 Lactate levels in microglia conditioned media were detected by L-lactate assay kit 
(Colorimetric) (Abcam) following manufacturer’s instructions. Briefly, protein was removed 
from the samples using the deproteinizing sample preparation kit – TCA (trichloroacetic acid; 
Abcam). Next, standards and samples were added to a flat-bottom well plate. Then wells were 
incubated for 30 mins with the reaction mix containing lactate assay buffer, lactate substrate 
mix, and lactate enzyme mix. Finally, the color change was measured spectrophotometrically 
at a wavelength of 450nm 
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5.5. NEUROPROGENITOR PROLIFERATION AND DIFFERENTIATION 
Neurospheres of passage 1 were thawed and expanded for a week prior to the 
experiment in proliferative conditions (two passages were performed in total).The day of the 
experiment passage 3 neurospheres were dissociated, cells were counted and plated at a 
80,000 cell/well density on poly-L-lysine coated glass coverslips in 24-well plates in 
supplemented (Penycillin/streptomycin, B27, EGF, and FGF2) DMEM/F12. Neuroprogenitors 
were allowed to proliferate for 48h (Babu et al., 2011) and then were treated with conditioned 
media from control or phagocytic (24h) microglia. The experimental group DMEM was also 
added as control because it is the media in which microglia is grown. Neuroprogenitors were 
then fixed with 4% PFA for 10 mins at 3d, and 5d of differentiation. 
 
For pluripotency experiments, neuroprogenitors treated for 3d with conditioned media 
(control, 24h phagocytosis of DMEM) were transferred back to DMEM/F12 (without trophic 
factors) medium and were allowed to differentiate for 5d and 9d.  
 
For late survival and differentiation assay, after the 48h of proliferation, 
neuroprogenitors were allowed to differentiate in DMEM/F12 (no trophic factors) for 10d and 
then were treated with conditioned media from control or phagocytic (24h) microglia or 
DMEM for another 3 and 5d. 
 
5.6. CALCIUM IMAGING 
Intracellular calcium imaging experiments were performed as described before (Alberdi 
et al., 2013). CM-treated neuroprogenitors were incubated and loaded with 5 µM Fura-2 AM 
(Invitrogen) for 30 min at 37°C and then washed in HBSS containing 20 mM HEPES, pH 7.4; 10 
mM glucose; and 2 mM CaCl2 for 10 min at room temperature. The perfusion chamber was 
assembled on the platform of a Zeiss (Oberkochen) inverted epifluorescence microscope 
(Axiovert 35) equipped with a 150-W xenon lamp Polychrome IV (TILL Photonics, Martinsried, 
Germany) and a Plan Neofluar 40× oil immersion objective (Zeiss). Neuroprogenitor cells were 
treated with 50mM KCl, 10µM AMPA, 1mM ATP and 100µM Histamine sequentially. Cells were 
allowed to recover their baseline prior to adding the next compound. Cells were visualized 
with a digital black/white CCD camera (ORCA; Hamamatsu Photonics Iberica, Barcelona, 
Spain). Intracellular calcium signaling responses were calculated as the proportion of different 
cell phenotype responding to the different stimuli. The baseline was calculated as the mean of 
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the first 60sec of recording for each cell. Only peaks that increase or decrease 3 times the SEM 
of the baseline were considered as response.  
 
5.7. FACS SORTING  
Microglia cells were isolated from brains as described previously (Abiega et al., 2016; 
Sierra et al., 2007). The corresponding tissues from fms-EGFP mice were dissected and placed 
in enzymatic solution (116 mM NaCl, 5.4 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 1.5 mM 
CaCl2,1mM MgSO4 , 0.5 mM EDTA, 25 mM glucose, 1 mM L-cysteine) with papain (20 U/ml) 
and DNAse I (150 U/μl, Invitrogen) for digestion at 37ºC for 15 min. The homogenization 
process was also helped by careful pipetting. After homogenization, tissue clogs were removed 
by filtering the cell suspension through a 40μm nylon strainer to a 50 ml Falcon tube quenched 
by 5 ml of 20% heat inactivated FBS in HBSS. For further enrichment of microglia, myelin was 
removed by using Percoll gradients. For this purpose, cells were centrifuged at 200 g for 5 min 
and resuspended in a 20% Solution of Isotonic Percoll (20% SIP; in HBSS), obtained from a 
previous stock of SIP (9 parts Percoll per 1 part PBS 10X). Then, each sample was layered with 
HBSS poured very slowly by fire-polished pipettes. Afterwards, gradients were centrifuged for 
20 min at 200 g with minimum acceleration and no brake so the interphase was not disrupted. 
Then the interphase was removed, cells were washed in HBSS by centrifuging at 200 g for 5 
min and pellet was resuspended in 500μl of sorting buffer (25 mM HEPES, 5 mM EDTA, 1% 
BSA, in HBSS). Microglia cell sorting was performed by FACS Jazz (BD), in which the population 
of green fluorescent cells was selected, collected in Lysis Buffer (Qiagen) containing 0.7% β-
mercaptoethanol and stored at −80ºC until processing. 
  
5.8. ADMINISTRATION OF MICROGLIA CONDITIONED MEDIA IN VIVO 
Conditioned media from control and phagocytic (Ph24h) microglia was administrated via 
osmotic pumps for 6d to 2mo fms-EGFP mice. Briefly, osmotic pump (Model 2001; flow rate 
1µl/h; Alzet) and infusion catheter tubes (Alzet) were filled with the conditioned media 
(200µl), and connected together. Pumps were incubated overnight at 37ºC in PBS before the 
surgery. Mice were anesthetized with ketamine/xylazine (10/1 mg/kg) and received a single 
dose of the analgesic buprenorphine (1 mg/kg) subcutaneously. The infusion cannulae were 
inserted at anteroposterior −1.7 mm (AP), laterolateral (LL) −1.6 mm, and −1.9 mm 
dorsoventral (DV) from Bregma. Afterwards, a surface of dental cement was created from the 
cannulae to the screw to avoid any unwanted removal of the cannulae. Osmotic pumps were 
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inserted inside the skin of the mice. After 6d, mice were intraperitoneally injected with BrdU 
(150mg/kg, single injection), and transcardically perfused 2h later to assess proliferation. 
 
For differentiations experiments, CM containing osmotic pumps were inserted for 6d to 
2mo fms-EGFP or Nestin-GFP negative mice. Pumps were removed at 6d and afterwards, a 
single injection of BrdU (150mg/kg) was administered, and mice were sacrificed 28d later. 
 
5.9. KAINATE ADMINISTRATION 
Intrahippocampal administration of kainate (KA) was performed as previously described 
(Abiega et al., 2016). Briefly, 2 mo fms-EGFP mice were anesthetized with ketamine/xylazine 
(10/1 mg/kg) and buprenorphine (1 mg/kg) was administered subcutaneously as analgesic. A 
0.6 mm hole was drilled and a glass microcapillary was inserted at AP -1.7 mm, LL -1.6 and DV -
1.9 mm in order to administer 50 nl of either saline of KA (20 mM) into the right hippocampus 
using a microinjector (Nanoject II, Drummond Scientific, Broomal, PA, US). Mice were sacrifice 
at 24h after the injection for FACS sorting. 
 
5.10. GENE EXPRESSION ARRAYS 
Gene arrays analysis was performed following the recommendations of the MIAME 
(Minimum Information About a Microarray Experiment) consortium (Brazma et al., 2001).  
 
Cell samples were lysed and kept at -80C until processing. Total RNA was isolated using 
PureLink RNA Mini kit (AMBION), following manufacturer´s instructions. RNA amount was 
quantified in a UV/VIS NanoDrop 1000 spectrophotometer (Thermofisher), and its integrity 
was analyzed with Lab-chip technology in an Agilent 2100 Bioanalyzer in combination with 
Agilent RNA 6000 Nano Chips. Eukaryote Total RNA Nano Assay was used as type of test. In all 
samples, RIN>9.3, and 28S/18S>1.3 values were obtained (Table 1). Sample labeling, 
hybridization and scanning Gene expression profiling was performed at the Gene Expression 
Unit of Genomics Core Facility (SGIKer) of the University of the Basque Country UPV/EHU. 
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Sample ng/ml A260/A280 A260/A230 RIN 28S/18S 
Control micro1 55.85 2.06 1 9.5 1.6 
Control micro2 60.47 1.96 1.06 9.7 1.6 
Control micro3 57.63 2.04 0.67 9.7 1.3 
SH1 Ph3h 117.95 2.06 1.72 9.7 1.8 
SH2 Ph3h 106.95 2.11 1.86 9.6 1.6 
SH3 Ph3h 121.71 2.11 1.68 9.7 1.8 
SH1 Ph24h 92.11 2.03 1.52 9.6 1.8 
SH2 Ph24h 80.9 2.1 1.35 9.6 1.7 
SH3 Ph24h 85.47 2.06 1.78 9.5 1.8 
Table 1. Characteristic of samples used for gene arrays. Concentration, A260/A280 ratio and A260/230 
ratio of naïve and phagocytic (3h, 24h) microglia samples used for gene arrays were measured by 
Nanodrop 2000, and RNA integrity (RIN and 28, 18 ribosomal subunits) were measured in a Agilent 2100 
Bioanalyzer. 
 
One-color microarray-based gene expression analysis was performed following the One-
Color (p/n5190-2305) protocol from Agilent Technologies (Low Input Quick Amp Labeling kit) 
for the labeling of the samples. First, 50 ng of total RNA were retrotranscribed with the 
AffinityScript Reverse enzyme Transcriptase (AffinityScript RT), a thermostable modified 
enzyme derived from Moloney murine leukemia virus retrotranscriptase (Moloney Murine 
Leukemia Virus (MMLV) reverse transcriptase), using promoter-coupled Oligo dT primers Of 
T7. The double-stranded cDNA synthesized by AffinityScript RT was transcribed in vitro by the 
T7 RNA pol in the presence of Cy3-CTP to generate labeled and amplified cRNA. The labeled 
samples were purified with columns of RNeasy Mini kit (Qiagen). Subsequently the labeled 
samples were quantified in the Nanodrop ND-1000 to determine the performance of the 
specific activity of the fluorochromes after labeling. All the hybridized samples met the 
following minimum requirements: Yield> 0.825 µg per reaction and Cyanine 3 specific activity> 
6 pmol / µg.  
 
For the hybridization, 600 ng of labeled cRNA were fragmented and co-hybridized to 
SurePrint G3 Mouse GE 8x60K Microarray Design ID: 028005. Each array/slide contained 8 
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identical subarrays of more than 60.000 60-mer oligonucleotides of high resolution and 
performance. It contained probes for 55.681 sequences or transcripts (biological features or 
non-control features). Several of these biological probes were replicated 10 times for the 
calculations and quality control measurements (QCMetrics) of the microarrays. It also 
contained probes for internal positive controls (spike-ins), which were added to the RNA 
sample before labeling and were used for evaluation and verification of the microarray 
processing. Manual washing method was performed following Agilent’s recommendations to 
prevent ozone-related problems.  
 
Slides were scanned on a G2565CA Microarray DNA Scanner from Agilent Technologies 
with a resolution of 3 µm and a Tiff image size of 20bit, using the Scan software version 8.5.1 
with default settings (Scan profile AgilentG3_GX_1color). The scanned TIFF images were 
processed and the fluorescence of the probes quantified using The Agilent Feature Extraction 
Software 10.7.3.1 (Agilent Technologies). Feature Extraction (FE) protocol for data extraction: 
GE1_107_Sep09, Design File: 28005_D_F_20140728. Software extracts information of the raw 
fluorescence signal (mean signal) for the fluorochrome or channel (Cy3: green Channel) from 
the spot containing the probes (positive and negative controls and no controls or biological 
feature) and the background, obtained from the negative controls (which contains sequences 
for which no hybridization is expected, non-specific binding indicators).  
 
Default parameters (The Agilent Feature Extraction Software 10.7.3.1) for one-color 
gene expression microarrays were used for flagging of non-uniform features, population 
outliers for replicated probes, and features with no significant intensities in Cy3 channel. 
Agilent Feature Extraction (AFE) raw data was processed with software GeneSpring GX 13.0 
(Agilent Technologies). Probes not present in any sample were filtered out. A list of the filtered 
36.665 probes was used in the statistical analysis. 
 
5.10.1. Statistical analysis  
To analyze the differential expression between naïve (t=0) and phagocytic (t=3h and 
t=24h) microglia groups over time the statistical analysis the maSigPro package of 
R/Bioconductor was used (R version 3.0.3, Bioconductor release version 2.13, maSigPro 
version 1.34.1). This method is based on a general regression approximation for the modeling 
and adjustment of the parameters required according to the type of analysis. The parameter 
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"Time" is considered as a continuous variable, and creates a regression model of the gene 
response. 
 
The analysis was performed in three steps. First genes that exhibited changes in 
expression over time were selected based on a p-corrected Benjamini-Hochberg (FDR) value. 
Secondly, for each of the genes that presented a significant change in their expression over 
time a regression was applied to determine their model in order to identify patterns or models 
of change based on time variables, obtaining 20,800 probes. Finally, the probes were selected 
according to their fit to the regression model. Next, the number of genes with a very high 
differential pattern was reduced by applying a more restrictive criterion (R-squared (rsq)> 0.9), 
obtaining 13,146. The rsq>0.7 list was used for the identification of neurogenesis related genes 
and the rsq>0.9 list was used for the study of transcriptional profile of phagocytic microglia. 
 
5.11. FUNCTIONAL ANALYSIS OF PHAGOCYTIC MICROGLIAL 
TRANSCRIPTOME 
 
5.11.1. Database for Annotation, Visualization and Integrated Discovery 
(DAVID) 
The Database for Annotation, Visualization and Integrated Discovery (DAVID) 
(https://david.ncifcrf.gov/) v6.8 provides a comprehensive set of functional annotation tools to 
understand biological meaning behind large list of genes. DAVID was used to generate a gene-
GO term enrichment analysis that identified enriched biological themes and to highlight the 
most relevant GO terms associated with the array gene list. The array gene list of rsq> 0.9 was 
used for this gene profile analysis. The analysis of each expression pattern was performed 
separately and only terms with an adjusted p-value (Benjamini-Hochberg) > 0.05 were 
considered significant. 
  
5.11.2. ClueGO 
ClueGO was used to generate protein pathways and to constitute the network of 
pathways based on the Gene Ontology and KEGG database (Bindea et al., 2013; Bindea et al., 
2009). ClueGO is a plugin of Cytoscape (http://www.cytoscape.org/) that visualizes the non-
redundant biological terms for large clusters of genes in a functionally grouped network. A 
ClueGO network is created with kappa statistics and reflects the relationships between the 
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terms based on the similarity of their associated genes (Mlecnik et al., 2018). Gene ontology 
(GO) analysis of mouse array data were performed with ClueGO v1.4 (Bindea et al., 2009) using 
the following parameters: enrichment/depletion two-sided hypergeometric statistical test; 
correction method: Benjamini-Hochberg; GO term range levels: 3–8; minimal number of genes 
for term selection: 10; minimal percentage of genes for term selection: 10%; κ-score threshold: 
0.8; general term selection method: smallest p value; group method: κ; minimal number of 
subgroups included in a group: 3; minimal percentage of shared genes between subgroups: 
50%. 
 
5.11.3. Weighted gene co-expression network analysis (WGCNA) 
Weighted gene co-expression network analysis (WGCNA) is a method to study biological 
networks that allows identifying modules (clusters) of highly co-expressed genes (Langfelder 
and Horvath, 2008, 2012). Filtering was performed on the raw datasets of the array. A cut-off 
was determined by the 95 quantile of the controls and at least four samples needed to have an 
expression higher than this cut-off before gene expression was determined. The proteins 
interactions, pathways, upstream regulatory analysis, and functional networks were generated 
with the Ingenuity Pathway Analysis (IPA) (QIAGEN Inc., www.qiagenbio-
informatics.com/prducts/ingenuity-pathway-analysis). Then, different molecular networks 
were generated according to biological or molecular functions, which include canonical 
pathways, upstream regulatory analysis, and disease-based functional networks. 
 
5.12. RNA ISOLATION, RETROTRANSCRIPTION AND qPCR 
5.12.1. Tissue or cultured cells RNA isolation and retrotranscription 
The corresponding tissue (right hippocampus for KA injected mice; retina or P8 
hippocampi for positive PCR controls) was rapidly isolated immediately under tribromoethanol 
overdose, and stored at -80°C. Tissue was disrupted with a roto-stator homogenizer with Lysis 
Buffer (Qiagen) containing 0.7% β-mercaptoethanol and stored at -80°C until processed. 
Cultured cells (> 500,000 cells) were lysate and stored at-80°C until processed. Total RNA was 
isolated using Qiagen RNeasy Mini Kit (Qiagen), following manufacturer’s instructions, 
including a DNAse treatment step to eliminate genomic DNA residues. RNA was quantified in a 
Nanodrop 2000, and 1.5µg were retrotranscribed using random hexamers (Invitrogen) and 
Superscript III Reverse Transcriptase kit (Invitrogen), following manufacturer’s instructions in a 
Veriti Thermal Cycler (Applied Biosystems).  
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5.12.2. FACS-sorted cells RNA isolation and retrotranscription 
RNA from FACS-sorted microglia (< 500,000 cells) was isolated by RNeasy Plus micro kit 
(Qiagen) according to the manufacturer instructions, and the RNA was retrotranscribed using 
an iScript Advanced cDNA Synthesis Kit (Biorad) following manufacturer instructions in a Veriti 
Thermal Cycler (Applied Biosystems).  
 
5.12.3. RT-qPCR 
Real Time-Quantitative Polymerase Chain Reaction (RT-qPCR) was performed following 
MIQE guidelines (Minimal Information for Publication of Quantitative Real Time Experiments 
(Bustin et al., 2009). Three replica of 1.5μl of a 1:3 dilution of cDNA were amplified using 
Power SybrGreen (Biorad) for tissue or cell culture experiments or SsoFast EvaGreen Supermix 
(Biorad) for FACS-sorted microglia experiments in a CFX96 Touch Real-Time PCR Detection 
System (Biorad). The amplification protocol for both enzymes was 3 min 95°C, and 40 cycles of 
10 s at 95°C, 30 s at 60°C.  
 
5.12.4. Primers 
Primers were designed to amplify exon–exon junctions using PrimerBlast (NIH) to avoid 
amplification of contaminating genomic DNA, and their specificity was assessed using melting 
curves and electrophoresis in 2% agarose gels. Primer sequences are listed in Table 2. For each 
set of primers, the amplification efficiency was calculated using the software LinRegPCR 
(Ramakers et al., 2003; Ruijter et al., 2009) or standard curve of 1:2 consecutive dilutions, and 
was used to calculate the relative amount using the following formula:  
 
ΔΔCt = (1 + eff.target gene)exp(Ct sample − Ct control)/(1 + eff.reference gene)exp(Ct 
sample − Ct control) 
 
Up to three independent reference genes were compared: L27A, which encodes a 
ribosomal protein of the 60S subunit (Sierra et al., 2007); OAZ-1, which encodes ornithine 
decarboxylase antizyme, a rate-limiting enzyme in the biosynthesis of polyamines and recently 
validated as reference gene in rat and human (Kwon et al., 2009); and HPRT, which encodes 
hypoxanthine guanine phosphoribosyl transferase (van de Moosdijk and van Amerongen, 
2016). The expression of L27A, OAZ-1 and HPRT remained constant independently of time and 
treatments (data not shown), validating their use as reference genes. In all experiments, the 
pattern of mRNA expression was similar using the assigned couple of reference genes, and in 
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each experiment the reference gene that rendered lower intragroup variability was used for 
statistical analysis. 
 
 Gene Gene Bank Amplicon 
size 
Sequence 5’-3’ 
Reference 
genes 
OAZ1 NM_008753 51 Fwd AGCGAGAGTTCTAGGGTTGCC 
Rev CCCCGGACCCAGGTTACTAC 
 L27A BC086939 101 Fwd TGTTGGAGGTGCCTGTGTTCT 
Rev CATGCAGACAAGGAAGGATGC 
 HPRT NM_013556.2 150 Fwd ACAGGCCAGACTTTGTTGGA 
Rev ACTTGCGCTCATCTTAGGCT 
Metabotropic 
receptors 
GRM1 NM_016976.3 150 Fwd AAACCCGAGAGGAATGTCCG 
Rev GCCGTTAGAATTGGCGTTCC 
 GRM2 NM_001160353.1 143 Fwd TGTCAAGTTTGATGCCCCCT 
Rev AGCCTACCTTCTGGTAGCGA 
 GRM3 
 
NM_181850.2 
 
73 
 
Fwd TTCACAGCTCCATTCAACCCA 
Rev CCATCCCGTCTCCGTAAGTG 
 GRM4 NM_001013385.1 107 Fwd CACCAAGCCTGAACGAGTGG 
Rev CGTAGCTGATCTGGGGGATCTTG 
 GMR5 
 
NM_001081414.2 
NM_001143834.1 
123 
 
Fwd ACAACCTCTACAGTGGTGCG 
Rev GGAGCTTAGGGTTTCCCCAG 
 GRM7 
 
NM_177328.3 
 
141 
 
Fwd CTCCAGGGCTGTCGTGATTT 
Rev TGCTGATGCAGTGGGTTGAT 
 GRM8 
 
NM_008174.2 
 
142 
 
Fwd ACCCATATTCACCAAGCCCG 
Rev GTCACTTAGCTCTGGGGCTG 
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AMPA 
ionotropic 
glutamate 
receptors 
Gria1 
 
NM_001113325.2 
NM_008165.4 
NM_001252403.1 
111 Fwd TACATTGAGCAACGCAAGCC 
Rev GTTTACGGGACCTCTCAGGG 
 Gria2 
 
NM_001083806.1 
NM_013540.2 
NM_001039195.1 
148 
 
Fwd GGGGACAAGGCGTGGAAATA 
Rev CCAATCTTCCGGGGTCCATT 
 
 Gria3 
 
NM_016886.4 
NM_001281929.1 
107 
 
Fwd TGACAGCTCATCCTCCGAGA 
Rev AGCGCTCATTTCCTTCCAGT 
 Gria4 
 
NM_019691.4 
NM_001113180.1 
NM_001113181.1 
135 
 
Fwd AAGCACGTCAAAGGCTACCA 
Rev TTTCGTCACCATGGGCGTAT 
 
KAINATE 
ionotropic 
glutamate 
receptors 
Grik1 
 
NM_146072.4 
NM_010348.3 
 
76 
 
Fwd CTCGCTTGCCTAGGAGTCAG 
Rev GGTGGGGGTTATACCACTCG 
 
 Grik2 
 
NM_001111268.1 
NM_010349.2 
102 
 
Fwd CTTCTCTTCCCTCAGCCGTG 
Rev TGCAAGCGAATGAGACCAGT 
 Grik3 
 
NM_001081097.2 
 
131 
 
Fwd GTTCCTAGTGTGCGCCTTCT 
Rev ATCGAAAGGCGTGCTCTTCA 
 Grik5 
 
NM_008168.2 
 
135 
 
Fwd TGATAGTCGCCTTCGCCAAT 
Rev TCCCATTGATCTGCTCTCGG 
NMDA 
ionotropic 
glutamate 
receptor 
Grin1 
 
NM_008169.2 
NM_001177656.1 
NM_001177657.1 
 
114 
 
Fwd GACACAAGGATGCCCGTAGG 
Rev TCTTTTTAGGGTCGGGCTCTG 
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 Grin2a 
 
NM_008170.2 
 
148 
 
Fwd CGCATCCATGGCTTGGTGTTT 
Rev TGGATGTCGGATCCTTGTCAG 
 Grin2b 
 
NM_008171.3 
 
112 
 
Fwd CATGGGTGTCTGTTCTGGCA 
Rev GGGGGAGTTCATCACGGATT 
 Grin3a 
 
NM_001276355.1 
NM_001033351.1 
146 
 
Fwd TGGTACAAGGGGTTTCAGCG 
Rev GTGCAGGGGATTCTGACTCT 
 Grin3b 
 
NM_130455.2 
 
140 
 
Fwd TGTTTGTCCTGCTGTGCCT 
Rev GTGGATCTTCTGGCTCGTGTGAA 
Recognition 
receptors 
Trem2 
 
NM_031254.3 
NM_001272078.1 
110 
 
Fwd CTGATCACAGCCCTGTCCCAA 
Rev CGTCTCCCCCAGTGCTTCAA 
 CR3 
 
NM_001082960.1 
NM_008401.2 
100 
 
Fwd AATTGAGGGCACGCAGACA 
Rev GCCCAGCAAGGGACCATTAG 
 MerKT 
 
NM_008587.1 
 
131 
 
Fwd AAGGTCCCCGTCTGTCCTAA 
Rev GCGGGGAGGGGATTACTTTG 
 GPR34 NM_011823.4 151 Fwd CTTCAGGAAAGCTTCAACTC 
Rev GTAACTATCAGGAGGAGAGC 
Purinergic 
receptors 
P2X4 NM_011026 52 Fwd TAAGTATGTGGAAGACTACGAGCAGG 
Rev TCACTGGTCCGTCTCTCCG 
 P2X7 
 
NM_011027 
NM_001038845 
NM_001038839 
51 Fwd ACTATACCACGAGAAACATCTTGCC 
Rev GAAAGGTACAAGAGCCGTTCATAGTT 
 
 P2Y6 NM_183168 82 Fwd ACAGACTCTCCGAGCATAGGAAA 
Rev GGCGGCAAGCCTGGA 
 P2Y12 NM_027571 88 Fwd GCAGAACCAGGACCATGGAT 
Rev CTGACGCACAGGGTGCTG 
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C1q subunits C1qA 
 
NM_007572.2 
 
97 
 
Fwd CACGGAGGCAGGGACAC 
Rev GGCAGACATCTTCAGCCACT 
 C1qB 
 
NM_009777.2 
 
77 
 
Fwd ATTCCATACACAGGAAGCCCC 
Rev GCAGTAACAGGTGTGTCCAGA 
 C1qC 
 
NM_007574.2 
 
147 
 
Fwd GCTGCTGCTGTTTCTTCTGG 
Rev GGGATTCCTGGCTCTCCCT 
Peptides & 
hormones 
Vgf 
 
NM_001039385.1 
 
74 
 
Fwd  CACCGGCTGTCTCTGGC 
Rev  AAGGAAGCAGAAGAGGACGG 
 Cartpt NM_013732.7 106 Fwd GCGCTATGTTGCAGATCGAAG 
Rev GCGTCACACATGGGGACTTG 
 SCG2 NM_001310680.1 90 Fwd CCTACCTGAGAAGGAATTTGCAG 
Rev CTGGCTCCACCAACCCATTT 
Trophic 
factors 
BDNF NM_007540.4 
NM_001048141.1 
NM_001048142.1 
NM_001048139.1 
104 
 
Fwd TACCTGGATGCCGCAAACAT 
Rev GCTGTGACCCACTCGCTAAT 
 
 GDNF 
 
NM_010275.2 
 
145 
 
Fwd CGCTGACCAGTGACTCCAA 
Rev TGCCGATTCCTCTCTCTTCG 
 FGF2 
 
NM_008006.2 
 
113 
 
Fwd CGGCTGCTGGCTTCTAAGTG 
Rev AGTGCCACATACCAACTGGAG 
 EGF 
 
NM_010113.3 
 
136 
 
Fwd GGACTGAGTTGCCCTGACTC 
Rev CAATATGCATGCACACGCCA 
 IGF-1 
 
NM_010512.4 
NM_184052.3 
122 
 
Fwd TTACTTCAACAAGCCCACAGG 
Rev GTGGGGCACAGTACATCTCC 
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NM_001111274.1 
NM_001111275.1 
NM_001111276.1 
 PDGFa 
 
NM_008808.3 
 
94 
 
Fwd TACCCCGGGAGTTGATCGAG 
Rev TCAGCCCCTACGGAGTCTATC 
 NT-4 
 
NM_198190.1 
 
130 
 
Fwd GGTTGCCCCCTCCCTCT 
Rev TTGCACACCTGTCAACAGCA 
 NGF NM_013609.2 112 Fwd ATCTCCCGGGCAGCTTTTTG 
Rev CACAGGCCAAAACTCCACCAT 
 VEGFa NM_001025250.3 88 Fwd GGCCTCCGAAACCATGAACT 
Rev CTGGGACCACTTGGCATGG 
Matrix 
protein 
Mmp3 NM_010809.2 
 
88 Fwd  ACCCAGTCTACAAGTCCTCCA 
Rev  GGAGTTCCATAGAGGGACTGA 
Surface 
ligands 
Jag1 
 
NM_013822.5 
 
119 
 
Fwd  TTCAGGGCGATCTTGCATCA 
Rev  CACACCAGACCTTGGAGCAG 
 Dll3 NM_007866.2 82 Fwd TGGATGCCTTTTACCTGGGC 
Rev GGAGCCAGAGGTTTCACTACA 
 Dll4 NM_019454.3 113 
 
Fwd GGTTACACAGTGAGAAGCCAGA 
Rev GGCAATCACACACTCGTTCC 
Cytokines Csf3 
 
NM_009971.1 
 
70 
 
Fwd GCAGCCCAGATCACCCAGAAT 
Rev  TGCAGGGCCATTAGCTTCAT 
 IL1β NM_000576.2 72 Fwd AGATGAAGTGCTCCTTCCAGG 
Rev GGTCGGAGATTCGTAGCTGG 
 IL6 NM_000600.3 107 Fwd GAAAGCAGCAAAGAGGCACTG 
Rev TTCACCAGGCAAGTCTCCTCAT 
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 TNFα NM_000594.3 142 Fwd TGCACTTTGGAGTGATCGGC 
Rev GCTTGAGGGTTTGCTACAACA 
 TGFβ NM_000660.5 112 Fwd TCCTGGCGATACCTCAGCAA 
Rev CAATTTCCCCTCCACGGCTC 
Table 2. Primer sequences. Primer sequences for mRNA expression analysis by RT-qPCR. The table 
indicates the gene name, the GeneBank code, the amplicon size, and the primer sequence 
 
5.13. SINGLE CELL RNA- SEQUENCING 
CA and DG were dissected from 1mo CX3CR1 mice by carefully cutting with a needle 
through the hippocampal fissure under a dissecting scope. The enthorrinal cortex was also 
dissected out from CA. Samples were enzymatically homogenized and FACS-sorted as 
describes in Section 5.7. Cell populations isolated by flow cytometry were diluted to a final 
concentration range of 250–400 cells per μl and were loaded onto C1 system (Fluidigm) to 
carefully isolate single cells into individual reaction chambers in its integrated fluidic circuit 
(IFC). The optically clear IFC allowed to automatically stain captured cells and examine them by 
microscopy for viability. After staining, cells were automatically lysed and their RNA was 
retrotranscribed with oligo (dT) primers and amplified on a C1 Single-cell Auto Prep System 
according to the mRNA-seq protocol of the manufacturer (Fluidigm). The amount of cDNA 
generated from single cells was quantified with a Quant-iT PicoGreen dsDNA Assay Kit (PN 
P11496; Life Technologies), and quality was checked with High Sensitivity DNA Reagents (PN 
5067-4626) according to the manufacturer's instructions (Agilent Technologies). Only single 
cells with high-quality cDNA were processed for RNA-seq. For the RNA-seq, single-cell 
multiplexed libraries were prepared utilizing a Nextera_XT Kit (PN FC-131-1096; Illumina) with 
dual indices (PN FC-131-1002; Illumina), which were sequenced as 51-bp single-end reads on 
the Illumina HiSeq 2000 platform. 
 
5.14. IMMUNOFLUORESCENCE 
5.14.1. Primary microglia cultures 
Primary microglial cultures were fixed for 10 min in 4% PFA and then transferred to PBS. 
Fluorescent immunostaining was carried out following standard procedures (Abiega et al., 
2016; Beccari et al., 2018). Coverslips with primary microglial cultures were blocked in 0.1% 
Triton X-100, 0.5% BSA in PBS for 30 min at RT. The cells were then incubated with primary 
antibodies in permeabilization solution (0.2% Triton X 100, 0.5% BSA in PBS) for 1 h at RT, 
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rinsed in PBS and incubated in the secondary antibodies containing DAPI (5 mg/ml) in the 
permeabilization solution for 1 h at RT. After washing with PBS, primary cultures were 
mounted on glass slides with DakoCytomation Fluorescent Mounting Medium 
(DakoCytomation, Carpinteria, CA).  
 
For VGF antibody immunostaining of primary microglia, all the procedure was 
performed without Triton X-100. Coverslips were blocked in 0.1% BSA for 1h at RT, following 
the incubation of primary antibodies in the same blocking solution overnight at 4oC. 
Afterwards, coverslips were rinsed in PBS and incubated in the secondary antibodies 
containing DAPI for 2h at RT. 
 
5.14.2. SH-SY5Y cell line 
For fluorouridine labeling, SH-SY5Y were treated with 2mM 5’-Fluorouridine (Sigma) for 
30min. Afterwards, cells were fixed in 4% PFA with 0.5% Triton X 100. The 
immunofluorescence was performed as described in section 5.14.1 and anti-BrdU primary 
antibody was used to detect fluorouridine. 
 
 
5.14.3. Neuroprogenitors cell cultures 
Neuroprogenitors cell cultures were fixed for 10 min in 4% PFA and then transferred to 
PBS. Coverslips containing the cells were blocked in blocking solution (0.5% Triton-X100, 3% 
BSA in PBS) for 1 hr at room temperature, and then incubated overnight with the primary 
antibodies diluted in the permeabilization solution (0.2% Triton-X100, 3% BSA in PBS) at 4oC. 
After overnight incubation, coverslips were allowed to thaw and were thoroughly rinsed in 
PBS. Next, the coverslips were incubated with fluorochrome-conjugated secondary antibodies 
and DAPI (5mg/ml; Sigma) diluted in the permeabilization solution for 2h at RT. After washing 
with PBS, the coverslips were mounted on glass slides with DakoCytomation Fluorescent 
Mounting Medium (DakoCytomation, Carpinteria, CA).  
 
5.14.4. Brain tissue sections  
Mice were transcardially perfused with 30ml of PBS followed by 30ml of 4% PFA. The 
brains postfixed with the same fixative for 3h at RT, then washed in PBS and kept at 4°C. Six 
series of 50μm-thick coronal sections of mouse brains were cut using a Leica VT 1200S 
vibrating blade microtome (Leica Microsystems GmbH, Wetzlar, Germany). Fluorescent 
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immunostaining was carried out following standard procedures (Beccari et al., 2018; Sierra et 
al., 2010). Free-floating vibratome sections were blocked in permeabilization solution (0.3% 
Triton-X100, 0.5% BSA in PBS; all from Sigma) for 3 hr at RT, and then incubated overnight with 
the primary antibodies diluted in the permeabilization solution at 4oC. For C1q immunostaining 
an incubation of two overnights was required. For BrdU (bromo-deoxyuridine) labeling an 
antigen retrieval procedure was performed by incubating in 2M HCl for 30min at 37oC and 
then washing with 0.1M sodium tetraborate for 10min at RT prior to the blockade of the 
sections. After overnight incubation with primary antibodies, brain sections were thoroughly 
washed with 0.3% triton in PBS. Next, the sections were incubated with fluorochrome-
conjugated secondary antibodies and DAPI (5mg/ml; Sigma) diluted in the permeabilization 
solution for 3h at RT. After washing with PBS, the sections were mounted on glass slides with 
DakoCytomation Fluorescent Mounting Medium (DakoCytomation, Carpinteria, CA).  
 
5.14.5. Antibodies 
The following antibodies were used (Table 3):  
 Primary Abs Source 
Primary microglia chicken anti-GFP (1:1000) 
guinea Pig anti-BQ17 (1:400) 
sheep anti-BQ42 (1:400) 
rabbit anti-BQ22 (1:400) 
rabbit anti-BQ28 (1:400) rabbit anti-
BQ11 (1:1000) 
Aves Labs 
Courtesy of Gian-Luca Ferri 
and Christina Cocco 
SH-SY5Y culture rat anti-BrdU (1:400) Biorad 
Neuroprogenitor cell 
culture 
chicken anti-nestin (1:1000) 
rabbit anti-GFAP (1:1000) 
goat anti-Dcx (1:500) 
rabbit anti-S100β (1:750) 
Aves Labs 
Dako 
Santa Cruz 
Dako 
In vivo chicken anti-GFP (1:1000) 
rat anti-C1q (1:100) 
Aves Labs 
AbD Serotech 
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rat anti-BrdU (1:400) 
rabbit anti-GFAP (1:1000)  
goat anti-Dcx (1:1000) 
Biorad 
Dako 
Santa Cruz 
Table 3. Antibodies. Primary and secondary antibodies used for immunofluorescent staining. 
 
5.15. IMAGE ANALYSIS AND QUANTIFICATION 
5.15.1. Phagocytosis analysis 
Apoptotic cells were defined based on their nuclear morphology after DAPI staining as 
cells in which the chromatin structure (euchromatin and heterochromatin) was lost and 
appeared condensed and/or fragmented (pyknosis/karyorrhexis) (Abiega et al., 2016). In 
addition, phagocytosis was defined as the formation of an enclosed, three-dimensional pouch 
of microglial processes surrounding an apoptotic cell.  
 
In microglia primary cultures, over 4-5 random z-stacks were collected per coverslip 
using a Leica SP8 laser scanning microscope under a 40X oil-immersion objective and a z-step 
of 0.7μm. The percentage of phagocytic microglia was defined as cells with pouches containing 
apoptotic NE-4C/SH-SY5Y nuclei and/or CM-DiI particles (Beccari et al., 2018). 
 
For mouse tissue sections for C1q experiment, the DG in 3-4 sections was fully scanned 
under the microscope to find all apoptotic cells using a 40X oil-immersion objective with a 
zoom of 2,5. Colocalization of C1q with microglia cells was determined by orthogonal 
projections. 
 
5.15.2. Neuroprogenitor cell analysis in vitro 
In neuroprogenitor cell cultures, over 4-5 random z-stacks were collected per coverslip 
using an Olympus Fluoview or a Leica SP8 laser scanning microscope under a 40X oil-
immersion objective, a z-step of 0.7μm, a zoom of 0,75 and a resolution of 1024x1024 pixels. 
The effect of microglia-derived conditioned media on neuroprogenitor cells was analyzed 
considering both their morphology and the expression of cell-specific markers. Percentages of 
the different morphologies present in the population were obtained as well as the percentages 
of the different cell markers (Nestin, GFAP, DCX, S100β) per morphology. 
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5.15.3. Neurogenesis analysis in vivo 
For the neurogenesis analysis in vivo, the three tissue sections closest to the injection 
site were analyzed. 5 z-stacks were collected per section using a Leica SP8 laser scanning 
microscope under a 40X oil-immersion objective, a z-step of 1 μm, a zoom of 1 and a 
resolution of 512x512 pixels. Proliferation was assessed by BrdU cell quantification; neural 
stem cells were identified by the expression of the markers Nestin and GFAP and their radial 
morphology for cell quantification; neuroblast were assessed by DCX+ cell quantification and 
morphology in order to classify them in AB, CD or EF neuroblasts; neurons were assessed by 
NeuN+ cell quantification; and astrocytes identified as GFAP+/Nestin- cells with stellated 
morphology. The proliferation of either of these populations was assessed by their mentioned 
staining combined with BrdU. Numbers of cells were estimated in the volume of the DG of the 
z-stack, which was determined by multiplying the thickness of the z-stack (12 μm) by the area 
of the DG at the center of the stack using the software ImageJ (Fiji).  
 
5.16. STATISTICAL ANALYSIS 
SigmaPlot (San Jose, CA, USA) was used for statistical analysis. For the analysis of 
neurocandidates and cytokine mRNA expression, a logarithmic transformation was performed 
to comply with ANOVA assumptions (normality and homocedasticity). In all cases, Holm-Sidak 
method was used as a posthoc test to determine the significance between groups in each 
factor. Only p < 0.05 is reported to be significant. Data is shown as mean ± SEM (standard error 
of the mean). 
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6. RESULTS 
 
6.1. SETTING UP AN IN VITRO MODEL OF PHAGOCYTOSIS 
In order to study the relationship between microglial phagocytosis and neurogenesis in 
vivo, we focused in the adult hippocampal neurogenic cascade, where the neural precursors of 
the subgranular zone (SGZ) of the dentate gyrus (DG) proliferate to give rise to granular 
neurons that incorporate in the hippocampal circuitry. Importantly, many of the newborn cells 
naturally undergo apoptosis and are rapidly and efficiently phagocytosed by resident, 
unchallenged microglia (Sierra et al., 2010). As neurogenesis rapidly declines with age, so does 
newborn cell apoptosis and phagocytosis (Sierra et al., 2010). Therefore, the hippocampus of 
young mice (1 month old) is a great model to study both phenomena, phagocytosis and 
neurogenesis, in physiological conditions in vivo. 
 
In addition, to study the interaction between phagocytosis and neurogenesis in vitro we 
developed an in vitro model of phagocytosis of apoptotic cells that mimicked as many features 
as possible of phagocytosis in vivo. Here we will focus on three cardinal features: phagocytosis 
cargo identity; early engulfment; and presence of key opsonizing molecules.  
 
The first key issue is the identity of the phagocytosed cargo. Microglia is in charge of the 
phagocytosis of multiple brain-specific types of cargo, such as axonal and myelin debris, Aβ-
deposits, invading microorganisms, apoptotic cells, etc (Sierra et al., 2013). For this study, we 
will specifically focus on microglial phagocytosis of apoptotic cells. Traditionally, one of the 
most utilized models to study microglial phagocytosis in vitro has been the use of latex beads 
as phagocytic targets; however, these artificial targets do not release the characteristic ‘find-
me’ molecules of the apoptotic cells to ensure the attraction of microglia (Diaz-Aparicio et al., 
2016). In addition, latex beads do not express ‘eat-me’ ligands and while they are commonly 
opsonized by a serum coating their mechanism of recognition is different from physiological 
targets. Similarly, synthetic latex beads cannot be degraded, and therefore their engulfment 
will result in incomplete phagocytosis. Thus, since latex beads cannot mimic the different steps 
of phagocytosis, we performed our in vitro phagocytic assay using a physiological relevant 
target, ie., apoptotic cells. We used the neuroprogenitor NE-4C cell line, in which we induced 
apoptosis prior to feeding them to microglia. We used this mouse neuronal cell line to 
characterize phagocytosis in mouse primary microglial cultures. However, to study 
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transcriptional changes induced by phagocytosis we later on switched to use the human 
neuronal cell line SH-SY5Y, which allowed discrimination of species-specific transcripts and 
thus, to specifically evaluate changes in mouse phagocytic microglia . 
 
A second key factor is the early engulfment. In vivo, phagocytosis is characterized by its 
rapid and efficient performance. As soon as a cell undergoes apoptosis, microglia completely 
engulf and degrade the apoptotic cell, as shown by the fact that over 90% of the apoptotic 
cells are already engaged in phagocytosis in the adult hippocampus (Abiega et al., 2016; Sierra 
et al., 2010). As a result, the estimated clearance time in vivo is around 90min (Sierra et al., 
2010). Therefore in our in vitro model we ensured that only primary apoptotic cells, but not 
cells undergoing primary or secondary necrosis, were fed to microglia. 
 
Finally, a key opsonizing molecule that facilitates and modulates engulfment is the 
complement protein C1q. The complement protein C1q plays several key functions in the 
innate immune system, and in particular as the key recognition protein of the C1 
macromolecular complex which initiates the classical complement pathway (Fraser and 
Tenner, 2008). In addition a large body of evidence now suggests that C1q is an important 
factor in the clearance of apoptotic cells (Trouw et al., 2008). In particular, the presence or 
absence of C1q results in a completely different outcome in the process of phagocytosis, 
determining the anti- or pro- inflammatory nature of the process respectively (Fraser et al., 
2010). Consequently, we deepened into the presence of C1q in the CNS and its relationship 
with apoptotic cells prior to deciding whether the complement protein would be part of our 
phagocytic system in vitro. 
 
In this section, we will first analyze the presence of C1q and its relationship with 
apoptosis and phagocytosis in vivo. Then, we will start the setup of our in vitro model of 
phagocytosis by characterizing the apoptosis induction of a mouse neuronal cell line. Finally, 
we will conclude our phagocytic model setup by feeding the apoptotic neuronal cell line to 
primary microglia in order to describe phagocytosis dynamics. 
  
6.1.1. Characterization of C1q expresion in the hippocampus 
6.1.1.1. Phagocytosed apoptotic cells are related to C1q 
To test whether C1q played a role in phagocytosis in vivo, we analyzed by 
immunofluoresce and confocal imaging the presence of C1q in the hippocampus of 1mo fms-
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EGFP+ mice (Figure 5A), in which microglia express the green fluorescent protein. We 
quantified a total of 159 apoptotic cells along the DG, pooled from 3 different mice. Apoptotic 
cells, likely to be newborn cells, located in the neurogenic niche (SGZ) were phagocytosed by 
ramified, unchallenged microglia (93.0% of the apoptotic cells), as shown by the formation of a 
three-dimensional phagocytic pouch surrounding the apoptotic cell, as already described 
(Sierra et al., 2010). C1q was expressed in the SGZ and showed a dotted pattern. To assess the 
relationship between C1q labeling and apoptosis, we quantified the expression of C1q in 
apoptotic cells (Figure 5B) and found that C1q labeling was associated with 84.9% of the 
phagocytosed apoptotic cells. To distinguish whether the C1q signal belonged to the cytoplasm 
of the apoptotic cell or the microglial pouch, we analyzed orthogonal projections of confocal z-
stacks. Orthogonal projections showed C1q labeling within the microglial cytoplasm (Figure 
5C), strongly suggesting that C1q was part of the microglial pouch, rather than the apoptotic 
cell cytoplasm. Moreover, we found that out of 8.1% of apoptotic cells without C1q staining in 
the phagocytic pouch, up to 69.3% belonged to a C1q+ microglia, as C1q staining was found 
either in the microglial soma and/or branches (Figure 5B). The remaining 30.7% of the C1q- 
pouches were formed by microglia that we cannot exclude as C1q+ because part of the 
microglial cell was located outside the Z-stack. On the other hand, none of the non-
phagocytosed apoptotic cells presented any C1q staining. Altogether, this data suggested a 
clear relationship between C1q and phagocytosis. 
  
6.1.1.2. C1q protein is mainly expressed in microglia in the hippocampus 
C1q labeling was found inside the microglial pouches surrounding apoptotic cells, but 
nonetheless the staining was not exclusive of the phagocytic pouches (Figure 5A, C). 
Therefore, we analyzed C1q expression in DG microglia and we found that 100% of the 
analyzed microglia from DG presented C1q staining especially in the soma –surrounding the 
nucleus-, although it could also be found throughout their processes (Figure 5D). We only 
consider complete cells for the quantification of microglia, therefore, microglial branches that 
had their soma outside the Z-stack or microglial somas with branches outside the Z-stack were 
not included. In addition, very few scattered C1q dots were found in non-microglial cells. 
 
To test whether microglia expression of C1q solely occurred in the presence of apoptotic 
cells, we also analyzed its expression in the Cornu Ammonis (CA), a nearby region of the 
hippocampus where there is no neurogenesis and therefore no apoptosis nor phagocytosis 
(Sierra et al., 2010). We analyzed two CA, CA1 and CA3, and found that microglia throughout 
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CA also expressed C1q protein either in their soma (perinuclearly) and/or inside the microglial 
processes, distributed as a dotted pattern along the branches (Figure 5E). Similarly to DG, 
almost no presence of C1q was found in non-microglial cells. Therefore, in the adult brain, 
microglia are the main cell type expressing the complement protein C1q.  
 
Thus, although we cannot exclude that the C1q plays an important role in non-
phagocytic microglia (from CA), the association of C1q to the phagocytic pouches strongly 
suggests that C1q is involved in the process of phagocytosis. 
 
6.1.1.3. Microglia is the major source of C1q in the hippocampus 
C1q was almost exclusively found inside microglia, however, the immunofluorescence 
data could not disregard that C1q was originated in apoptotic cells and incorporated in 
microglia during their engulfment and degradation. To further confirm the microglial origin of 
C1q, we compared the C1q mRNA expression in microglia versus non-microglial cells. The two 
cell populations were acutely purified from the hippocampus of fms-EGFP mice by fluorescent-
activated cell sorting (FACS) (Figure 5F). Microglia were selected as GFP+ cells, whereas other 
non-microglial cell types were characterized as GFP- (See description of Fig 5F for gating 
strategy). Next, the mRNA expression of the three subunits conforming C1q protein (C1qA, 
C1qB and C1qC) was assessed by RT-qPCR (Figure 5G). We found that the mRNA of each 
subunit was almost exclusively restricted to microglia, with an enrichment of 98.1 ± 0.5 % for 
C1qA, 97.5% ± 1.4 for C1qB, and 84.1 ± 7.5 % for C1qC. Therefore, the translation of this mRNA 
into protein likely renders microglia as the major source of C1q in the hippocampus. 
 
Consequently, since we found a close interaction between C1q and microglia in the CNS 
and the presence or absence of the protein would have dramatic differences in the 
downstream experiments, which would determine the immunomodulatory nature of the 
process (Fraser et al., 2010), we decided that the complement protein would be part of our in 
vitro phagocytosis model by using non-inactivated serum in the cell culture medium. 
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Figure 5. Characterization of the presence of C1q protein in the mouse adult brain. [A] Representative 
confocal z-stack of C1q immunofluorescence in the mouse hippocampal DG in physiological conditions at 
1 month. Microglia were labeled with fms EGFP+ (cyan), C1q (red) and apoptotic nuclei were detected by 
pyknosis/karyorrhexis (white, DAPI). C1q presented a dotted pattern in the cytoplasm of microglia cells, 
both in the soma and the processes. Phagocytic microglia showed C1q also in the pouches that 
surrounded apoptotic cells. High magnification details show each apoptotic cell individually. Apoptotic 
cell 1 was not phagocytosed and did not present C1q staining. Apoptotic cells 2 and 3 were engulfed by 
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microglia and C1q was present in the phagocytic pouches. Scale bars = 20μm (C, G), z = 16,5μm (DG). [B] 
Percentage of phagocytosed and non-phagocytosed apoptotic cells with and without C1q labeling. The 
majority of the phagocytosed apoptotic cells had C1q in their surrounding microglia pouch. A small 
percentage of the phagocytic pouches did not present C1q in the pouch per se, but the majority of the 
microglia forming those pouches did have C1q in their soma and/or branches. Few phagocytosed 
apoptotic cells did not express C1q neither in their pouch nor in the microglia engulfing them. A total of 
159 apoptotic cells were quantified along the DG of 3 different mice (2 sections per mouse) by confocal 
microscopy. [C] Orthogonal projection of a confocal z-stack of C1q immunofluorescence in the mouse 
hippocampal DG in physiological conditions at 1month. Microglia were labeled with fms EGFP+ (cyan), 
C1q (red) and apoptotic nuclei were detected by pyknosis/karyorrhexis (white, DAPI). [D] Percentage of 
microglia with C1q labeling in the soma, branches or pouch. A total of 289 microglia cells were quantified 
along the DG of 3 different mice (2 sections per mouse) by confocal microscopy. [E] Representative 
confocal z-stack of the presence of C1q in the CA1 and CA3 of 1mo fms-EGFP mice in physiological 
conditions. Microglia were labeled with fms EGFP+ (cyan), C1q (red), and cell nuclei were labeled with 
DNA marker DAPI (White). C1q presented a dotted pattern inside microglia cells, both in the soma and 
the processes. High magnification details show each microglia cell individually. C1q staining colocalized 
with the soma and/or branches of microglia. Scale bars = 20μm, z = 7.5 μm (CA1), 9 μm (CA3). [F] 
Experimental design used to isolate microglia (GFP+) vs non-microglial cells (GFP-) from 1 mo fms-EGFP 
mice. Flow cytometry analysis of the expression of C1q subunits in hippocampal cells. First, debris was 
excluded using the P1 gate in FSC versus SSC (left panel). Next, gates for GFP+ microglia cells (P3) and 
GFP- non-microglial cells (P2) were defined based on the distribution of the fms-EGFP+ cells in EGFP vs 
FSC (right panel). [G] Expression of C1q subunits in microglia (G   )  s non-microglial cells (G  -) by 
  q C  in  ACS-sorted cells  rom  ms- G   mice hippocampi (n = 3, each  rom 8 pooled hippocampi). 
 A 1 was selected as a re erence gene.  ars represent mean   S  .     indicates p   0.001 by Student  s 
t test.  
 
6.1.2. Characterization of apoptosis in a mouse neuroprogenitor cell line 
(NE-4C) 
After determining the use of non-inactivated serum in the culture medium, we 
continued with the setup of our phagocytic assay by characterizing apoptosis induction in the 
neuroprogenitor mouse cell line NE-4C. Apoptosis induction was performed by treatment with 
staurosporine (STP), a protein kinase inhibitor and a well-known apoptotic inductor (Lawrie et 
al., 1997). Two different techniques were used for the quantification of apoptotic cells in order 
to contrast and compare results: flow-cytometry and fluorescence microscopy.   
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For the analysis of cell death using flow-cytometry, we cultured NE-4C cells with 1µM 
STP along a time course of 2h, 4h, and 6h. Then, cells were stained with propidium iodide (PI), 
a DNA intercalating agent that is not extruded by cells with a disrupted cytoplasmic 
membrane, a hallmark of necrosis (Krishan, 1975), and they were also labeled with Annexin V, 
which binds to phosphatidylserine when it becomes exposed on the outside leaflet of the 
membrane, hallmark of apoptosis (Wlodkowic et al., 2012). Five different populations were 
observed in the cytometer depending on the PI/Annexin labeling (Figure 6A):  
1. Cells with no labeling (PI-, Annexin-) were defined as live since they possessed an 
intact membrane and no exposure of phosphatidylserine (PS).  
2. Cells with an intact membrane (PI-) but exposure of PS (Annexin+) were considered 
primary apoptotic cells.  
3. On the other hand, Annexin+ combined with high levels of PI+ (loss of cell integrity) 
characterized secondary necrotic cells. 
 4. An Annexin+ / low PI+ cell population was also found, and these cells were identified 
as primary apoptotic cells that were evolving into secondary necrotic cells.  
5. Loss of membrane integrity without PS exposure (PI+, Annexin-) determined necrotic 
cells.  
 
The quantification of these data (Figure 6B) showed a decrease in the percentage of live 
cells over time (67.0% ± 4.6% at 4h; 54.2% ± 3.2% at 6h), while the percentage of primary 
apoptotic cells significantly increased (27.4% ± 10.4% at 4h; 40.4% ± 8.2% at 6h). Necrotic cells 
never reached more than the 2.5 ± 1.1 % of the total number of cells (Figure  6C).  
 
For the analysis of cell death using fluorescence microscopy, we again induced NE-4C 
apoptosis with 1µM STP for different time points and labeled the cells with propidium iodide 
(PI, 5µg/ml) during the last hour of STP treatment to minimize its toxicity. Apoptosis was 
determined by aberrant nuclear morphology, as visualized with the DNA dye DAPI, defined as 
pyknotic (condensed nuclei) and karyorrhectic (fragmented nuclei) cells (Eidet et al., 2014; 
Krysko et al., 2008). The results were consistent to those obtained by cytometry: apoptosis 
significantly increased over time reaching 35.0 ± 7.4% of apoptotic cells after 4h and 69.5 ± 
7.0% after 6h (Figure 6D, E). Based on the collective data obtained by flow cytometry and 
fluorescence microscopy, we selected a 4h STP treatment that was enough to induce early 
apoptosis in vitro which, as mentioned above, mimics the physiological conditions where 
apoptotic cells do not evolve into necrotic due to the rapid efficiency of phagocytosis.  
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6.1.3. Setting up the microglial phagocytosis assay 
After characterizing NE-4C apoptosis and determining the use of non-inactivated serum 
in the culture medium, we continued with the setup of the phagocytosis assay. Primary 
microglia obtained from P0-P2 fms-EGFP mice were fed with NE-4C, which were previously 
labeled with CM-DiI (membrane marker; 5µM, 25mins) and treated with staurosporine (1µM, 
4h) for the induction of apoptosis. Microglia were allowed to phagocytose over a time course 
of 1, 3, 5, and 15h and phagocytosis was assessed by the presence of phagocytic pouches, i.e., 
apoptotic cell fragments completely surrounded by microglia (Figure 6F, G). For this analysis 
only fully closed pouches with CM-DiI and/or DAPI inclusions were quantified. When cultured 
with apoptotic NE-4C cells, the quantification showed that, as early as 1h, 66.2 ± 0.8% of 
microglia were phagocytic, a percentage that kept increasing over time reaching 95.6 ± 1.1% of 
phagocytosis at 15h (Figure 6H). A further analysis of the different engulfed particles (DAPI, 
CM-DiI or DAPI and CM-DiI) revealed that the proportion of each inclusion type varied 
throughout the time course. At early time points, more and larger DAPI and CM-DiI particles 
were observed, whereas at later time points, small and numerous CM-DiI inclusions were 
detected, indicative of their degradation (Figure 6I). There was a small decrease in microglia 
cell numbers along the time course (Fig ure6J), which was in agreement with a small increase 
in microglial apoptosis. Nonetheless, microglial apoptosis never reached more than the 9.6 ± 
1.7% of the total number of cells (Figure 6K). In order to exclude the possibility that some STP 
residue could remain when feeding microglia with apoptotic NE-4C, we washed the apoptotic 
NE-4C with PBS several times prior to adding them to the assay. However, microglia died in the 
same proportion as before, suggesting that virtual STP residue was not inducing their 
apoptosis (data not shown). We also speculated that microglia undergo apoptosis because 
they were overfed with a large amount of apoptotic cells; however, as we will see in Section 
4.4, lower and more physiological amounts of apoptotic cells also resulted in microglial 
apoptosis. While in physiological conditions in the adult neurogenic DG niche we never 
observed any apoptotic microglia {Abiega, 2016 #9102}, the possibility that apoptotic cell 
engulfment triggers microglial death is an interesting hypothesis that deserves further testing, 
although it is out of the scope of this thesis.  
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Figure 6. Characterization of the apoptosis of a mouse neuroprogenitor cell line (NE-4C) and set up of 
microglial phagocytosis assay. [A] Flow cytometry analysis of the induction of apoptosis of NE-4C cell 
line by 1µM STP. Gating strategy for different cell populations according to their distribution in Annexin V 
(green fluorescence) versus PI (red fluorescence) chart. The populations live (Annexin
-
/PI
-
), apoptotic 
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(Annexin+/PI-), secondary necrotic (Annexin+/PI+) and necrotic (Annexin-/PI+) were identified based on 
Annexin V/PI labeling. [B, C] Quantification of the different cell populations identified by flow cytometry 
(N=3 independent experiments). [D] Representative epifluorescence images of NE-4C cells treated with 
STP for 4h. Images were obtained with an oil-immersion 40x objective. Nuclei were labeled with DAPI 
(blue) and cell death was detected by pyknosis/karyorrhexis (white, DAPI) and/or PI (red). Scale 
bar=30µm. [E] Quantification of live and dead (both apoptotic and secondary necrotic cells) NE-4C cells 
after STP treatment (N=3 independent experiments). Bars represent mean ± SEM. [F] Experimental 
design of the phagocytosis assay. [G] Representative confocal microscopy images of primary microglia 
(GFP, green) fed with NE-4C, which were previously labeled with CM-DiI (red) and treated with STP (1µM, 
4h) for the induction of apoptosis (pyknosis/karyorrhexis, DAPI, white). N, microglial nucleus; white 
arrowheads, phagocytosed apoptotic NE-4C cells; blue arrowheads, phagocytosed CM-DiI; scale bars, 
30µm. z=6.3 µm. [H] Quantification of the percentage of microglia with CM-DiI and/or DAPI inclusions 
along a time course. Only fully closed pouches with particles within were identified as phagocytosis. [I] 
Breakdown of the percentage of each inclusion type (DAPI, CM-DiI or DAPI and CM-DiI). [J] 
Quantification of average microglia density in control and different phagocytic time points. [K] 
Quantification of the percentage of pyknotic microglia. N=3 independent experiments. Bars represent 
mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-Sidak posthoc 
test (after one-way ANOVA was significant at p < 0.05). 
 
6.1.4. Microglial phagocytosis assay in vitro with a human neuronal 
apoptotic cell line (SH-SY5Y) 
As stated above, the use of mouse origin cell line (NE-4C) might not be ideal to perform 
further transcriptional analysis of phagocytic microglia due to the technical unfeasibility to 
design cell-specific probes or primers when the apoptotic cells derive from the same species as 
microglia. At the end of the phagocytic process, the apoptotic cells would completely degrade 
within microglial lysosomes, resulting in almost inexistent mRNA from apoptotic cells. 
However, should any residual mRNA from apoptotic cells be left, the use of the mouse origin 
NE-4C cells would not permit to differentiate between the changes from microglia and residual 
apoptotic cells mRNA in transcriptional studies since designed probes and primers for 
transcriptional purposes would recognize genes of mouse origin, regardless of the cell of 
origin. Therefore, after characterizing microglial phagocytosis of allogeneic apoptotic cells 
(mouse NE-4C cells) we switched to a xenogeneic model (human SH-SY5Y cells) that would 
allow the use of species-specific probes and primers, and to specifically assess transcriptional 
changes in phagocytic microglia. 
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As in the NE-4C experiments, we started by characterizing SH-SY5Y apoptosis. Two 
different STP concentrations, 1µM and 1.5µM, were used for the induction of apoptosis at 
different time points. When applying 1µM (Figure 7A, B), no SH-SY5Y apoptosis occurred over 
time, whereas 1.5µM STP showed a similar apoptosis pattern as in mouse cells: 41.4 ± 5.3% of 
apoptosis was induced after 4h and 67.0 ± 5.4% after 6h (Figure 7C, D). In order to make 
downstream results more comparable, we chose 4h of STP treatment, as with mouse NE4C 
cells. For phagocytosis assays, primary microglia obtained from P0-P2 fms-EGFP mice were fed 
for different time points (1, 3, 5, 15 and 24h) with SH-SY5Y cells that were previously labeled 
with CM-DiI and treated with STP (1.5uM, 4h) for the induction of apoptosis (Figure 7E, F). 
When cultured with apoptotic human cells, we found that as early as 1h, 30.2% ± 5.8% of 
microglia were phagocytic, a percentage that kept increasing until 15h (81.9% ± 3.7%), and was 
maintained until 24h (83.8% ± 3.6%) (Figure 7G). A breakdown of the engulfed inclusion type 
(DAPI, CM-DiI or DAPI and CM-DiI) showed that the proportion of particle type varied 
throughout the time course, similar to what occur during phagocytosis of NE-4C cells. Early 
time points showed more and larger DAPI and CM-DiI particles, whereas at later time point, as 
apoptotic cells degrade within microglia, small and numerous CM-DiI inclusions were detected 
(Figure 7H). A small decrease in microglia density along the time course was found (Figure 7I), 
which was in accordance with a small increase in microglial apoptosis, similar to phagocytosis 
of NE-4C cells. Microglial apoptosis never reached more than the 12.6 ± 0.9 % of the total 
(Figure 7J). Therefore, although the phagocytosis of human apoptotic cells was slightly delayed 
in comparison to the mouse cell line, probably due to the need of alternative recognition 
mechanisms to phagocytose human apoptotic cells, SH-SY5Y also proved to be a valid target to 
study microglial phagocytosis in vitro. 
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Figure 7. Phagocytosis assay with a human neural cell line (SH-SY5Y). [A] Representative confocal 
images of SH-SY5Y cell treated with 1 µM STP for 4h. Images were obtained with an oil-immersion 40x 
objective. Nuclei were labeled with DAPI (white) and cell death was detected by pyknosis/karyorrhexis 
(white, DAPI). Scale bar=30µm. [B] Quantification of live and dead SH-SY5Y cells after 1 µM STP 
treatment. [C] Representative confocal images of SH-SY5Y cell treated with 1.5 µM STP for 4h. Nuclei 
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were labeled with DAPI (white) and cell dead was detected by pyknosis/karyorrhexis (white, DAPI). Scale 
bar=30µm. [D] Quantification of live and dead SH-SY5Y cells after 1.5 µM STP treatment. [E] 
Experimental design of the phagocytosis assay. [F] Representative confocal microscopy images of 
primary microglia (GFP, green) fed with NE-4C, which were previously labeled with CM-DiI (red) and 
treated with STP for the induction of apoptosis (pyknosis/karyorrhexis, DAPI, white). N, microglial 
nucleus; white arrowheads, phagocytosed apoptotic SY-SY5Y cells; blue arrowheads, phagocytosed CM-
DiI; scale bars, 30µm. z=6.3 µm. [G] Quantification of the percentage of microglia with CM-DiI and/or 
DAPI inclusions along a time course. Only fully closed pouches with particles within were identified as 
phagocytosis. [H] Breakdown of the percentage of each inclusion type (DAPI, CM-DiI or DAPI and CM-
DiI). [I] Quantification of average microglia density in control and different phagocytic time points.  [J] 
Quantification of the percentage of pyknotic microglia (N=3 independent experiments). Bars represent 
mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-Sidak posthoc 
test (after one-way ANOVA was significant at p < 0.05). 
 
6.2. PHAGOCYTOSIS OF APOPTOTIC CELLS TRIGGERS TRANSCRIPTIONAL 
CHANGES IN CULTURED MICROGLIA 
 
6.2.1. Specific detection of phagocytic microglia transcripts  
Using the xenogeneic phagocytic assay model, we performed a full genome-wide 
transcriptomic analysis of the phagocytic microglia using gene expression arrays comparing 
naïve vs phagocytic microglia. In order to evaluate changes in microglia that could be triggered 
at different phagocytic times, both early (3h) and late (24h) phagocytosis time points were 
chosen for the arrays (Figure 8A).  
 
We used the SurePrint G3 Mouse GE 8x60K Microarray (Agilent), which possessed a 
complete coverage of known RefSeq for mouse coding transcripts, and is `mouse-specific’ as 
per manufacturer´s specifications. In addition, we double-checked every mouse probe 
sequence of the array against the whole human transcriptome by BLAST (Basic Local Aligment 
Search Tool, https://blast.ncbi.nlm.nih.gov/Blast.cgi) in order to find those probes that could 
virtually detect residual mRNA from human apoptotic cells. We found that 4% of the mouse 
array probes had a high homology (MegaBlast, homology ≥ 95%) with the human 
transcriptome (data not shown), which urged us to further study the possible presence of 
apoptotic mRNA in the phagocytic microglia samples. For this purpose we compared the RNA 
of control and phagocytic microglia as well as apoptotic SH-SY5Y cells that were allowed to 
degrade for 24h by an Agilent 2100 Bioanalyzer, a microfluidics-based platform for sizing, 
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quantification, and quality control of DNA and RNA. We examined the integrity of the 
ribosomal subunits 18S and 28S, which would determine the degradation state of the RNA of 
the different samples (Figure 8B). We found that control microglia showed two clear peaks in 
the electropherogram that represented 18S and 28S rRNAs. On the contrary, apoptotic SH-
SY5Y cells that were allowed to degenerate for 24h presented a strong degradation profile, in 
which no 18S or 28S were found. Phagocytic microglia displayed a very similar profile than 
control microglia and no degradation profiles were found, probably due to the ability of 
microglia to digest apoptotic cell mRNA. This data suggested that no RNA from apoptotic SH-
SY5Y could be found in phagocytic microglia. 
 
In addition, we also studied whether SH-SY5Y apoptotic cells could still have the capacity 
of synthesizing new mRNA. To study transcription during apoptosis, we used 5’-Fluorouridine 
(FU), a uridine analog that integrates at transcription sites (Figure 8C). We found that live SH-
SY5Y cells displayed a large FU signal in their nuclei, which evidenced the high transcriptional 
activation of live cells. On the contrary, apoptotic SH-SY5Y cells did not exhibit any FU signal, 
which indicated, as expected, that apoptotic cells did not have the capacity of synthesizing 
new mRNAs. 
 
Altogether, the RNA profiling and analysis of transcription in apoptotic cells strongly 
suggests that although the gene arrays used could virtually detect up to 4% of mRNAs from 
apoptotic cells, the lack of residual RNA from apoptotic cells would result solely in the 
detection of microglial-specific transcriptional changes after phagocytosis. In addition, the 
results obtained from the arrays were later validated by RT-qPCR using mouse-specific primers. 
 
6.2.2. Whole genome transcriptome of phagocytic microglia reveals four 
main patterns of gene expression 
Hence, we performed a full genome-wide transcriptomic analysis of the phagocytic 
microglia using gene expression arrays comparing naïve vs phagocytic microglia (3h and 24h). 
The clustering of the samples (control microglia, Ph3h, and Ph24h) in each experiment was 
analyzed by Hierarchical Clustering (HCL) and Principal Component Analysis (PCA). Both 
clustering methods showed that the three experimental groups had strong differences in their 
expression profile (Figure 8D, E). 
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To analyze which particular genes were different among the three experimental groups, 
we searched for array probes with significant changes over time. The analysis was performed 
in three steps (Conesa et al., 2006). First, probes that exhibited changes in expression over 
time were selected based on a p-corrected Benjamini-Hochberg value. Second, for each probes 
with a significant change in its expression over time a polynomial regression model was 
applied to identify the pattern. Finally, probes with significant expression changes over time 
were selected according to the fitness to the regression model. We obtained 20,800 
significantly regulated probes using a conventional fitness criterion for R squared (rsq) > 0.7, 
and 13,146 probes using a more restrictive criterion of rsq > 0.9. This restrictive gene list was 
used to identify the transcriptional profile of phagocytic microglia. 
 
Further screening of the probes was performed by selecting those with a fold change 
(FC) higher than 1.5 or lower than -1.5, resulting in 10,000 probes with significant changes in 
expression over time within the experimental groups. Since several probes corresponded to 
the same gene and some probes recognized sequences of yet unknown genes, eventually we 
obtained 6,585 genes that presented significant changes over time (Figure 8F). The genes were 
classified according to four main expression patterns: UP (up-regulation both at 3h and 24h) 
(Figure 8G), DOWN (down-regulation in both time points) (Figure 8H), Transient UP (up-
regulation at 3h and down-regulation at 24h) (Figure 8I) and Transient DOWN (down-
regulation at 3h and up-regulation at 24h) (Figure 8J). Genes in the expression pattern UP 
showed the largest average FC changes (14.2 ± 2.7 for 3h, 20.8 ± 3.1 for 24h) among all the 
patterns, some of them even reaching 8,000FC at 24h. The rest of the patterns presented more 
modest changes on average. 
 
In the next section, we will describe the functional analysis of these patters using three 
different bioinformatics tools: DAVID, ClueGO and WGCNA and IPA. With these tools, we will 
analyze in detail changes in both functions and pathways. 
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Figure 8. Transcriptional profile of phagocytic microglia. [A] Experimental design of the gene expression 
arrays. [B] Electropherogram obtained by a Bioanalyzer comparing the RNA profile of control and 
phagocytic microglia as well as apoptotic SH-SY5Y that were allowed to degrade for 24h. [C] 
Representative confocal images of active transcription sites of SH-SY5Y cells after FU administration. 
Nuclei were labeled with DAPI (white), cell death was detected by pyknosis/karyorrhexis (white, DAPI, 
arrowheads), and transcription sites were detected by FU (red). Scale bar=20µm. [D] Principal 
Component Analysis (PCA) of the different replica of the samples: Control microglia, Ph3h, and Ph24h. [E] 
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Hierarchical Clustering (HCL) of the different replica of the samples Control microglia (blue), Ph3h 
(brown), and Ph24h (red). [F] Representation of the strategy followed to screen genes from the gene 
array. [G] FC mean of the 1,951 genes classified under the UP regulation pattern. [H] FC mean of the 
2,901 genes classified under the DOWN regulation pattern. [I] FC mean of the 692 genes classified under 
the Transient UP regulation pattern. [J] FC mean of the 1,041 genes classified under the Transient DOWN 
regulation pattern. N=3 independent experiments. Bars represent mean ± SEM. 
 
6.3. The transcriptional profile of phagocytic microglia reveals 
major general changes such as metabolism, cytoskeleton and 
transcription, as well as several potential modulators of 
neurogenesis  
 
6.3.1. Functional analysis of the phagocytic microglia transcriptome by 
DAVID  
Next, we performed a functional analysis of the phagocytic microglia transcriptome 
using the DAVID software (Database for Annotation, Visualization and Integrated Discovery, 
https://david.ncifcrf.gov/) in the four main expression patterns separately. This software 
analyzes the Gene Ontology (GO) of groups of genes related to biological processes rather than 
individual genes in order to find significant changes in different cellular pathways. The analysis 
revealed many biological functions that were significantly enriched in phagocytic microglia. For 
a better understanding of these biological functions and after discarding redundant functions, 
we grouped them in 16 major pathways: ‘neurogenesis’, ‘cell cycle’, ‘differentiation’, 
‘migration’, ‘development’, ‘angiogenesis’, ‘death’, ‘immune system’, ‘behavior’, 
‘cytoskeleton’, ‘metabolism’, ‘transcription’, ‘DNA modifications’, ‘RNA modifications’, 
‘signaling’, ‘phosphorylation’, and ‘others’ (Figure 9A). The majority of these pathways 
presented a generalized up-regulatory pattern in their functions. Only pathways related to 
DNA and RNA modification showed a generalized down-regulatory pattern in their functions. 
The categories ‘cell cycle’, ‘immune system’, and ‘others’ exhibited a more mixed expression 
patterns with up, down, and transient-up regulations. 
 
Taking these data into account, we focused on the major pathways that are grouped 
under the up-regulatory pattern. We found that the transcription profile revealed several up-
regulatory changes in functions related to metabolism, specially glycolisis (GO:0006096) and 
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catabolism of different macromolecules (Figure 9A). In addition, the transcription profile 
analysis also showed up-regulatory changes in many functions related to transcription. 
Moreover, the phagocytic transcription profile analysis also revealed that all the functions 
grouped under ‘neurogenesis’ term appeared significantly up-regulated. Only enriched 
functions with P value <0.05 were considered. Many of these changes in biological functions 
were also observed by ClueGO and IPA functional analysis and will be further detailed in 
sections 6.3.2, 6.3.3 and 6.3.4. 
 
In addition to study changes in biological functions, we also analyzed which pathways 
were enriched in the regulatory patterns. We specially focused on the UP and DOWN patterns 
in the pathways found using DAVID (Figure 9B). First, we found a variety of ubiquitous classical 
signaling pathways (MAPK (mitogen-activated protein kinase), Ras, AMPK (AMP-activated 
protein kinase), PI3K-Akt (phosphatidylinositol3 kinase), cAMP, etc.). In addition, the analysis 
of the UP-regulated pattern also revealed several significantly enriched pathways related to 
neurogenesis such as ‘neurotrophin signaling pathway’, ‘TNF (tumor necrosis factor) signaling 
pathway’, ‘Dopaminergic synapse’, ‘Notch signaling pathway’, ‘Wnt (Wingless) signaling 
pathway’, ‘VEGF (vascular endothelial growth factor) signaling pathway’ and ‘Axon guidance’. 
Besides, we shall also highlight the significant enrichment in Hif1 signaling pathway, since, as 
we will further explain in section 6.3.4, this transcription factor is able to regulate metabolism 
as well as trigger the release of several trophic factors. On the other hand, the analysis of the 
DOWN-regulated pattern showed more miscellanea results (Figure 9C). The analysis revealed a 
general down regulation in several organelles such as ribosomes, lysosomes, and peroxisomes. 
Importantly, it also showed a shutdown of the oxidative phosphorylation and metabolic 
pathways, a result that will also be found in IPA analysis (section 6.3.3) and further explained 
in section 6.3.4. 
 
Therefore, both GO terms and pathway analysis by DAVID software revealed several 
neurogenesis-related functions in phagocytic microglia suggesting that phagocytic microglia 
might be involved in the maintenance and correct regulation of the neurogenic niche.  
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Figure 9. Functional analysis of phagocytic microglia by DAVID. [A] Functional analysis of phagocytic 
microglia using DAVID software. Left axis represents the fold enrichment of each biological function and 
right axis represents the adjusted p-value of each GO term. The regulatory patterns of each function are 
represented under the following color code: UP (green), DOWN (purple), Transient-UP (blue), and 
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Transient-DOWN (orange). Key for the GO terms: GO:0014032, neural crest cell development; 
GO:0045664, regulation of neuron differentiation; GO:0050767, regulation of neurogenesis; 
GO:0019226, transmission of nerve impulse; GO:0007049, cell cycle; GO:0051301, cell division; 
GO:0008283, cell proliferation; GO:0000278, mitotic cell cycle; GO:0008284, positive regulation of cell 
proliferation; GO:0051726, regulation of cell cycle; GO:0042127, regulation of cell proliferation; 
GO:0048762, mesenchymal cell differentiation; GO:0045596, negative regulation of cell differentiation; 
GO:0045597, positive regulation of cell differentiation; GO:0006935, chemotaxis; GO:0016477, cell 
migration; GO:0048870, cell motility; GO:0060485, mesenchyme development; GO:0051094, positive 
regulation of developmental process; GO:0060284, regulation of cell development; GO:0007517, muscle 
organ development; GO:0035295, tube development; GO:0007507, heart development; GO:0051094, 
positive regulation of developmental process; GO:0060429, epithelium development; GO:0001525, 
angiogenesis; GO:0001568, blood vessel development; GO:0048514, blood vessel morphogenesis; 
GO:0042981, regulation of apoptosis; GO:0043067, regulation of programmed cell death; GO:0006955, 
immune response; GO:0002520, immune system development; GO:0006954, inflammatory response; 
GO:0045321, leukocyte activation; GO:0002694, regulation of leukocyte activation; GO:0007626, 
locomotory behavior; GO:0030036, actin cytoskeleton organization; GO:0007015, actin filament 
organization; GO:0030029, actin filament-based process; GO:0006096, glycolysis; GO:0046365, 
monosaccharide catabolic process; GO:0006796, phosphate metabolic process; GO:0006796, phosphate 
metabolic process; GO:0051173, positive regulation of nitrogen compound metabolic process; 
GO:0045935, positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic 
process; GO:0051254, positive regulation of RNA metabolic process; GO:0016568, chromatin 
modification; GO:0016481, negative regulation of transcription; GO:0010628, positive regulation of gene 
expression; GO:0045941, positive regulation of transcription; GO:0045944, positive regulation of 
transcription from RNA polymerase II promoter; GO:0045893, positive regulation of transcription, DNA-
dependent; GO:0045449, regulation of transcription; GO:0006357, regulation of transcription from RNA 
polymerase II promoter; GO:0051276, chromosome organization; GO:0006310, DNA recombination; 
GO:0006260, DNA replication; GO:0006974, response to DNA damage stimulus; GO:0034660, ncRNA 
metabolic process; GO:0009451, RNA modification; GO:0043039, tRNA aminoacylation; GO:0006399 
tRNA metabolic process; GO:0007267, cell-cell signaling; GO:0007242, intracellular signaling cascade; 
GO:0007243, protein kinase cascade; GO:0051056, regulation of small GTPase mediated signal 
transduction; GO:0007264, small GTPase mediated signal transduction; GO:0016055, Wnt receptor 
signaling pathway; GO:0016310, phosphorylation; GO:0043038, amino acid activation; GO:0001775, cell 
activation; GO:0001775, cell activation; GO:0033554, cellular response to stress; GO:0030097, 
hemopoiesis; GO:0044271, nitrogen compound biosynthetic process; GO:0048285, organelle fission; 
GO:0009891, positive regulation of biosynthetic process; GO:0010557, positive regulation of 
macromolecule biosynthetic process; GO:0051258, protein polymerization; GO:0050865, regulation of 
cell activation; GO:0044057, regulation of system process; GO:0006979, response to oxidative stress; 
GO:0070482, response to oxygen levels; GO:0009611, response to wounding; GO:0022613, 
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ribonucleoprotein complex biogenesis; GO:0051225, spindle assembly; GO:0006412, translation. [B] 
Pathway analysis of the UP-regulated pattern of phagocytic microglia using DAVID software. Left axis 
represents the fold enrichment of each biological function and right axis represents the adjusted p-value 
of each GO term. Only statistically significant changes are shown. [C] Pathway analysis of the DOWN-
regulated pattern of phagocytic microglia using DAVID software. Left axis represents the fold enrichment 
of each biological function and right axis represents the adjusted p-value of each GO term. Only 
statistically significant changes are shown. 
 
6.3.2. Functional analysis of the phagocytic microglia transcriptome by 
ClueGO  
To obtain further information from the array data, we also performed a functional 
analysis of the phagocytic microglia transcriptome with the ClueGO network 
(http://apps.cytoscape.org/apps/cluego), which allows investigating interrelationships among 
pathways. Gene-annotation enrichment analysis based on ClueGO, a computational tool that 
integrates GO terms as well as Kyoto encyclopedia of genes and genomes (KEGG)/ BioCarta 
pathways (Bindea et al., 2009), also revealed a number of functional biological pathways 
associated with each of the four main expression patterns of the phagocytic microglia obtained 
from the array. 
 
The network graph showed several enriched GO terms for each expression pattern. 
Related terms were automatically grouped under the highest enriched term and, in turn, 
groups were connected based on shared genes (kappa score or k score; k score was fixed at 
0.8, which means that only groups that share 80% of the genes or more will be connected) 
(Figure 10). Similarly to those results obtained from the DAVID analysis, ClueGO also showed 
downregulation in pathways related to DNA and chromosomes. In addition, different functions 
associated with metabolism also exhibited an upregulation. Importantly, for many upregulated 
genes, ClueGO revealed specific terms like ‘generation of neurons’, ‘neuron differentiation’ or 
‘neuron development’ that were grouped under the term ‘Neurogenesis’ and had a direct 
interrelation with ‘Neuron projection development’ group. Altogether, both DAVID and 
ClueGO analyses suggest that phagocytosis triggers a neurogenic-modulator program in 
microglia. 
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Figure 10. Functional analysis of phagocytic microglia by ClueGO. Functional analysis of phagocytic 
microglia using ClueGO software. Charts showing the interactions among the significantly different 
functions for the four main expression patterns. Biological pathways are visualized as colored nodes 
linked to related groups based on their kappa score level. The node size reflects the enrichment 
significance of the term and functionally related groups are linked. Non-grouped terms are shown in 
grey. 
 
6.3.3. Functional analysis of the phagocytic microglia transcriptome by 
WGCNA and IPA analysis 
In order to independently analyze the transcriptomic profile of phagocytic microglia, we 
established a collaboration with Erik Boddeke (University Medical Center of Groningen, The 
Netherlands).  
 
First, we performed a weighted gene co-expression network analysis (WGCNA), a 
method to study biological networks that allows defining gene modules (clusters). Filtering was 
performed on the raw datasets of the array. A cut-off was determined by the 95 quantile of 
the controls and at least four samples needed to have an expression higher than this cut-off 
before gene expression was determined. With these conditions, 34,617 probes were selected 
for further classification. We found four main modules that showed significant changes and 
carried biological information (Figure 11). The yellow module presented an up-regulatory 
pattern throughout the phagocytosis time course (Figure 11A), whereas on the contrary, 
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brown module was defined as down-regulatory pattern along the time course (Figure 11B). 
There were also blue and turquoise modules, which presented a pattern that switched at 3h of 
phagocytosis, up regulation at 3h and down regulation at 24h for the blue module (Figure 11C) 
and down regulation at 24h and up regulation at 24h for the turquoise module (Figure 11D). 
The four modules found by WGCNA analysis, highly resembled the results obtained by R-
squared (rsq)> 0.9 criterion analysis where we had found the four main expression patterns 
(Figure 8 G-J). 
 
In order to give some insight into the signature of the modules of the WGCNA, we next 
performed an Ingenuity Pathway Analysis (IPA) as a functional analysis. Similar to the results 
obtained with DAVID (section 3.1), the Yellow module (up-regulatory profile) also showed 
strongly significant GOs related to neurogenesis, such as ‘positive regulation of dendrite 
development’ (GO:1900006), ‘regulation of synaptic plasticity’ (GO:0048167), and ‘neuron 
projection development’ (GO:0031175) among others (Figure 11E). In addition, Yellow module 
also displayed some functions associated with metabolism (‘negative regulation of catalytic 
activity’, GO:0043086) of chromatin modification (‘covalent chromatin modification’, 
GO:0016569). On the other hand, the Brown module (down-regulatory profile) showed a 
miscellany of functions, some of them related to junctions (‘cell substrate adherens junction’, 
GO:0005924 or ‘cell matrix junction’, GO:0009989) or transport (‘intracellular protein 
transport’, GO:0006886) (Figure 11F). The Blue module (transient up-regulatory profile) 
displayed a large number of significantly changed GO associated with cell cycle, such as ‘G1 
phase’ (GO:0051318), ‘mitotic cell cycle checkpoint’ (GO:0007093) or ‘cytokinesis’ 
(GO:0000910) among others (Figure 11G). Finally, the Turquoise module (transient down-
regulatory profile showed some significant changes in functions related to vesicles, such as 
‘trans golgi network transport vesicle’ (GO:0030140) or ‘coated vesicle’( GO:0030135) (Figure 
11H). 
 
In addition, we also studied the top canonical KEGG pathways that were enriched in 
each module (Figure 11I). We found that both the Yellow and the Brown module shared some 
pathways such as EIF2 (eukaryotic initiation factor 2) and mTOR (mammalian target of 
rapamycin) signaling. The Brown module also presented changes in Oxidative Phosphorylation, 
suggesting that phagocytic microglia might undergo metabolic modifications. As stated above 
(section 3.1), DAVID analysis also showed changes in metabolism, such as an increase in 
glycolysis. In addition, the Blue module revealed changes in different signaling pathways and in 
Fcγ (fragment crystallizable γ) receptor-mediated phagocytosis. The Turquoise module showed 
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changes in pathways related to NGF (nerve growth factor) signaling and glucocorticoid 
receptor signaling. 
 
Thus, the three functional analyses performed (DAVID, ClueGO and IPA) revealed several 
neurogenesis-related functions in phagocytic microglia suggesting that phagocytic microglia 
might be involved in the maintenance and correct regulation of the neurogenic niche.  
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Figure 11. Functional analysis of phagocytic microglia by WGCNA and IPA analysis. [A] Yellow module 
obtained by WGCNA analysis presented an up-regulatory pattern. [B] Brown module obtained by 
WGCNA analysis presented a down-regulatory pattern. [C] Blue module obtained by WGCNA analysis 
presented a transient up-regulatory pattern. [D] Turquoise module obtained by WGCNA analysis 
presented a transient down-regulatory pattern. [E] IPA analysis showing top 20 significantly changed GO 
terms associated to Yellow module. GO:0022613, ribonucleoprotein complex biogenesis; GO:0006396, 
RNA processing; GO:0043603, cellular amide metabolic process; GO:0034622, cellular macromolecular 
complex assembly; GO:0044265, cellular macromolecule catabolic process; GO:0007005, mitochondrion 
organization; GO:0006974, cellular response to DNA damage stimulus; GO:0031175, neuron projection 
development; GO:0090150, establishment of protein localization to membrane; GO:0016569, covalent 
chromatin modification; GO:0048167, regulation of synaptic plasticity; GO:1905114, cell surface receptor 
signaling pathway involved in cell-cell signaling; GO:0060341, regulation of cellular localization; 
R.HSA.1852241, organelle biogenesis and maintenance; GO:0007017, microtubule-based process; 
GO:0043086, negative regulation of catalytic activity; GO:2000573, positive regulation of DNA 
biosynthetic process; GO:1900006, positive regulation of dendrite development; GO:0051338, regulation 
of transferase activity; ko05010, Alzheimer's disease.  [F] IPA analysis showing top 20 significantly 
changed GO terms associated to Brown module. GO:0030054, cell junction; GO:0005657, replication 
fork; GO:0016323, basolateral plasma membrane; GO:0031252, leading edge; GO:0005912, adherens 
junction; GO:0005924, cell substrate adherens junction; GO:0009989, cell matrix junction; GO:0001726, 
ruffle; GO:0005925, focal adhesion; GO:0044427, chromosomal part; GO:0006886, intracellular protein 
transport; GO:0032270, positive regulation of cellular protein metabolic process; GO:0015031, protein 
transport; GO:0019955, cytokine binding; GO:0005794, golgi apparatus; GO:0007599, hemostasis; 
GO:0017038, protein import; GO:0051325, interphase; GO:0044431, golgi apparatus part; GO:0006915, 
apoptotic program.  [G] IPA analysis showing top 20 significantly changed GO terms associated to Blue 
module. GO:0051321, meiotic cell cycle; GO:0051318, G1 phase; GO:0004422, metalloendopeptidase 
activity; GO:0000794, condensed nuclear chromosome; GO:0004527, exonuclease activity; GO:0004707, 
MAP kinase activity; GO:0000775, chromosome rericentric region; GO:0000776, kinetochore; 
GO:0000910, cytokinesis; GO:0051301, cell division; GO:0008237, metallopeptidase activity; 
GO:0000793, condensed chromosome; GO:0006310, DNA recombination; GO:0007565, female 
pregnancy; GO:0000279, M phase; GO:0007093, mitotic cell cycle checkpoint; GO:0022402, cell cycle 
process; GO:0051017, actin filament bundle formation; GO:0051640, organelle localization; 
GO:0001934, positive regulation of protein amino acid phosphorylation. [H] IPA analysis showing top 20 
significantly changed GO terms associated to Turquoise module. GO:0044437, vacuolar part; 
GO:0005765, lysosomal membrane; GO:0005774, vacuolar membrane; GO:0030136, clathrin coated 
vesicle; GO:0043235, receptor complex; GO:0030140, trans golgi network transport vesicle; GO:0008360, 
regulation of cell shape; GO:0022604, regulation of cell morphogenesis; GO:0046519, sphingoid 
metabolic process; GO:0006959, humoral immune response; GO:0007423, sensory organ development; 
GO:0016627, oxidoreductase activity acting on the ch-ch group of donors; GO:0005179, hormone 
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activity; GO:0016830, carbon carbon lyase activity; GO:0005048, signal sequence binding; GO:0000151, 
ubiquitin ligase complex; GO:1903622, transcription from RNA polymerase III promoter; GO:0004930, G 
protein coupled receptor activity; GO:0051087, chaperone binding; GO:0030135, coated vesicle. [I] IPA 
analysis showing significantly changed top 5 canonical pathways associated to each module. 
 
6.3.4. Functional analysis of the phagocytic microglia transcriptome 
reveals changes in apoptosis 
The functional analysis of the phagocytic microglia transcriptome using DAVID analysis 
(sections 6.3.1) showed significant up-regulated changes in functions related to the regulation 
of cell death. The genes associated to these functions encoded a mixture of cytoplasmic and 
nuclear proteins i.e., genes that would act directly on the cell expressing them (autologous 
genes); as well as released proteins or membrane proteins acting on neighbor cells, i.e., genes 
whose protein would exert their function outside the expressing cell (heterologous genes) 
(Figure 6). We found that the majority of the cell death-related heterologous genes were anti-
apoptotic, suggesting that the effect that microglial phagocytosis might exert over the 
neurogenic cascade could be related to an increase in neuroprotection or survival. On the 
other hand, the majority of the autologous genes were pro-apoptotic; however, autologous 
genes expressed by phagocytic microglia can only affect the expressing cell, and therefore, 
these pro-apoptotic genes would not modulate neurogenesis (Figure 12). Nevertheless, the 
fact that phagocytic microglia expressed autologous pro-apoptotic genes could explain the 
increase in microglial apoptosis that we observed upon phagocytosis (Figure 6, 7).  
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Figure 12. Functional analysis of the phagocytic microglia transcriptome reveals changes in apoptosis. 
Classification of the genes related to death cell obtained from DAVID analysis. The genes were classified 
according to their FC, to the effects on microglia (autologous) or on the surrounding cells (heterologous) 
and to the positive or negative effect on apoptosis. 
 
6.3.5. Functional analysis of the phagocytic microglia transcriptome 
reveals changes in metabolism 
The functional analysis of the phagocytic microglia transcriptome using different 
bioinformatic tools (sections 6.3.1, 6.3.2 and 6.3.3) revealed significant changes in different 
metabolic pathways such as glycolysis and oxidative phosphorylation, which highly suggested 
that phagocytosis might trigger some metabolic modification in microglia. In order to analyze 
these changes in depth, we searched in the array for the main genes involved in glycolysis, 
oxidative phosphorylation, and glucose and lactate transport (Figure 13A). We found that in 
general terms, genes encoding glycolytic enzymes were up-regulated, whereas mitochondrial 
Krebb’s cycle and oxidative phosphorylation were down-regulated. In addition, lactate shuttles 
were up-regulated, suggesting that instead of processing pyruvate in the mitochondria, 
phagocytic microglia might convert pyruvate to lactate through lactic fermentation and release 
it through lactic shuttles. The possible metabolic switch from oxidative phosphorylation to 
glycolysis in phagocytic microglia might be a key signature of phagocytosis but is out of the 
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scope of this thesis and will be studied in the future by analyzing mitochondrial respiration and 
glycolysis in live naïve and phagocytic microglia cells with an Agilent Seahorse XF Analyzer. 
 
Interestingly, our arrays suggest one key candidate to regulate metabolic adaptations in 
phagocytic microglia: the Hif-1α signaling pathway (Figure 13B). Hif-1α (Hypoxia-inducible 
factor-1-α) is a heterodimeric transcription factor considered the master transcriptional 
regulator in response to hypoxia (Nizet and Johnson, 2009). Under hypoxic conditions, Hif1α 
induces the transcription of more than 60 genes, including VEGF and erythropoietin, which are 
involved in biological processes such as angiogenesis and erythropoiesis (Lee et al., 2004), and 
neurogenesis (Nowacka and Obuchowicz, 2012). In addition, Hif-1α also exerts hypoxia-
independent functions by inducing transcription of genes involved in cell proliferation and 
survival, as well as glucose and iron metabolism (Weidemann and Johnson, 2008). More 
specifically, Hif-1α promotes anaerobic metabolism (glycolysis) and inhibits Krebb’s cycle, 
functions that highly resembles the gene expression pattern found in our array data.  
 
Therefore, since phagocytic microglia presents a transcriptional profile suggestive of  
enhanced glycolysis and decreased Krebb’s cycle, and it also displays a variety of functions that 
might regulate neurogenesis, we propose that Hif-1α might be a possible master regulator of 
the metabolic and neurogenic functions of phagocytic microglia. Along with the metabolic 
switch, the role of Hif-1α in phagocytic microglia will be studied in depth outside this project. 
 
RESULTS 
128 
 
 
Figure 13. Functional analysis of the phagocytic microglia transcriptome reveals changes in 
metabolism. [A] Schematic representation of the metabolic pathways of the phagocytic microglial cell 
and the main genes changed in each of them. Up-regulated genes are shown in green and down-
regulated genes are shown in purple. [B] Hif1 signaling pathway scheme obtained by DAVID software. 
The red star shows the significantly changed molecules of the array in the pathway. 
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6.4. THE POTENTIAL MODULATORS OF NEUROGENESIS ARE MAINLY 
PEPTIDES AND HORMONES 
 
6.4.1. The validation of phagocytosis-related neurocandidates confirms 
the expression of several potential modulators of neurogenesis triggered 
by microglial phagocytosis 
After confirming the existence of an up-regulation in the function of neurogenesis by 
phagocytic microglia in the three functional analyses with DAVID, ClueGO, and IPA, we focused 
on the identity of the neurogenesis-related genes. In order to avoid excluding any candidate 
gene due to our initial highly strict filtering (rsq > 0.9), we stepped back and used a less 
restrictive (rsq > 0.7) gene list that contained 20,800 probes with no further screening of the 
fold change.  
 
To identify the potential regulators of neurogenesis, we compared our database with 
MANGO (The Mammalian Adult Neurogenesis Gene Ontology), a database of genes already 
described to be involved in the regulation of adult hippocampal neurogenesis (Overall et al., 
2012). The MANGO database enlists 259 neurogenesis-related genes that include a large range 
of molecules such as transcription factors (E2F1, E2F transcription factor 1; Atf1, activating 
transcription factor 1), enzymes (Plcγ, phospholipase C γ; Rrm1, ribonucleotide reductase 
catalytic subunit M1), cell cycle molecules (Cyclins), receptors (dopamine, glutamate or ephrin 
receptors), growth factors (IGF1, VEGF) etc. We compared our list of 20,800 probes with the 
MANGO database and found that 213 MANGO genes were differentially expressed in naïve vs 
phagocytic microglia.  
 
In this list of 213 MANGO genes, there were two different types of neurogenesis-related 
genes. One set of genes encoded receptors as well as cytoplasmic and nuclear proteins, i.e., 
genes that would act directly on the cell expressing them (autologous genes). An example of 
an autologous gene is the transcription factor REST (RE1 silencing transcription factor), which 
is a molecule involved in neurogenesis when expressed by neuroprogenitor cells since it 
represses neuronal genes {Kohyama, 2010 #12027}. The other set of genes encoded released 
proteins or membrane proteins (ligands, metalloproteases, etc.) acting on neighbor cells, i.e., 
genes whose protein would exert their function outside the expressing cell (heterologous 
genes). An example of a heterologous gene is the trophic factor EGF (epidermal growth factor), 
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which can be expressed by different types of cells within the neurogenic niche in order to 
affect neurogenesis. We focused on heterologous genes, as only their expression in microglia 
could influence neurogenesis.  
 
Using the criteria defined above (where we only focused on proteins that were released 
or bound to the membrane), we found that the MANGO database contained 26 heterologous 
genes that had previously been involved in regulating neurogenesis. To further extend the list 
of heterologous genes in our array that could be potential regulators of neurogenesis genes 
outside of the MANGO database, we developed the following strategy. First, we found the GO 
terms associated with each MANGO heterologous gene and selected those terms that could be 
related to different steps of the neurogenic process (proliferation, differentiation, migration, 
chemotaxis, survival and development). The MANGO heterologous genes encompassed 57 
different neurogenesis-related GO terms, such as growth factor activity (GO:0008083), nervous 
system development (GO:0007399), learning (GO:0007612), memory (GO:0007613), cell 
proliferation (GO:0008283), cell differentiation (GO:0030154), neuron development 
(GO:0048666), etc. Next, we found in our arrays the genes with differential expression 
between naïve and microglia that were associated to each neurogenic GO term, generating 57 
gene lists in our arrays. As each gene could be classified under more than one neurogenesis-
related GO term, we next double crossed the 57 gene lists to obtain a single list which 
comprised 1,669 non-repeated neurogenic genes.  
 
At this point, our neurogenic gene list from the array contained both heterologous and 
autologous genes; therefore, in order to select only the heterologous genes, we again double-
crossed the neurogenic gene list with two gene lists obtained by the search of the GO terms 
extracellular region (GO:0005576) and extracellular space (GO:0005615), and obtained 281 
neurogenic heterologous genes in our arrays. Finally, genes that encoded receptors were 
discarded manually with the help of Protein Analysis Through Evolutionary Relationships 
(PANTHER, http://pantherdb.org/), a comprehensive software system for inferring the 
functions of genes based on their evolutionary relationships. In addition PANTHER also 
provides information about each gene, allowing us to discard 57 genes that encoded receptors 
[Note: it is coincidental that 57 genes were discarded and that 57 gene lists were generated 
from the GO terms contained in MANGO]. In order to validate our strategy, we checked the 26 
heterologous MANGO genes in our screened neurogenic list and found that all had been 
selected, confirming our methodology as a valid filtering approach to discover heterologous 
neuroregulatory genes. Therefore, we finally selected 224 genes with differential expression 
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between naïve and phagocytic microglia, which were heterologous, non-receptors, and whose 
function had been previously involved in neurogenesis. The 224 neurocandidate genes were 
classified according to the main regulatory expression patterns: 94 genes UP, 73 DOWN, 28 
Transient-UP and 29 Transient-DOWN (Figure 14).  
 
 
Figure 14. Phagocytic microglia express several potential modulators of neurogenesis. Diagram 
depicting the strategy followed to search for potential modulators of neurogenesis produced by 
phagocytic microglia in the arrays. The filtering started by differentiating the heterologous and 
autologous genes in the MANGO database. Then, GO terms related to neurogenesis were selected for 
the heterologous MANGO genes. Afterwards, the molecules that presented the neurogenic GO terms 
were searched in the array. Finally, the genes were filtered only to select those that appeared 
extracellularly (heterologous genes), and genes with receptor activity were discarded. 
 
6.4.2. The potential modulators of neurogenesis are mainly peptides and 
hormones 
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After identifying the 224 neurocandidate genes, we performed a further classification to 
determine their nature. Using again PANTHER, the neurocandidates were grouped according 
to Panther Protein Class, which gives information about the type of protein that encoded by a 
gene (for example, growth factor, chemokine, membrane-bound signaling molecule, etc.). Ten 
different categories were established: trophic factors, peptides and hormones, chemokines, 
cytokines, membrane-bound signaling molecules, extracellular matrix, signaling molecules, 
enzymes, enzymes inhibitors, and others. We found that in the four regulation patterns, the 
majority of the genes were categorized as trophic factors (between 23-29% in all regulatory 
patterns). We also found cytokines, chemokines and peptides and hormones as the main gene 
types of the neurocandidates. Despite the fact that trophic factors were found to be the 
largest percentage in each regulation pattern, they showed a similar and rather lower mean FC 
(4.7 ± 1.2% in UP, 3.5 ± 1.4% in DOWN, 2.4 ± 0.6% in Transient-UP and 1.6 ± 0.2% in Transient-
DOWN) than the other categories. Only the up-regulated peptides and hormones revealed a 
large mean of 800 FC at both 3h and 24h of phagocytosis (Figure 15A, B). This data suggests 
that peptides and hormones are the most likely molecules to perform neurotrophic functions 
in the neurogenic niche by phagocytic microglia. 
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Figure 15. Phagocytosis-related neurocandidates include trophic factors and peptides and hormones. 
[A] A further classi ication o  the 224 potential modulators o  neurogenesis. ‘ rophic  actor’ is the 
category with the highest percentage of genes in every regulatory pattern, however, the category 
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‘ eptides and Hormones’ includes genes with the highest  C changes in the UP regulation pattern. [B] 
The 224 neurocandidates classified by their identity and FC. 
 
6.4.3. The validation of phagocytosis-related neurocandidates confirms 
the mRNA expression of several potential modulators of neurogenesis 
triggered by microglial phagocytosis 
Next, we validated the mRNA expression of the neurocandidates in naive and phagocytic 
microglia by RT-qPCR. We selected a subset of genes for validation considering both the high 
FC obtained in the array and/or the well-known neuromodulatory potential described in the 
literature: VGF (non-acronym), Cartpt (cocaine- and amphetamine-regulated transcript 
prepropeptide), FGF2 (fibroblast growth factor), VEGFa (vascular endothelial growth factor A), 
PDGFa (platelet-derived growth factor A), IGF-1 (insulin growth factor 1), MMP3 (matrix 
metallopeptidase 3), Jag1 (jagged 1), CSF3 (colony stimulating factor 3), IL-1β (interleukin-1β), 
IL-6 (interleukin-6), TNF-α (Tumor necrosis factor-α), and TGF-β (transforming growth factor-
β). We also included some classical trophic factors (Brain Derived Neurotrophic Factor, BDNF; 
Epidermal Growth Factor, EGF; Glial Cell Derived Neurotrophic Factor, GDNF; Nerve Growth 
Factor, NGF; and Neurotrophin 4, NT4) that were not detected in the array, probably due to 
any technical problem that lead to missing values of the probes in the array.  
 
We found that the expression pattern of the selected neurocandidates determined by 
RTqPCR was largely in agreement with that obtained in the arrays. Among the genes with the 
largest mRNA expression were the neuropeptide VGF (no abbreviation), the matrix 
metalloprotease 3 (MMP3), and the cytokine colony stimulating factor 3 (CSF3) (Figure 16A, 
B). Some of the high FC genes from the array (Secretogranin II, SCG2; Delta-like4, Dll4; and 
Delta-like3, Dll3) were not significantly changed, while some of the added classical trophic 
factors (BDNF, NT4, and NGF) were not detected by RT-qPCR either (data not shown). This 
validation of neurocandidates reinforced the idea that phagocytosis promotes the production 
of neurotrophic molecules by microglia. 
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Figure 16. Validation of phagocytosis-related neurocandidates by RT-qPCR. [A] Summary of the FC in 
the array of the neurocandidate genes selected for validation. Up-regulated FCs are displayed in green 
and down-regulated FCs in red. Different color intensities show ranges of FC: <2FC (light), 2-4FC 
(medium), >4FC (dark). Those genes not detected in the array have no color. [B] mRNA expression levels 
of the neurocandidates selected for validation by RT-qPCR. N=4. HPRT was selected as a reference gene. 
Bars represent mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-
Sidak posthoc test (after one-way ANOVA was significant at p < 0.05). Only significant effects are shown. 
 
6.4.4. The increase of potential modulators of neurogenesis by 
phagocytic microglia is also triggered by physiological levels of apoptotic 
cells and even before the engulfment of apoptotic cells 
Up until now, we had worked with the most classically used in vitro phagocytosis assay 
in which microglia were fed with a large amount of phagocytic targets (10:1 apoptotic cells to 
microglia (Witting et al., 2000). Since in physiological conditions in adult mice microglia is not 
challenged with such high rates of apoptotic cells, we switched our assay to a more 
physiological paradigm; thus, we varied the proportion of apoptotic cells to 1:1. In this model, 
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we first tested whether the features of the 10:1 model were conserved. We fed primary 
microglia with apoptotic SH-SY5Y and allowed them to phagocytose through a time course of 
1, 3, 5, 15 and 24h (Figure 17A, B). In the 1:1 model, microglia showed a very similar response 
compared to the previous paradigm. As early as 1h, 49.2 ± 2.7% of microglia were already 
engaged in phagocytosis, and as expected, this percentage kept increasing over time reaching 
92.2 ± 4.5% of phagocytosis at 24h (Figure 17C). A further analysis of the different engulfed 
particles (DAPI, CM-DiI or DAPI and CM-DiI) revealed that the proportion of each inclusion type 
varied throughout the time course. At early time points, more and larger DAPI and CM-DiI 
particles were observed, whereas at later time points, as apoptotic cells degrade within 
microglia, small and numerous CM-DiI inclusions were detected (Figure 17D). There was a 
small decrease in microglia cell numbers along the time course (Figure 17E), which was in 
accordance with a small increase in microglial apoptosis. Microglial apoptosis never reached 
more than the 6.9 ± 4.8 % of the total (Figure 17F). 
 
We also validated the expression of the neurocandidates by RT-qPCR in the 1:1 model 
(Figure 17G). The neuropeptide VGF, metalloprotease MMP3, and cytokine CSF3 were some of 
the genes with largest increase in mRNA expression. Overall, phagocytosis induced similar 
changes in neurocandidates regardless of the amount of apoptotic cells. In addition, we delved 
into the requirements for triggering the neurogenic program, whether a physical contact 
between microglia and apoptotic cells (tethering and engulfment) was necessary or whether 
the program started in microglia as soon as they sensed the find-me signals released from 
apoptotic cells. For this purpose, we also added media obtained from apoptotic cells to naïve 
microglia and analyzed the mRNA expression of neurocandidates after 24h (Figure 17G). We 
found that candidates from extracellular space (matrix and cell-surface) and cytokines were 
highly up-regulated after culturing microglia with apoptotic cell media. The obtained mRNA 
levels in this group were very similar to those at 24h of phagocytosis (Ph24h). However, the 
majority of ‘peptides and hormones’ and ‘trophic factors’ were not significantly changed. 
These results suggest that the neurogenic program triggered by microglial phagocytosis might 
be initiated by the detection of find-me signals, but further steps in the phagocytic process are 
required to develop a complete neurogenic program. 
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Figure 17. Validation of a physiological model of phagocytosis using a 1:1 proportion of apoptotic cells 
and microglia. [A] Experimental design of the phagocytosis assay. [B] Representative confocal 
microscopy images of primary microglia (GFP, green) fed with SH-SY5Y, which were previously labeled 
with CM-DiI (red) and treated with STP for the induction of apoptosis (pyknosis/karyorrhexis, DAPI, 
white). N, microglial nucleus; white arrowheads, phagocytosed apoptotic SH-SY5Y cells; blue 
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arrowheads, phagocytosed CM-DiI; scale bars, 30µm. z=6.3 µm. [C] Quantification of the percentage of 
microglia with CM-DiI and/or DAPI inclusions along a time course. Only fully closed pouches with 
particles within were identified as phagocytosis. [D] Breakdown of the percentage of each inclusion type 
(DAPI, CM-DiI or DAPI and CM-DiI). [E] Quantification of average microglia density in control and 
different phagocytic time points. [F] Quantification of the percentage of pyknotic microglia. N=3. Bars 
represent mean ± SEM. [G] mRNA expression levels of the neurocandidates selected for validation by RT-
qPCR in control microglia (microC), 24h phagocytic microglia (Ph24h) and microglia cultured with 
apoptotic cell media (Ph M dead). N=4 independent experiments. HPRT was selected as a reference gene. 
Bars represent mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-
Sidak posthoc test (after one-way ANOVA was significant at p < 0.05). Only significant effects are shown. 
 
6.5. CONDITIONED MEDIA FROM PHAGOCYTIC MICROGLIA AND NAÏVE 
MICROGLIA DRIVE NEUROPROGENITOR CELLS TOWARDS DIFFERENT 
PHENOTYPES 
Once we had validated that phagocytosis triggers the increase in the expression of 
several potential modulators of neurogenesis, we tested the effect of microglial phagocytosis-
related neurocandidates on neurogenesis in vitro. To model neurogenesis in vitro, we used 
neurospheres obtained from whole P0-P1 brains. Neuroprogenitor cells from disaggregated 
neurospheres were allowed to proliferate 48h in DMEM/F12 with trophic factor EGF/FGF2 
(Babu et al., 2011). We performed a neurogenesis differentiation assay in which 
neuroprogenitors were allowed to differentiate during a time course (1-5 days) in the presence 
of conditioned media from control (naïve microglia; CM microC) and phagocytic (CM microPH) 
microglia. DMEM was used as an internal control, as microglia were cultured in this media 
(Figure 18A, B). Cell death (apoptosis) was observed in all conditions, but higher rates of 
apoptosis were found in neuroprogenitor cells cultured in CM microPH, with a peak of 57.1 ± 
10.7% apoptosis at 3d of differentiation (Figure 18C, D) that diminished to 34.8 ± 8.3% at 5d 
(Figure 18E, F). On the contrary, apoptosis was maintained at both 3d and 5d and never 
reached more than 10.2 ± 3.8% in CM microC and DMEM (Figure 18D-F). However, apoptosis 
was quantified as pyknotic and karyorrhectic nuclei attached to the coverslips, therefore, total 
cell numbers do not match between different conditions because cells that were detached 
prior to fixation were not included, which led to an underestimation in the proportion of 
apoptotic cells in every condition (Figure 18C, E).  
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Figure 18. Effect of phagocytic microglia secreted factor on neurogenesis in vitro. [A] Experimental 
design of the in vitro neurogenesis assay. [B] Representative confocal microscopy images of 
neuroprogenitors treated with CM microC or microPH. DMEM was used as control. Scale bars, 20µm. z=9 
µm. [C] Total numbers of live and dead cells (determined by pyknosis/karyorrhexis) after CM treatment 
in 3d of differentiation. [D] Proportion of live and dead cells (determined by pyknosis/karyorrhexis) after 
CM treatment in 3d of differentiation. [E] Total numbers of live and dead cells (determined by 
pyknosis/karyorrhexis) after CM treatment in 5d of differentiation. [F] Proportion of live and dead cells 
(determined by pyknosis/karyorrhexis) after CM treatment in 5d of differentiation. Bars represent mean 
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± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-Sidak posthoc test 
(after one-way ANOVA was significant at p < 0.05). 
 
We next analyzed the cell types produced in the neurogenesis differentiation assay. We 
observed 4 major types of cells based on morphology and marker expression: bipolar, stellate, 
early-ramified, and late-ramified (Figure 19A). Unlabeled nuclei and cells with unclear 
morphology were not taken into account for the quantification (14.6 ± 4.1%).  
1. Bipolar cells presented an elongated shape and expressed high levels of nestin, an 
intermediate filament protein that is involved in proliferation and is commonly used as a stem 
cell marker (Lopez-Atalaya et al., 2017). They also expressed GFAP (glial fibrillary acid protein), 
another intermediate filament protein involved in migration and proliferation, which is 
generally used to distinguish astrocytes from other cell types, although is also expressed in the 
radial process of NSCs (Encinas and Sierra, 2012; Moeton et al., 2016). However, none of them 
expressed DCX (doublecortin), a microtubule-associated protein implicated in neuroblast 
migration (Brown et al., 2003).  
2. Stellate cells displayed a starry morphology with or without processes; they expressed 
high levels of GFAP, but showed variable levels of nestin and never presented DCX staining.  
3. Ramified cells had very thin processes and never expressed GFAP. Early ramified cells 
were less complex, expressed nestin, and could also express low levels of DCX; in contrast, 
late-ramified cells exhibited more process complexity. Some of the late-ramified cells had 
already lost nestin expression and all of them had high DCX expression. 
 
After identifying the different cell types, we quantified total numbers and the proportion 
of each of the cell types in the different CM media (Figure 19B-E). We found that CM microC 
treatment mainly produced stellate cells both at 3d and 5d (73.60% ± 6.90% and 69.81% ± 
2.18% respectively). Control (DMEM) conditions showed very similar results to CM microC, as 
stellate cells were the main phenotype (54.4 ± 2.9% at 3d). On the contrary, in CM microPH 
cultures, 72.8% ± 4.0% and 79.1% ± 8.9 cells were bipolar, whereas 14.9% ± 4.5% and 8.7% ± 
2.7% were stellated at 3d and 5d of differentiation, respectively. Therefore, we concluded that 
CM microC mainly drove cells towards a stellate phenotype (GFAPhigh, nestin+/-, DCX-) as well as 
ramified DCX+ cells, whereas CM microPH drove cells towards a bipolar phenotype (nestinhigh 
GFAP+, DCX-).  
 
Taking the morphology and the cell markers into account, stellate cells resemble to 
astrocytes in culture, whereas ramified DCX+ cells would belong to immature neuronal linage. 
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However, the identity of bipolar cells remained elusive and thus, we performed further studies 
to characterize this phenotype. 
 
 
Figure 19. CM microC and microPH give rise to different cell phenotypes in vitro. [A] Schematic shapes, 
representative confocal microscopy of the different morphologies observed in the neurogenesis assay 
images and a summary of the markers expressed by each cell type. [B] Quantification of total numbers of 
the different cell types found after 3d treatment with CMmicroC or microPH. [C] Quantification of the 
RESULTS 
142 
 
proportion of the different cell types found after 3d treatment with CM microC or microPH. [D] 
Quantification of total numbers of the different cell types found after 5d treatment with CM microC or 
microPH. [E] Quantification of the proportion of the different cell types found after 5d treatment with 
CM microC or microPH. Bars represent mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** 
indicates p < 0.001 by Holm-Sidak posthoc test (after one-way ANOVA was significant at p < 0.05). 
 
6.5.1. Identifying the nature of the bipolar phenotype triggered by 
conditioned media from phagocytic microglia 
In order to understand the identity of the bipolar cells produced by CM microPH, we 
performed several studies to characterize their phenotype. Since bipolar cells expressed nestin 
and GFAP but never showed DCX staining, we considered that these cells could be either 
astrocytes or still be progenitor cells. Therefore, we followed different strategies in order to 
prove this hypothesis.  
 
6.5.1.1. Bipolar cells triggered by conditioned media from phagocytic 
microglia are likely to be immature astrocytes 
First, we tested whether bipolar cells could be mature astrocytes. Since GFAP staining 
did not provide sufficient information on the maturity levels of astrocytes, as it labels both 
stem cells, mature astrocytes, and reactive astrocytes (Sierra et al., 2015), we stained the CM-
treated cultures with S100β, a marker of mature astrocytes and oligodendrocytes (Wang and 
Bordey, 2008) (Figure 20A).  
 
We found that in CM microC very few stellate cells (Nestin+/-, GFAPHigh) were S100β+ (0.7 
± 0.7% and 4.6 ±1.3% at 3 and 5d, respectively). However, the labeling in these cells was 
notorious but rather dim, suggesting that stellate cells were still immature astrocytes (Figure 
20B, C). In addition, we also found that 3.1 ± 1.3% and 1.6 ± 0.3% of cells at 3 and 5d, 
respectively were stained only by S100β but not by Nestin or GFP. Therefore, these cells were 
included in the unlabeled nuclei in the first differentiation experiment (Section 5). These cells 
expressed high levels of S100β and had several processes with smaller branches in each of 
them. Due to their well-defined morphology and expression marker, we identified these cells 
as oligodendrocytes (Wang and Bordey, 2008). On the other hand, in CM microPH, no 
oligodendrocytes were found and 64.0 ± 24.0% at 3d and 45.4 ±7.9% at 5d of bipolar and 91.7 
± 8.3 at 3d and 63.3 ± 3.3% at 5d of stellate cells presented a very dim S100β staining (all the 
pictures were compared to a negative control without primary antibody in the 
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immunofluorescence). Results with DMEM were very similar to those obtained with CM 
microC (Figure 20B, D). Therefore, the faint S100β expression in bipolar cells triggered by 
conditioned media from phagocytic microglia suggested that they could either be immature 
astrocytes or neuroprogenitors. 
 
Figure 20. S100β expression in CM cell types. [A] Experimental design of the in vitro neurogenesis assay 
 or S100β staining. [B] Representative confocal microscopy images of neuroprogenitors treated with CM 
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microC or microPH. DMEM was used as control. Scale bars, 20µm. z=9 µm. [C] Quantification of the 
proportion o  S100β in the di  erent cell types  ound a ter 3d treatment with C  microC or microPH. [D] 
Quanti ication o  the proportion o  S100β in the di  erent cell types  ound a ter 5d treatment with C  
microC or microPH. N = 2 independent replica. Bars represent mean ± SEM. 
 
6.5.1.2. Bipolar cells triggered by conditioned media from phagocytic 
microglia are unlikely to be pluripotent 
As mentioned above, bipolar cells expressed high amounts of nestin and GFAP. 
Hippocampal NSCs also display these markers in vivo (Encinas and Sierra, 2012) and thus, it 
was possible that bipolar cells represented an undifferentiated phenotype. In order to answer 
this question, we hypothesized that if bipolar cells were an undifferentiated form of 
neuroprecursors, they would possess the potential to give rise to neurons and astrocytes. 
Therefore, we differentiated the neuroprogenitor cells into stellate, ramified, and bipolar cells 
using CM microC and microPH for 3d. We then studied the pluripotency of these phenotypes 
by switching the culture media to DMEM/F12 culture media (the regular media to grow 
neurospheres) without trophic factors. We allowed cells to differentiate for another 5d and 9d. 
Treatments with CM 3d were always performed in parallel as control (Figure 21A, B).  
 
We found differences in cell density between the cultures that had been treated with 
CM microPH and CM microC or DMEM (Figure 21C). After the treatment with 3d CM microC or 
DMEM followed by 5d DMEM/F12 the cultures presented a density of 99.3 ± 9.3 and 104.5 ± 
7.0 of live cells respectively, a density that was maintained over time (9d). In contrast, 
culturing with 3d CM microPH followed by 5d DMEM/F12, live cells were at a density of 11.8 ± 
0.3 cells. The differences in cell density among treatments were the result of the culturing with 
the different CMs, as observed in Figure 19, and those differences were maintained after the 
switch to the DMEM/F12 media. We then analyzed the cell types resulting from differentiation 
after switching to DMEM/F12 in the pluripotency assay. The cultures that had been treated 
with CM microC presented a large proportion of stellate cells both at 5d (78.9 ± 1.1%) and 9d 
(92.8 ± 3.4%) and a small percentage of ramified cells (14.8 ± 0.9% at 5d; 3.8 ± 0.1% at 9d) 
(Figure 21D, E). Interestingly, after CM microPH treatment followed by DMEM/F12 we found 
that now the proportion between bipolar and stellate cells was inverted compared to the 
neurogenesis assay (Figure 19). We found a majority of stellate cells after 5d of DMEM/F12 
(57.4 ± 0.9%) and 42.6 ± 0.9% of bipolar cells, percentages that were maintained until 9d of 
DMEM/F12 (Figure 21D, E). No DCX+ cell was found after CM microPH followed by DMEM/F12 
treatment. This data strongly suggested that bipolar cells are unlikely to still be 
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neuroprogenitor cells since they only give rise to astrocytes and never to neuron-committed 
cells.  
 
These results, along with the S100β data, led us to perform a further characterization of 
the cells using calcium imaging to study the calcium response of these cells to certain stimuli, 
as we will explain in the next sections. 
 
Figure 21. Pluripotency assay in CM cell types. [A] Experimental design of the in vitro pluripotency 
assay. [B] Representative confocal microscopy images of neuroprogenitors treated with CM microC or 
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microPH followed by 5 or 9d of DMEM/F12. DMEM was used as control. Scale bars, 20µm. z=9 µm. [C] 
Quantification of the cell density after each treatment [D] Quantification of the proportion of the 
different cell phenotypes found after 3d treatment with CM microC or microPH followed by 5d 
DMEM/F12. [E] Quantification of the proportion of the different cell phenotypes found after 3d 
treatment with CM microC or microPH followed by 9d DMEM/F12. N = 2 independent replica. Bars 
represent mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-Sidak 
posthoc test (after one-way ANOVA was significant at p < 0.05). 
 
6.5.1.3. Bipolar cells triggered by conditioned media from phagocytic 
microglia belong to an astrocytic linage 
In order to further unravel the identity of bipolar cells, we characterized their calcium 
response to different insults: KCl, AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid), ATP (adenosine triphosphate), histamine, and NMDA (N-methyl-D-aspartate). KCl would 
trigger an intracellular Ca+2 response in excitable cells; AMPA and NMDA would depolarize 
neurons expressing the corresponding receptors (Bloodgood and Sabatini, 2008); ATP would 
activate purinergic receptors in astrocytes and neurons (De Melo Reis et al., 2011); and 
histamine would trigger intracellular Ca+2 response in immature cells through histamine 
receptor, which are highly expressed on immature/stem cells and embryonic stem cells (Eiriz 
et al., 2011). In order to visualize the Ca+2 response of the different cells, CM-treated 
neuroprogenitors were incubated and loaded with 5µM Fura-2 AM, a radiometric compound 
that changes its conformation upon Ca+2 binding and consequently changes its maximum 
excitation from 340nm to 380nm. Freshly dissociated neuroprogenitor cells were used to 
characterize the responses of neuroprogenitor cells to the different insults used and compare 
with the Ca+2 responses of bipolar cells (Figure 22A). In total, 38 stellate cells, 8 ramified cells, 
19 bipolar cells and 33 neuroprogenitor cells were analyzed in 2 independent experiments. We 
found that 69.7% neuroprogenitor cells responded to ATP and histamine and presented a 
hyperpolarization to KCl. In CM microC treated cultures (5d), 76.3% of stellate cells depolarized 
in response to KCl, AMPA and ATP, and 62.5% of ramified cells responded to every stimuli but 
NMDA, most likely because they were still immature astrocytes (Figure 22B,C). On the other 
hand, in CM microPH treated cultures, 89.5% of bipolar cells highly depolarized when 
incubated with ATP, and, in addition, they also presented a hyperpolarization in response to 
KCl (Fig 22B,C). These data showed that bipolar cells presented similarities with both 
neuroprogenitor cells and astrocytes, suggesting that bipolar cells are immature astrocytes. 
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Figure 22. Calcium imaging in CM cell types. [A] Experimental design of the in vitro calcium imaging 
assay. Neuroprogenitor cells were treated with CM microC or microPH for 5d and the resulting stellate, 
ramified and bipolar cells were incubated and loaded with Fura-2 AM and afterwards, cells were 
challenged with KCl, AMPA, ATP and Histamine in order to measure their Ca
+2
 response. [B] 
Representative epifluorescence microscopy images of neuroprogenitors treated with CM microC or 
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microPH for 5d. Freshly dissociated neuroprogenitor cells were used as control. [C] Quantification of the 
proportion of the different cell phenotypes responding to each stimulus. The baseline was calculated as 
the mean of the first 60sec of recording for each cell. Only peaks that increase or decrease 3 times the 
SEM of the baseline were considered as response. N = 2 independent replica.  
 
6.5.2. Identification of the molecules that drive the bipolar phenotype 
triggered by phagocytic microglia conditioned media 
 
6.5.2.1 Cytokines are unlikely to drive the bipolar phenotype triggered by 
phagocytic microglia conditioned media 
After characterizing bipolar cells as astrocyte-committed cells, we next focused on the 
identity of the molecules that could give rise to this phenotype. As we observed in the arrays 
(Figure 23), phagocytic microglia produce several cytokines, such as Csf3, IL-1β, IL-6, TNF-α, or 
TGF-β among others. In addition to phagocytosis, these molecules are also released by 
microglia upon an inflammatory stimulus and have already been reported to affect 
neurogenesis (Sierra et al., 2014; Valero et al., 2017). Thus, we focused our attention on these 
cytokines as the possible mechanism that drives the bipolar phenotype.  
 
Since cytokine expression after phagocytosis shares similarities with their expression in 
inflammation, we compared the phenotypes obtained from CM microPH, with the ones 
obtained from CM of microglia treated with LPS, a well-known inductor of inflammation and 
cytokine release (Cavaillon, 2017). 
 
First, we studied the mRNA expression of the cytokine neurocandidates by RT-qPCR in 
naïve, Ph24h or LPS-treated (150ng/ml;(Fraser et al., 2010)) microglia. Moreover, we added a 
group of cultures of Ph24h followed by LPS in order to determine whether microglial 
phagocytosis could alter the cytokine production induced by LPS exposure (Ph+LPS) (Figure 
23A). We found that Csf3, IL-1β and IL-6 presented significantly higher mRNA expression in all 
the treatments (Ph24h, LPS or Ph+LPS) compared to the control group. On the other hand, 
TNF-α showed a significantly increased expression in every treatment compared to naïve 
microglia and, additionally, LPS treatment induced higher levels of this cytokine than Ph24h or 
Ph+LPS. TGF-β mRNA increased after LPS and Ph+LPS treatments compared to the control 
group. 
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After determining that both phagocytic and LPS-treated microglia presented similar 
mRNA expression levels of the neurocandidate cytokines, we treated our neuroprogenitor 
culture with the LPS treated microglia CM (CM microLPS) to test whether these cytokines could 
be responsible of the bipolar phenotype found in CM microPH (Figure 23B). LPS was used as 
control and was maintained for the whole duration of the experiment. The first characteristic 
that we observed was that neither LPS nor CM microLPS treated neuroprogenitors presented a 
bipolar phenotype. Moreover, the vast majority of the cells in LPS and CM microLPS 
treatments, after both 3d (65.5 ± 7.8% in LPS and 63.9 ± 4.7% in CM microLPS) and 5d (75.2 ± 
4.4 in LPS and 63.8 ± 9.0% in CM microLPS), presented a stellate phenotype indistinguishable 
from the stellate phenotype previously found in CM microC and DMEM (Figure 23C). However, 
DCX+ cells were highly more abundant in LPS and CM microLPS treatments compared to CM 
microC and DMEM and also showed a shorter and thicker morphology than the ones observed 
in CM microC. There were no differences between LPS and CM microLPS (Figure 23D). 
Therefore, CM LPS did not promote the same phenotype as CM microPH, which may suggest 
that cytokines are not responsible for the effect of CM microPH. 
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Figure 23. Effect of CM microLPS on neurogenesis in vitro. [A] mRNA expression levels of the cytokine 
neurocandidates by RT-qPCR in naïve, phagocytic, LPS treated and phagocytic followed by LPS treated 
microglia. N=4 independent replica. HPRT was selected as a reference gene. [B] Experimental design of 
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the in vitro neurogenesis assay. [C] Representative confocal microscopy images of neuroprogenitors 
treated with CM from LPS treated microglia or LPS (150ng/ml; 18h). N=2 independent replica. Scale bars, 
20µm. z=6.3 µm. [D] Quantification of the different cell types found after 3d or 5d treatment with CM 
from LPS treated microglia or LPS. Bars represent mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; 
*** indicates p < 0.001 by Holm-Sidak posthoc test (after one-way AN VA or Student’s t-test was 
significant at p < 0.05). 
 
Interestingly, the levels of cytokines after phagocytosis were as high as those with LPS 
and the DCX+ cells were much more abundant after CM microLPS treatment than in CM 
microC. These were surprising results because pro-inflammatory cytokines are well-
documented to exert detrimental consequences for neurogenesis. We first thought that these 
unexpected results might be due to the low LPS dosage. Therefore, we performed the same 
experiments with a higher concentration of LPS (1ug/ml; 24h) as described by Monje (Monje et 
al., 2003), where they found a reduction in DCX+ cells after CM microLPS treatment. 
 
We treated the neuroprogenitor cell culture with CM from microglia incubated with a 
high concentration of LPS (CM microLPShigh) to test whether we could find any LPS dose-
dependent differences in CM cell phenotype. Again LPS was used as control and was 
maintained for the whole duration of the experiment (Figure 24A). Similar to the experiment 
with the low concentration of LPS, neither LPShigh nor CM microLPShigh resulted in the formation 
of bipolar cells (Figure 24B). In addition, the majority of the cell phenotypes after LPS and CM 
microLPShigh treatments were stellate cells (70.7 ± 7.4 in LPShigh and 71.9 ± 2.6% in CM 
microLPShigh at 5d), identical to those observed in CM microC and DMEM (Figure 19). Similar to 
the low dose LPS experiment, ramified cells presented a larger proportion compared to CM 
microC and DMEM. No differences were found between LPS and CM microLPShigh treatments 
(Figure 24C).  
 
These results strongly suggested again that cytokines were not responsible for the 
bipolar phenotype induced by CM microPH. However, we found again a higher proportion of 
DCX+ cells in CM microLPShigh than in CM microC (9.9 ± 3.5% and 2.5 ± 1.7% at 5d respectively) 
), in disagreement with previous findings (Monje et al., 2003). To further analyze this 
difference, we mimicked Monje’s paradigm by switching primary microglia to BV2 (Monje et 
al., 2003), a microglia cell line, in order to determine whether the differences between our 
results and the literature might be originated by the use of different cells. 
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Figure 24. Effect of conditioned media from LPS
high
 treated primary microglia on neurogenesis in vitro. 
[A] Experimental design of the in vitro LPS
high
 neurogenesis assay. [B] Representative confocal 
microscopy images of neuroprogenitors treated with CM MicroLPS
high
 or LPS
high
 (1µg/ml; 24h). Scale bars, 
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20µm. z= 7.4µm. [C] Quantification of the different cell types found after 3d or 5d treatment with CM 
MicroLPShigh or LPShigh. Bars represent mean ± SEM.  
 
Thus, we cultured the neuroprogenitors with CM from BV2 cells treated the high 
concentration of LPS (CM BV2 LPShigh) or naïve BV2 CM (CM BV2). LPShigh was used as control, 
and was maintained for the whole duration of the experiment (Figure 25A). Similar to the 
experiments performed in primary microglia, no bipolar cells were found after the treatment 
with CM BV2 LPShigh or CM BV2 (Figure 25B, C). Moreover, all the treatments induced a large 
proportion of stellate cells (65.4 ± 2.0% in LPShigh; 67.2 ± 0.8% in CM BV2high and 84.2 ± 10.7% in 
BV2 at 5d) and a smaller proportion of ramified cells. There were no differences among the 
treatments, but all of them produced a higher proportion of ramified cells than CM microC or 
DMEM (Figure 19). Therefore, neither by mimicking Monje’s (Monje et al., 2003) by increasing 
the LPS concentration nor by using BV2 cells did we observe the reduction in neuronal-
committed cells that they found, suggesting that the effects of inflammation might be more 
complex than what previously thought, and should be a matter of study in the future.  
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Figure 25. Effect of CM BV2 LPS
high
 on neurogenesis in vitro. [A] Experimental design of the in vitro CM 
BV2 LPS high neurogenesis assay. [B] Representative confocal microscopy images of neuroprogenitors 
treated with CM BV2, CM BV2 LPS high or LPS high (1ug/ml; 24h). Scale bars, 20µm. z= 6.3µm. [C] 
Quantification of the different cell types found after 3d or 5d treatment with CM BV2, CM BV2 LPS
high
 or 
LPS
high
. N = 2 independent replica. Bars represent mean ± SEM. 
 
In summary, the experiments above suggest that neither LPS per se, nor LPS-induced 
microglial inflammation differentiated neurospheres into bipolar cells, which highly suggests 
that cytokines are not responsible for the induction of this phenotype by phagocytic microglia. 
Importantly, the results obtained with MicroLPS or BV2 CM were very similar to the ones 
obtained with neuroprogenitor cells directly treated with LPS. This fact led us to hypothesize 
that LPS might have not been degraded in the CMs and that the results we observed might be 
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due to the remaining LPS within the CMs rather than the effect of released cytokines. Thus, we 
developed another paradigm in which we treated primary microglia with LPShigh (1µg/ml) for 
6h in order to trigger the inflammatory response and then change to fresh media for another 
18h, which would not contain any LPS. Next, we treated neuroprogenitor cells with either 
LPShigh or CM microLPShigh 6h + 18h. In addition, we also added another experimental group in 
which we treated neuroprogenitor cells with the CM from apoptotic SH-SY5Y in order to 
discard the possibility that bipolar cells could be the result of the molecules released by 
apoptotic cells (Figure 26A). We found that both LPShigh and CM microLPShigh 6h + 18h 
presented a majority of stellate cells (87.4 ± 1.9% and 86.0 ± 3.0% at 5d, respectively) and a 
small proportion of ramified cells (12.6 ±1.8% and 14.1 ± 2.9% at 5d, respectively), and there 
were no differences between the two treatments in terms of cell type proportion (Figure 26B, 
C). However, after 5d of CM microLPShigh 6h + 18h, all the ramified cells expressed high levels 
of nestin. In addition, apoptotic SH-SY5Y CM treated neuroprogenitor cells did not show 
differences compared to CM microC (Figure 26B, C). Neither LPShigh, CM microLPShigh 6h + 18h 
nor apoptotic SH-SY5Y CM treatments give rise to bipolar cells, which highly suggest that 
cytokines or molecules released from apoptotic cells are not responsible for this phenotype 
and show a unique effect of microglial phagocytosis released molecules on neuroprogenitors. 
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Figure 26. Effect of the CM MicroLPShigh 6h + 18h on neurogenesis in vitro. [A] Experimental design of 
the in vitro neurogenesis assay. [B] Representative confocal microscopy images of neuroprogenitors 
treated with CM MicroLPShigh 6h + 18h or LPShigh (1ug/ml; 24h), CM MicroC and CM SH apoptotic. Scale 
bars, 20µm. z= 6.3µm. [C] Quantification of the different cell types found after 3d or 5d treatment with 
CM MicroLPShigh 6h + 18h or LPShigh (1ug/ml; 24h), CM MicroC and CM SH apoptotic. N = 3 independent 
replica. Bars represent mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by 
Holm-Sidak posthoc test (after one-way ANOVA was significant at p < 0.05). 
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6.5.2.2 The neuropeptide VGF is highly increased in phagocytic microglia 
After discarding cytokines as the possible mechanism that drives CM microPH effects on 
in vitro neurogenesis, we studied the role of the neurocandidate that showed the highest FC 
changes in both the arrays and RT-qPCR, the neuropeptide VGF (Figure 16). VGF is a 
neuropeptide that has been implicated in metabolism and neurogenesis (Foglesong et al., 
2016; Thakker-Varia et al., 2014), and we have identify its increased expression in phagocytic 
microglia in vitro in the gene arrays (Figure 15 and 16). In order to determine whether VGF 
could play a role in the effects we observed in the neurogenesis assay in vitro, we first studied 
the production of VGF by microglia at the protein level. Therefore, we performed an ELISA of 
the microglia control and phagocytic CMs in order to analyze the release of this neuropeptide. 
However, the concentration of VGF in the samples was below the detection level of the ELISA 
kit (data not shown). VGF is post-translationally processed, which give rise to a variety of VGF 
peptides, and in addition, the variety of VGF that is detected by the VGF ELISA kit is 
undetermined. Therefore, we set up a collaboration with Gian Luca Ferri and Christina Cocco 
(University of Cagliari, UNICA, Italy), experts in VFG signaling (Brancia et al., 2018), who have 
developed antibodies against different terminus of the different VGF varieties (Figure 27A). 
Using these antibodies, we tested the production of VGF in control and phagocytic (24h) 
microglia. Five antibodies were used:  
1. BQ11 (selective for the VGF C-terminal 3-5 amino acids) 
2. BQ17 (selective for the cleaved N-terminus of TLQP-peptide variants) 
3. BQ42 (selective for the N-terminus of the TLQP-variants) 
4. BQ22 (selective for the N-terminus of rat VGF) 
5. BQ28 (selective for the N-terminus of an internal VGF peptide, repeatedly identified in 
proteomic studies).  
 
We found that both control and phagocytic microglia were labeled with all the VGF 
antibodies. The expression in control microglia was rather faint, whereas phagocytic microglia 
expressed higher levels of VGF, which was especially noticeable with the antibodies BQ17 and 
BQ42, both selective for TLQP variants (Figure 27 A, B). This data suggested that upon 
phagocytosis, microglia triggers the production of some of the VGF variants. However, 
whether phagocytic microglia drives its effects on neurogenesis in vitro and in vivo will remain 
to be studied in future experiments. 
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Figure 27. VGF protein expression in control and phagocytic microglia in vitro. [A] Schematic overview 
of the VGF peptide amino-acids and its derived variants: TLQP-62, TLQP-21, HHPD-41, AQEE-30, 
AQEE-11, LQEQ-19, and NERP-1 and -2. [B] Representative confocal microscopy images of different 
antibodies against VGF-derived peptides. Scale bars, 20µm. z= 6.3µm. N = 2 independent experiments. 
 
6.5.2.3 Lactate is not increased in phagocytic microglia 
In addition to cytokines and VGF, we also focused our attention on the metabolite 
lactate, which is a by-product of the glycolytic process. As we mentioned in Figure 13, 
phagocytic microglia showed major transcriptional changes in genes related to metabolism; 
genes related to mitochondrial pathways such as Krebb’s cycle and oxidative phosphorylation 
were downregulated, whereas glycolysis genes were increased. These alterations in 
metabolism could lead to the production of lactate by phagocytic microglia. Lactate has been 
described to exert hormone functions and it has been related to memory formation and 
neuroprotection (Proia et al., 2016), and it might also support neurogenesis in vivo (Alvarez et 
al., 2014). Therefore, we studied the production and release of this metabolite by control, and 
phagocytic microglia (Figure 28A). In addition, the metabolic switch towards glycolysis had 
been described in macrophages upon LPS stimulation (Palsson-McDermott et al., 2015), and 
therefore, CM MicroLPShigh 6h+18h was also added to the study in order to validate this 
response in LPS stimulated microglia. We found no significant differences between the lactate 
concentration produced by control and phagocytic microglia (Fig 28B). In addition, CM 
MicroLPShigh 6h+18h lactate production was significantly enhanced compared to control 
microglia. Since phagocytic microglia did not produce higher levels of lactate, it is unlikely that 
lactate mediated the neuromodulatory effects triggered by phagocytosis. 
 
 
Figure 27. Lactate release in conditioned media from control and phagocytic microglia in vitro. [A] 
Experimental design of lactate production. [B] Quantification of lactate concentration in CM from 
control, phagocytic and LPS 6h+18h-treated microglia N=4 independent replica. Bars represent mean ± 
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SEM. *** indicates p < 0.001 by Holm-Sidak posthoc test (after one-way ANOVA was significant at p < 
0.05).  
 
6.5.3. Phagocytosis conditioned media induces astrogenesis 
After determining that CM microPH affects neurogenesis in vitro by inducing the 
differentiation of neuroprogenitors towards astrocyte-commited bipolar cells, we next 
characterized the effect of the CMs at later stages of neurogenesis. Therefore, we performed a 
late survival and differentiation assay in which neuroprogenitor cells were allowed to 
differentiate for 10d into neuroblasts and astrocytes using DMEM/F12 without trophic factors. 
After this period, differentiated cultures were treated for 3 and 5d with CM microC and 
microPH as well as DMEM for positive control (Figure 29A, B). Importantly, contrary to what 
we found in the early differentiation assay, culturing differenciated astrocytes and neuroblast 
with CM microPH did not result in an increase in apoptosis compared to CM microC (Figure 
29C, D). In addition, we found that after 10d in DMEM/F12 the culture showed both stellate 
and ramified cells in a similar proportion between CM microC and DMEM (Figure 29E, F). After 
3 and 5 days of treatment with CM microC and DMEM, the cultures presented 96.8 ± 3.4 % of 
stellate cells and 1.9 ± 1.9% of ramified cells. Interestingly, the treatment with CM microPH 
give rise to a different phenotype from the ones observed until this point. These cells shared 
similarities with the stellate cells in marker expression and morphology; however, they 
displayed even a more starry morphology than the stellate cells and, thus, we identified them 
as mature stellate cells. The CM microPH culture showed 21.7 ± 2.7% stellate cells and 78.3 ± 
4.14% mature stellate cells at 5d, and DCX+ cells were never found. These data suggest that CM 
microPH induces astrogenesis. 
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Figure 29. Effect of CM microC and microPH in a late survival and differentiation assay. [A] 
Experimental design of the in vitro late survival and differentiation assay. [B] Representative confocal 
microscopy images of neuroprogenitors treated with 10d of DMEM/F12 followed by 3-5d of CM microC 
or microPH and DMEM. The upper image represents the DMEM/F12 treatment of 10d, prior to adding 
any CM. Scale bars, 20µm. z= 6.3µm. [C] Quantification of the different cell types found after 10d of 
DMEM/F12 followed by 3-5d of CM microC or microPH and DMEM. N = 2 independent experiments. Bars 
represent mean ± SEM. ** indicates p < 0.01; *** indicates p < 0.001 by Holm-Sidak posthoc test (after 
one-way ANOVA was significant at p < 0.05). 
 
 
6.6. VALIDATION OF THE EFFECTS OF MICROGLIAL PHAGOCYTOSIS ON 
NEUROGENESIS IN VIVO 
To sum up, we have confirmed that microglia phagocytosis triggers a neuromodulatory 
program in vitro by the production of several molecules. Our next step was to validate this 
program in vivo. 
 
In order to replicate the expression of neuromodulatory factors by phagocytic microglia 
in vivo, we resorted to utilize as a model the adult hippocampal neurogenic cascade. In young 
mice, SGZ neural precursors are abundant and proliferate at high rates, generating many 
apoptotic cells (Sierra et al., 2010). Thus, in the DG of young mice (1mo), microglial 
phagocytosis can be frequently observed. Therefore, we utilized an ex vivo approach consisting 
in analyzing the transcriptomic profile in microglia acutely isolated by fluorescent activated cell 
sorting (FACS). We compared a population enriched in phagocytic microglia isolated from the 
dentate gyrus (DG), where neurogenesis occurs and apoptosis is abundant; with non-
phagocytic microglia isolated from the CA region of the hippocampus, where there is no 
neurogenesis and therefore no apoptosis (Figure 30A). We dissected the DG and CA from 1-
month-old fms-EGFP mice and microglia cells were acutely purified in a FACS sorter (Figure 
30B). Next, the expression of neuromodulatory molecules was quantified by RT-qPCR. While 
we found that DG microglia showed a tendency to express higher levels of trophic factors than 
CA microglia the results were not significant (Figure 30C). However, it must be noticed that the 
DG contains a highly heterogeneous population of microglia. In the 1mo hippocampus, only 
30% of microglia is engaged in phagocytosis in the SGZ (Sierra et al., 2010). In addition, as 
phagocytosis is fast (around 1.5h) (Sierra et al., 2010) many microglia that do not appear 
phagocytic (i.e., do not contain phagocytic pouches) may have just finished phagocytosing. 
Furthermore, the DG includes many non-phagocytic cells from the hilus and the molecular 
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layer. This heterogeneity likely interferes with our ability to detect transcriptional changes 
associated to phagocytosis in vivo. For these reasons, we pursue the phagocytic microglia 
expression analysis by utilizing a combination of single-cell transcriptomics with bioinformatics 
in collaboration with Dr. Florent Ginhoux (Agency for Science, Technology, and Research, 
Singapore). For this task, we followed the same methodology as in Figure 30A and we acutely 
isolated microglia cells using FACS-sorting from the DG and CA of heterozygous CX3CR1-GFP 
mice, a mouse strain in which the microglia-specific CX3CR1 gene is replaced by a green 
fluorescent protein (GFP) reporter gene. The single-cell RNA seq was performed in a total of 
192 cells from DG and 96 cells from CA. Our strategy was aimed at identifying those microglia 
cells with a gene-expression profiles ranging from phagocytic and non-phagocytic stages 
usingthe NBOR algorithm ('neighborhood-based ordering of single cells') developed in the 
Ginhoux laboratory (Schlitzer et al., 2015). This algorithm can objectively determine the 
position of a given cell in a developmental continuum and calculate the similarity of each single 
cell's gene-expression profile to a defined gene set of a particular cell population (landmark) 
and then order each cell according to such similarity score into a spatial continuum around 
those landmarks. This algorithm would help us to determine the transcriptional changes 
occurring along the process of phagocytosis. However, we did not observed differences 
between the two populations (Figure 30D, E), most likely because the DG is not sufficiently 
enriched in phagocytic microglia.  
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Figure 30. Transcriptional analysis of control and phagocytic microglia in vivo. [A] Experimental design 
used for the transcriptional analysis of control and phagocytic microglia in vivo. [B] Experimental design 
used to isolate microglia (GFP+) vs non-microglial cells (GFP-) from 1 mo fms-EGFP mice. Flow cytometry 
analysis of the expression of neuromodulatory molecules from dentate gyrus (DG) microglia and CA 
microglia. Gates for GFP+ microglia cells (P2, blue) and GFP- non-microglial cells (red) were defined based 
on the distribution of the fms-EGFP+ cells in EGFP vs FSC for both DG and CA (left and right panel 
respectively). [C] Expression of neuromodulatory molecules in DG microglia vs CA microglia by RTqPCR in 
FACS-sorted cells from fms-EGFP mice hippocampi (n = 4, each from 20 pooled hippocampi). OAZ1 was 
selected as a reference gene. Bars represent mean ± SEM. [D] Experimental design used for the single-
cell RNA sequencing of control and phagocytic microglia in vivo. [E] Distribution of the 96 cells from CA 
and 192 cells from DG used for single cell RNA sequencing in a tSNE (t-distributed Stochastic Neighbor 
Embedding) analysis.  
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Since the in vivo transcriptional analysis presented high variability and the methods used 
did not allowed us to validate the transcriptional program of phagocytosis, we switched the 
strategy and we focused on confirming the neuromodulatory role of the molecules secreted by 
phagocytic microglia in vitro on adult hippocampal neurogenesis. Therefore, we injected CM 
microC and microPH into 2mo fms-EGFP mice for 6d using osmotic pumps. After this period, 
BrdU, was administered to track proliferating cells and mice were sacrificed 2h later (Figure 
31A). We observed no differences in total BrdU proliferative cells in CM microPH treated mice 
compared to CM microC treatment (Figure 31B, C). Importantly, contrary to what we observed 
in vitro, CM microPH did not induce apoptosis in vivo (Figure 31D). In addition, there was a 
tendency (p=0.1849) to find fewer total numbers of NSCs labeled with nestin and GFAP (Figure 
31E, F) and a decreased the number of proliferating stem cells (p=0.1637) (Figure 31G) CM 
microPH compared to CM microC. Moreover, when analyzing neuroblast cells, we found no 
differences between CM microC and microPH, neither in the total number of neuroblasts nor 
in the proportion of the different neuroblast subpopulations (AB, CD and EF), nor in neuroblast 
proliferation (Figure 31H-I). Further experiments are currently being performed to increase the 
‘n’ and confirm the statistically significance of the downregulation of proliferative cells and 
proliferating stem cells in CM microPH compared to CM microC. 
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Figure 31. Effects of phagocytic microglia secreted molecules on neurogenesis in vivo. [A] Experimental 
design used for the administration of CM microC or microPH by osmotic pumps to 2mo fms-EGFP mice. 
[B] Representative confocal images of cell proliferation after the CM treatments for 6d. Cell nuclei were 
labeled with DAPI (white) and BrdU was used as a proliferative marker (magenta). Scale bars, 50µm. z= 
12µm. [C] Quantification of BrdU+ cells per mm3 after CM microC or microPH treatment. N = 7 
independent experiments. [D] Quantification of apoptotic cells after the CM microC or microPH 
treatment. N= 3 independent experiments. [E] Representative confocal images of stem cells labeled with 
nestin (Nes, Red) and GFAP (Green). Scale bars, 20µm. z= 12µm. [F] Quantification of stem cells per mm
3
 
after the CM microC or microPH treatment. N= 7 independent experiments. [G] Quantification of 
proliferation of stem cells after the CM microC or microPH treatment. N= 7 independent experiments. [H] 
Representative confocal images of neuroblast cell populations AB, CD and EF. Neuroblast cells are 
labeled with DCX (green). Scale bars, 20µm. z= 12µm. [I] Quantification of the proportions of neuroblast 
cell population AB, CD and EF. N = 4 independent experiments. [J] Quantification of total number of 
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BrdU+/DCX+ cells per mm3 after treatment with CM microC or microPH. Bars represent mean ± SEM. * 
indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by after Student’s t-test was significant 
at p < 0.5 in all the comparisons with the exception of figure [I] in which Bonferroni posthoc test was 
applied (after two-way ANOVA was significant at p < 0.05).  
 
Because we observed a tendency to find decreased NSCs after 6ds in the presence of CM 
microPH, we hypothesized that the induced alterations would accumulate over time. 
Therefore, we performed a long-term experiment in which mice were treated with CM microC 
and microPH in osmotic minipumps for 6h, followed by BrdU administration, and sacrificed 
28d later to allow the differentiation of the labeled cells (Figure 32A). The total number of 
BrdU+ cells was significantly reduced in mice treated with CM microPH compared to CM microC 
(Figure 32B, C). Importantly, CM microPH did not induce apoptosis in vivo (Figure 32D). In 
addition, there was a tendency (p=0.1383) to find fewer total numbers of NSCs labeled with 
nestin and GFAP (Figure 32E, F). In addition, we also found a significant reduction in the most 
mature neuroblast cell subpopulation (EF) in mice treated with CM microPH compared to CM 
microC (Figure 32G-H). Moreover, after 28d, newborn neurons (NeuN+/BrdU+) showed a 
tendency to decline (p= 0.119, respectively) in CM microPH compared to CM microC (Figure 
32I, J). No proliferating NSC, neuroblast or astrocytes were found in any of the treatments 
(data not shown). 
 
All these data, together with the tendency to observe fewer proliferative cells found at 
2h after BrdU, suggest that the acute (24h) release of mediators by phagocytic microglia limits 
neurogenesis via the reduction in the survival of neuronal-committed cells. 
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Figure 32. Long term effects of phagocytic microglia secreted molecules on neurogenesis in vivo. [A] 
Experimental design used for the administration of CM microC or microPH by osmotic pumps to 2mo 
fms-EGFP mice. [B] Representative confocal images and quantification of total BrdU
+
 cells. Scale bars, 
50µm. z= 12µm. [C] Quantification of BrdU+ cells per mm3 after CM microC or microPH treatment. N = 3 
independent experiments. [D] Quantification of apoptotic cells after CM microC or microPH treatment. 
N= 3 independent experiments. [E] Representative confocal images of stem cells labeled with nestin (Nes, 
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Red) and GFAP (Green). Scale bars, 20µm. z= 12µm. [F] Quantification of stem cells per mm3 after CM 
microC or microPH treatment. N = 3 independent experiments. [G] Representative confocal images of 
neuroblast cell populations AB, CD and EF. Neuroblast cells are labeled with DCX (green). Scale bars, 
20µm. z= 10µm. [H] Quantification of the proportions of neuroblast cell population AB, CD and EF. N = 3 
independent experiments. [I] Representative confocal images and quantifications of new neurons labeled 
with BrdU (magenta) and NeuN (cyan). Scale bars, 20µm. z= 10µm. [J] Quantification of new neurons per 
mm
3
 after CM microC or microPH treatment. N = 3 independent experiments. Bars represent mean ± 
SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by after Student’s t-test was 
significant at p < 0.5 in all the comparisons with the exception of figure [H] in which Bonferroni posthoc 
test was applied (after two-way ANOVA was significant at p < 0.05). 
 
6.7. Characterization of microglial receptors 
Finally, we developed alternative strategies to demonstrate the role of microglial 
phagocytosis on neurogenesis in vivo, based on the genetic knock-down or pharmacological 
manipulation of key phagocytic receptors. In the next section we will focused on the 
characterization of several of these microglial receptors.  
 
Our group has recently reported an impairment of microglial phagocytosis in a mouse 
model of epilepsy by intrahippocampal injection of the glutamate agonist kainic acid (Abiega et 
al., 2016) and thus we hypothesized that hippocampal microglia may express glutamate 
receptors, which had been shown in vitro (Beppu et al., 2013; Fontainhas et al., 2011; Kaindl et 
al., 2012). Thus, we analyzed by RT-qPCR the expression of the 23 glutamate receptor subunits 
(both ionotropic and metabotropic) in FACS-sorted microglia from the hippocampus and cortex 
of 2mo fms-EGFP mice. We detected a residual expression of all ionotropic and metabotropic 
subunits in hippocampal and cortical microglia (Figure 33), however, this poor expression was 
unlikely to lead to the formation of functional receptors. Therefore, it is unlikely that microglia 
interacts with the neurogenic niche via glutamate signaling. 
 
We next focused on the receptors involved in finding and tethering apoptotic cells, and 
characterized their expression on acutely purified microglia from the hippocampus of control 
and kainic mice. We selected purinergic receptors such as P2X4, P2X7, P2Y6 or P2Y12, which 
are able to sense ATP and UTP, well-described ‘find-me’ signals released by apoptotic cells 
(Elliott et al., 2009); as well as recognition receptors such as triggering receptor expressed in 
myeloid cells 2 (Trem2) (Hsieh et al., 2009), Mer Tyrosine Kinase (MerTK) (Scott et al., 2001), 
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complement receptor 3 (CR3) (Veldhoen et al., 2007), and the G protein coupled receptor 
(GPR34)(Preissler et al., 2015). 
 
We found that purinergic receptors (P2X4, P2Y6, and P2Y12) were significantly 
increased, while the apoptotic cell recognition receptors (Trem2, MerTK, CR3, and GPR34) 
were significantly decreased in microglia from KA mice (Figure 33). These results suggest that 
modulating the expression or function of purinergic and recognition receptors may alter 
microglial phagocytosis and allow us to further test its impact on neurogenesis. 
 
 
Figure 33. Characterization of microglial receptors. [A, B]Experimental design for RT-qPCR expression of 
KA; NMDA, AMPA and metabotropic receptor subunits in acutely purified microglia (FACS-sorted) from 
the hippocampus and the cortex of 2mo mice. N = 4 from 8 pooled hippocampi and cortices each. The 
relative expression was compared to a positive control, a P8 hippocampus,except for Grm6, in which the 
retina from a 2mo mouse was used. L27A was used as a reference gene. [C] Experimental design and 
expression of phagocytic and purinergic receptors by RT-qPCR in FACS-sorted microglia from control and 
KA mice at 1 dpi. N = 3 from 8 pooled hippocampi. HPRT was used as a reference gene. Bars represent 
mean ± SEM. * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 by Holm-Sidak posthoc 
test (after Student’s t-test or one-way ANOVA was significant at p < 0.05). 
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7. DISCUSSION 
 
During adult hippocampal neurogenesis, the majority of the newborn cells undergo 
apoptosis. To avoid disturbing the surrounding neurons, these apoptotic cells are quickly and 
efficiently removed by phagocytosis by resident microglia. Here we propose that phagocytosis 
is not merely a passive process of corpse removal but has an active role in maintaining the 
homeostasis of the adult hippocampal neurogenic cascade by producing neurogenic 
regulators. To test this hypothesis we first performed a genome-wide transcriptomic analysis 
using gene expression arrays to compare cultured naïve vs. phagocytic microglia. Gene 
ontology analysis revealed that, in addition to major changes in different metabolic and 
signaling pathways, phagocytosis triggered a neuromodulatory program in microglia. We found 
a significant upregulation of the neurogenesis function and identified significant changes in 
several genes involved in functions related to different stages of the neurogenic cascade, 
including trophic factors, matrix metalloproteases, neuropeptides, and surface ligands. 
Furthermore, conditioned media from phagocytic microglia altered differentiation of cultured 
neural progenitors, which was unrelated to cytokines. Finally, these results were confirmed in 
vivo by the administration of the conditioned media from phagocytic microglia via osmotic 
pumps, which resulted in a reduction of proliferation and neuroblast cell population. 
 
Altogether, our data supports that upon engulfment of apoptotic newborn cells, 
microglia initiates a transcriptional program devoted to control the adult hippocampal 
neurogenic cascade. 
 
In this Thesis Project we have set up an in vitro model of phagocytosis, studied the 
transcriptional changes induced in microglia upon phagocytosis, and characterized the 
modulation that phagocytic microglia exerts over neurogenesis, all of which will be discussed 
in the following sections. 
 
7.1. IN VITRO MODEL OF PHAGOCYTOSIS 
In order to study phagocytosis-induced microglial changes and the interaction between 
phagocytosis and neurogenesis in vitro, we have developed a model of phagocytosis of 
apoptotic cells based on the characteristics observed in phagocytosis in the adult hippocampal 
neurogenic niche (Beccari et al., 2018), based on models previously published (De Simone et 
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al., 2003; Parnaik et al., 2000). To develop this model we selected several features: the type of 
microglia; the type of cargo; the culture medium; and the quantification method. All these 
characteristics play an important role in the outcome of the phagocytic process and influence 
the strengths and limitations of our in vitro model of phagocytosis. 
 
7.1.1. Selection of microglia: primary cultures  
A strong advantage of our model is the use of primary microglia over microglial cell 
lines such as BV2. Microglia cell lines are commonly used due to their highly proliferative 
nature and ease of use. However, these immortalized cells usually greatly differ from the in 
vivo target cell. For these reason, we have used primary microglia grown using a well-
established protocol. Different procedures have been used to grow primary microglia. 
Classically, mixed cultures of astrocytes and microglia are grown in the presence of 
macrophage colony stimulating factor (M-CSF), a mitogen that allows obtaining high yields of 
microglial cells (Kloss et al., 1997). We resorted to culture microglia with granule macrophage 
colony stimulating factor (GM-CSF) (Sierra et al., 2008), to obtain a higher yield of cells. 
Nonetheless, it has been recommended to culture microglia with a mixture of M-CSF and TGF-
β in order to develop the molecular signature of adult microglia (Butovsky et al., 2014). 
Butovsky et al., compared FACS-sorted adult microglia to adult primary microglia grown with 
M-CSF, GM-CSF or M-CSF with TGF-β, and newborn primary microglia without any mitogen. 
They found that the transcriptome of adult primary microglia cultured with M-CSF and TGF-β 
was the most similar to FACS-sorted adult microglia. However the comparison between GM-
CSF treated newborn primary microglia and adult microglia was not assessed. Therefore, in the 
future it would be interesting to compare our results obtained in primary postnatal microglia 
grown in GM-CSF with other established protocols to grow adult microglia, and to validate key 
results in vivo. In addition, in the recent years a new approach has also started to emerge in 
which microglia is cultured in serum-free conditions because it promotes a ramified microglial 
morphology (Collins and Bohlen, 2018). However, although it is a morphological resemblance 
to in vivo microglia in physiological conditions, there is no correlation between morphology 
and function, as we will also discuss later. Indeed, serum-free cultured microglia have been 
shown to fail in the phagocytosis of beads or myelin debris regardless of a previous 
opsonization process of the phagocytic targets with serum (Bohlen et al., 2017). Thus, prior to 
establishing a methodology to culture microglia, it is necessary to assess whether it disturbs 
the proper functioning of the cell. 
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7.1.2. Selection of cargo: early apoptotic cells 
Another advantage of our model is that it uses a physiologically relevant target, i.e., 
apoptotic cells. Traditionally, many in vitro phagocytosis assays have been performed using 
artificial targets, such as latex beads. These targets can be engulfed by microglia, however, 
they do not release or express ‘find-me’ or ‘eat-me’ molecules and they cannot be degraded 
within microglia (Diaz-Aparicio et al., 2016). In addition, the engulfment of latex beads triggers 
a different downstream signaling than apoptotic cells in macrophages (Park et al., 2011). Only 
the uptake of apoptotic cells, and not of latex beads, leads to the up-regulation of Ucp2 
(uncoupling protein 2), which in turn, lowers the mitochondrial membrane potential, 
necessary for a correct engulfment (Park et al., 2011). Therefore, the results obtained in these 
assays must be carefully considered, especially if the resulting immunomodulatory effects of 
phagocytosis are aimed to be addressed because each type of cargo is recognized by different 
receptors and triggers different signaling pathways. For example, microglia identify invading 
pathogens through scavenger and Toll-like receptors (TLRs) that recognize pathogen-
associated molecular patterns (PAMPs) (Sierra et al., 2013; Takeda et al., 2003). The receptor-
ligand interaction results in the production of pro-inflammatory cytokines, chemokines, and 
reactive oxygen species, and enhances phagocytic activity and antigen presentation in 
microglia (Hanisch, 2002; Ribes et al., 2010). On the other hand, microglia identify apoptotic 
cells through different phagocytic receptors that recognize ‘find-me’ and ‘eat-me’ signals 
produced by apoptotic cells (Diaz-Aparicio et al., 2016; Sierra et al., 2013), and over the past 20 
years this process has strongly been proposed to have an anti-inflammatory nature (De Simone 
et al., 2003; Fadok et al., 1998; Fraser et al., 2010). In this Thesis Project, we specifically 
focused on the phagocytosis of apoptotic cells (murine NE-4C and human SH-SY5Y) because 
microglia engulf the excess of newborn cells that undergo apoptosis in the neurogenic niches 
in physiological conditions, and therefore it is a genuine model to study the relationship 
between microglial phagocytosis and neurogenesis. 
 
A key feature of microglial phagocytosis in the adult hippocampus is that in 
physiological conditions is a very fast and efficient mechanism, as we have estimated that 
microglia remove apoptotic cells in approximately 1.5h (Sierra et al., 2010) and live imaging 
experiments in vitro have shown phagocytosis to last 25-90min (Parnaik et al., 2000). In 
addition, around 90% of the hippocampal apoptotic cells are contained within phagocytic 
pouches (Sierra et al., 2010), ensuring that apoptotic cells do not evolve into secondary 
necrotic cells and spill over intracellular compounds. In contrast to apoptotic cells, necrotic cell 
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engulfment is pro-inflammatory, at least in macrophages (Erdman et al., 2009). Therefore, it is 
important to ensure an early apoptotic cell induction in order to mimic physiological 
conditions accurately. Different strategies to induce apoptosis have been utilized in the 
literature. Chemical inductors, such as staurosporine (Abiega et al., 2016) or etoposide (Fraser 
et al., 2010) are used as cancer treatments due to their ability to inhibit proliferation, which 
results in cell death. On the other hand, there are also non-chemical inductors of apoptosis, 
such as irradiation (Zhao et al., 2016), which triggers the accumulation of DNA mutations in 
proliferative cells, eventually causing cell death. For this reason, we avoided the use of 
irradiation, since apoptosis initiation would depend on the number of mutations in each cell 
and therefore, it would be more difficult to synchronize apoptotic induction. Thus, we used 
staurosporine and we selected a short incubation time (4h) in order to ensure that microglia 
was fed with early apoptotic cells rather than primary or secondary apoptotic cells. 
 
Importantly, we observed that in our model up to 30% of microglia was already engaged 
in phagocytosis within the first hour, a percentage that increased over time. Although we did 
not directly assess the time that our microglia need to completely engulf and degrade an 
apoptotic cell, both Parnaik (Parnaik et al., 2000) and our assay coincide in around 60% of 
phagocytic microglia at 5-6h, which suggests that the engulfment and degradation process of 
our assay might follow a similar timing to Parnaik’s results. Therefore, the in vitro microglial 
phagocytosis assay that we set up also achieves the rapid and early phagocytosis observed in 
vivo.  
 
7.1.3. Selection of culture media: presence of opsonins 
Opsonins are molecules that tag apoptotic cells in order to facilitate their recognition 
and engulfment. Importantly, the opsonin C1q has recently been shown to modulate the 
outcome of the phagocytic process, since its presence has been related to an anti-
inflammatory response of microglia, whereas its absence is associated to a pro-inflammatory 
response (Fraser et al., 2010). Taking into account that C1q might exert such a drastic 
immunomodulatory outcome, we studied the role of C1q and its relationship with 
phagocytosis in the hippocampus in physiological conditions. We found that most of the 
phagocytic pouches contained C1q and that the majority of microglial cells presented C1q 
within the microglial cytoplasm conforming the phagocytic pouch. In addition, we also showed 
that microglia is the main source of C1q in the hippocampus. The production of C1q by 
microglia and the macrophage linage had also been reported before, but the majority of the 
  DISCUSSION 
177 
 
studies performed in this area are related to the overproduction of C1q upon microglial 
activation (Lynch et al., 2004) or under pathological conditions such as ischemic stroke (Schafer 
et al., 2000) or viral infection (Depboylu et al., 2005). Since we found a relationship between 
C1q and microglial phagocytosis in physiological conditions, C1q was included in the in vitro 
phagocytosis model by using non-inactivated serum. However, traditionally microglia cultures 
have been performed in the presence of heat-inactivated serum in order to inhibit 
complement proteins (Lee and Tansey, 2013). Thus, it is not surprising that the 
inmunomodulatory outcome of our phagocytic assay differs from the previously described 
anti-inflammatory response upon phagocytosis of apoptotic cells, as we will further discuss in 
section 7.4. 
 
7.1.4. Selection of quantification method: confocal microscopy 
We have strengthened our method by the direct observation and quantification of 
phagocytic pouches. In contrast, phagocytosis is commonly quantified using indirect 
methodologies, such as the expression of “activation markers” or changes in microglial 
morphology of (Diaz-Aparicio et al., 2016). Classical microglial “activation markers”, such as 
CD68 (macrosialin) have traditionally been used as indicators of microglial phagocytosis 
(Perego et al., 2011; Schafer et al., 2012). However, the expression of CD68 and phagocytosis 
do not correlate as observed during epilepsy, where CD68 is overexpressed while microglial 
phagocytosis is impaired (Abiega et al., 2016); or after LPS treatment, where many non-
phagocytic microglia overexpress CD68 (Sierra et al., 2010). In addition, microglial morphology 
has also been used as an indirect method to assess microglial phagocytosis. Traditionally, 
ameboid-shaped microglia was believed to be phagocytic, whereas ramified microglia was 
supposed to be quiescent (Bohatschek et al., 2001). Nevertheless, microglial morphology is not 
an indicator of phagocytosis since in physiological conditions microglial phagocytosis is 
executed by ramified microglia (Sierra et al., 2010). In contrast, hypertrophic microglia after 
LPS treatment are highly phagocytic but after epilepsy they are not (Abiega et al., 2016; Sierra 
et al., 2010). Using indirect techniques as an approximation for phagocytosis can result in 
misleading conclusions and thus, direct quantifications of this process should always be 
performed.  
 
One commonly used method is based on using flow cytometry to assess microglial 
engulfment of fluorescent cargo (either latex beads, transgenic cells that express a fluorescent 
protein or labeled using membrane dyes such as cm-DiI) (Pul et al., 2013). However, detaching 
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cultured microglia cells is an extremely complicated task due to their strongly adhesion 
capacity, reducing their survival. Therefore, to directly assess phagocytosis we used confocal z-
stacks and orthogonal projections to confirm the presence of the cargo within the microglial 
pouch.  
 
A crucial issue when analyzing microglial phagocytosis by confocal imaging is the ability 
to visualize the phagocytic pouches surrounding the apoptotic cell in order to perform a 
correct identification of the phagocytosis process. In vivo, phagocytosis is usually executed by 
microglial terminal branches (“ball-and-chain”) (Sierra et al., 2010); these processes are long 
and very thin, and therefore, failing to correctly label microglial branches would result in an 
underestimation of phagocytosis. The use of transgenic mice in which the microglial cytoplasm 
is labeled is a powerful tool to allow the discrimination of the fine branches that generate the 
phagocytic pouches and, thus, ensure a correct classification of the phagocytosed apoptotic 
cells (Beccari et al., 2018). The most frequently used transgenic mice are CX3CR1+/GFP, in which 
the fluorochrome GFP is inserted in the locus of one fractalkine receptor allele (Jung et al., 
2000). There is an increasing variety of reporter mouse lines available, but we here we have 
used fms-EGFP mice, in which EGFP is expressed under the control of the macrophage colony-
stimulating factor receptor promoter (Geissmann et al., 2010; Sasmono et al., 2003; Sierra et 
al., 2010) to study microglial phagocytosis.  
 
In conclusion, in vitro models represent a reductionist but valuable approach to unravel 
different signaling pathways involved in phagocytosis. Thus, although our in vitro model of 
phagocytosis presents some limitations, it comprises many characteristics of microglial 
phagocytosis in vivo, which will be advantageous in order to utilize it as a pivotal strategy to 
unravel the microglial changes triggered by phagocytosis. 
 
7.2. PHAGOCYTOSIS ALTERS GENES INVOLVED IN MICROGLIAL 
PHYSIOLOGY, INCLUDING METABOLISM AND APOPTOSIS 
We next analyzed the phagocytic microglial transcriptome using the in vitro microglial 
phagocytosis assay described above. We compared genome-wide transcriptome of naïve vs 
phagocytic microglia using gene expression arrays. We analyzed two time points after 
engulfment, an early (3h) and a late time point (24h), in order to study transcriptional changes 
over time.  
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There are numerous studies in the literature in which the microglial transcriptome has 
been analyzed in order to find unique microglial signatures compared to macrophages 
(Butovsky et al., 2014; Wes et al., 2016) or to analyze microglia in different neurodegenerative 
diseases (Hirbec et al., 2018), or against other brain cell types (Holtman et al., 2015; Zhang et 
al., 2014), but no systematic transcriptome analysis of phagocytic microglia (in vitro or in vivo) 
has been performed before. The only study we found on this topic compares ameboid vs 
ramified microglia using gene arrays by the long-standing assumption that ameboid microglia 
are phagocytic, whereas ramified microglia present a quiescent non-phagocytic phenotype 
(Parakalan et al., 2012). In this study, ameboid and ramified microglia from the corpus 
callosum of adult rats were isolated by laser-capture microdissection in order to perform gene 
arrays. They found that ameboid (presumably phagocytic) microglia was enriched in functions 
such as cell cycle, cytoskeleton, ribosome activity or migration, whereas ramified (presumably 
non-phagocytic) microglia expressed functions related to cellular homeostasis, cell projection, 
glial cell development, axon ensheathment, and regulation of synaptic transmission and 
plasticity. On the contrary using our well defined in vitro model of phagocytosis we found that 
phagocytic (24h) microglia comprised many of those functions that Parakalan (Parakalan et al., 
2012) ascribed to both ameboid and ramified cells. The difference between our results might 
arise from their assumption that microglial morphology (ameboid and ramified) is directly 
related to a specific function (phagocytosis vs non-phagocytosis respectively). However, as we 
have mentioned in the previous section, this widely-held belief is changing, as there are 
growing evidences that confirm that microglia does not present discrete morphological 
phenotypes, but rather show different responses to different stimuli (Ransohoff, 2016). In 
agreement, our group has observed microglial phagocytosis regardless of their morphology. 
For instance, ramified microglia in physiological conditions are efficient phagocytes, whereas 
hypertrophic microglia during epilepsy are not (Abiega et al., 2016). Therefore, Parakalan’s 
differences in gene expression between ameboid and ramified microglia cannot be ascribed to 
phagocytosis. 
 
One main function that emerged from our gene arrays comparing naïve and phagocytic 
microglia is the cell physiology, including genes related to both apoptosis and metabolism. It is 
important to note that human SH-SY5Y cells do not have active transcription sites labeled with 
5-Fluorouridine and their mRNA shows a degraded profile in a Bioanalyzer, suggesting that the 
transcripts found were specific to microglia, and not to engulfed apoptotic cells.  
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7.2.1. Phagocytic microglial show expression changes in genes related to 
apoptosis 
Transcriptional analysis of phagocytosis showed genes involved in the regulation of cell 
death. These apoptosis-related genes could also be classified according to the cell in which 
they could exert their function: autologous genes would regulate apoptosis inside microglia, 
whereas heterologous genes would affect cells outside microglia. We found that the majority 
of the apoptosis-related autologous genes were pro-apoptotic, such as BAD (BCL2 associated 
agonist of cell death), FAS (Fas cell surface death receptor), FOXO3 (forkhead box O3), GAS1 
(growth arrest specific 1), or PTEN (phosphatase and tensin homolog) and were upregulated in 
phagocytic microglia. The overexpression of these pro-apoptotic autologous genes could 
explain the microglial cell death that we observed in the in vitro phagocytic assay, as we found 
increasing levels of microglial apoptosis along the time course of phagocytosis, reaching 10% 
of apoptosis by 24h. We disregarded that this microglial death was the result of staurosporine 
present in the SH-SY5Y culture media since similar results were observed after several washes 
of the apoptotic cells prior to adding them to microglia. Importantly, microglial death was also 
unrelated to an excessive amount of apoptotic cells, or to the type of apoptotic cell (SH-SY5Y 
or NE-4C). Nonetheless, it is important to notice that we have never observed microglial 
apoptosis in vivo in physiological conditions (Abiega et al., 2016; Sierra et al., 2010), suggesting 
that the microglial death found in the in vitro phagocytic assay might be intrinsic to the 
culture. 
 
On the other hand, the majority of the apoptosis-related heterologous genes were anti-
apoptotic, such as CNTF (ciliary neurotrophic factor), FGF2 (fibroblast growth factor 2), FGF8 
(fibroblast growth factor 8), or VEGFa (vascular endothelial growth factor) and were 
upregulated upon phagocytosis. These heterologous anti-apoptotic genes could support 
survival of other cells and they might be related to the neuromodulatory functions that 
phagocytic microglia exerts, and that will be further discussed in section 7.5.  
 
7.2.2. Phagocytic microglia show expression changes in genes related to 
metabolism 
Another notorious modification we found in the transcriptional analysis was changes in 
genes related to metabolism. We found that phagocytic microglia showed genes that 
suggested an enhanced glycolysis, decreased Krebb’s cycle, and shutdown of oxidative 
phosphorylation. This gene expression pattern is reminiscent of the metabolic switch known as 
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the Warburg effect, which was originally described in cancer cells (Warburg, 1956). Warburg 
proposed that, independent of oxygen levels, tumor cells increase glucose uptake and produce 
ATP through glycolysis and fermentation, which leads to local acidification due to the increase 
in lactate production. Originally, Warburg proposed that cancer cells performed this metabolic 
switch due to mitochondrial impairment; however, subsequent studies disregarded 
mitochondrial malfunction in cancer cells (Moreno-Sanchez et al., 2007). Later on, the 
Warburg effect was also observed in other cell types, including macrophages upon LPS 
stimulation (Palsson-McDermott et al., 2015), which was characterized by an increase in 
glucose uptake, an enhancement of glycolysis, and a reduction in Krebb’s cycle (Tannahill et al., 
2013). The decrease Krebb’s cycle results in an increment of succinate levels, which leads to 
the stabilization of the transcription factor hypoxia inducible factor-1α (Hif-1α), in turn 
inducing the production of the pro-inflammatory cytokine IL-1β (Koivunen et al., 2007; 
Palsson-McDermott et al., 2015; Tannahill et al., 2013). In microglia, the Warbug effect is also 
triggered by inflammation in vitro (O'Neill and Hardie, 2013; Orihuela et al., 2016). The 
stabilization of Hif-1α does not only induce the production of IL-1β, but it also triggers the 
enhancement of different trophic factors related to angiogenesis, cell survival and 
proliferation, such as VEGF, IGF2, or TGF-β3 (Lee et al., 2004b), which might suggest a role of 
this metabolic switch in neuroprotection. However, the possible metabolic switch from 
oxidative phosphorylation to glycolysis in phagocytic microglia might be a key signature of 
phagocytosis and will be studied in the future by analyzing mitochondrial respiration and 
glycolysis in live naïve and phagocytic microglia cells. 
 
In addition, the metabolic shift towards glycolysis has been recently shown at the core 
of trained immunity in monocytes and macrophages (Netea et al., 2015). Trained immunity 
refers to the memory that immune cells develop upon different stimuli and it has been 
associated to both beneficial and detrimental consequences, such as the improved response of 
the immune cells after vaccination (Blok et al., 2015) or the exacerbated pro-inflammatory 
response in inflammatory diseases (Bekkering et al., 2015). Moreover, trained immunity has 
been associated to be mediated by mTOR, Hif-1α, and interleukin-1 family cytokines in 
monocytes and macrophages (Cheng et al., 2014; Moorlag et al., 2018). Moreover, repeated 
systemic inflammation also triggers trained immunity in microglia, resulting in a subsequent 
exacerbated inflammatory response, which is also known as priming (Haley et al., 2017; 
Wendeln et al., 2018). Our gene array data suggest that phagocytosis of apoptotic cells may 
trigger a similar metabolic switch in microglia, in which glycolysis and lactic fermentation are 
enhanced over Krebb’s cycle and oxidative phosphorylation. This switch might be necessary for 
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the development of microglial immune memory (i.e., trained immunity), which could lead to a 
more rapid and efficient response by microglia upon reiterated exposure to apoptotic cells, a 
hypothesis that will be tested in the future.  
 
7.2.3. Phagocytic microglial show expression changes in genes related to 
chromatin remodeling 
Interestingly, we also found several functions in phagocytic microglia that are related to 
chromatin modification and transcription factors. The gene expression results suggest that 
phagocytosis might also trigger long-term transcriptional changes in microglia through 
epigenetic modifications. In order to test this hypothesis, we performed a DNA methylation 
analysis of naïve and phagocytic microglia at 24h and 3d post phagocytosis to detect long-term 
changes. However, this experiment is currently under analysis and thus, it will not be part of 
the results of this Thesis Project. Nevertheless, these changes in chromatin modification and 
transcription factors might be related to the metabolism changes that we observed in 
phagocytic microglia, as trained immunity in macrophages requires the metabolic switch and is 
based on chromatin remodeling and epigenetic reprogramming (Pennisi, 2014). In more detail, 
trained immunity in macrophages is supported by epigenetic modifications in positive histone 
regulatory marks such as H3K4me1, H3K4me and H3K27ac (van der Meer et al., 2015). 
Similarly, trained immunity has been recently observed in microglia as a result of reiterative 
exposure to peripheral inflammatory stimuli, and also requires epigenetic modifications such 
as H3K4me2 and H3K27ac (Haley et al., 2017). 
 
Taking all this data into account, it is not surprising that in the transcriptional analysis of 
phagocytic microglia we observe changes that point towards chromatin modification. These 
data suggest that upon phagocytosis microglia may alter their metabolism, becoming more 
glycolytic, which might be related to epigenetic modifications in order to provide microglia 
with the capacity to maintain long-term changes. In addition, this memory triggered by the 
phagocytosis of apoptotic cells could contribute to the establishment of microglial heterogenic 
populations in different regions of the brain, a hypothesis that would be tested in the future. 
 
7.3. PHAGOCYTOSIS TRIGGERS AN IMMUNOMODULATORY PROGRAM IN 
MICROGLIA 
In addition to changes in apoptosis and metabolism, transcriptomic analysis of microglial 
phagocytosis also showed changes in inflammation-related genes. Phagocytosis of apoptotic 
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cells was initially considered as immunologically silent process; however, over the past 20 
years phagocytosis has been proposed to trigger an active anti-inflammatory response (De 
Simone et al., 2003; Fadok et al., 1998; Fraser et al., 2010; Lucas et al., 2006). Fadok and 
colleagues showed that phagocytosis of apoptotic neutrophils by human monocyte-derived 
macrophages actively decreased the production of pro-inflammatory mediators such as IL-1β, 
IL-8, IL-10, TNF-α, or leukotriene C4, whereas in turn, it increased the production of anti-
inflammatory TGF-β, PGE2 (prostaglandin E2), or PAF (platelet-activating factor) (Fadok et al., 
1998). The addition of any of these three anti-inflammatory mediators to LPS-stimulated 
macrophages decreased the production of cytokines and therefore, they related the molecules 
produced upon phagocytosis with an-anti-inflammatory effect. Similarly, Lucas (Lucas et al., 
2006) showed that feeding mouse macrophages with human neurophils decreased the 
production of the pro-inflammatory TNF-α and increased the anti-inflammatory TGF-β. In 
addition, they reported that this TGF-β release was partially the responsible of the decrease in 
TNF-α..  
 
7.3.1. Phagocytic microglia present an enhanced expression of several 
both pro- and anti-inflammatory cytokine genes 
Surprisingly we found that the expression of several both pro- and anti-inflammatory 
cytokines were significantly changed in phagocytic microglia compared to naïve microglia. 
Contrary to what was reported in the literature we observed an overexpression of pro-
inflammatory CSF3, IL-1β, IL-6, TNF-α, whereas in agreement with previous reports, we found 
an increase in the anti-inflammatory TGF-β. Nevertheless, our gene arrays also showed 
changes in over 40 different cytokines, such as IL-10 (up-regulated at 3h and down-regulated 
at 24h) or IL-4 (down-regulated at 3 and 24h). 
 
The majority of the above mentioned studies (De Simone et al., 2003; Fadok et al., 1998; 
Fraser et al., 2010; Lucas et al., 2006) did not perform genome-wide expression analysis, but 
focused only on a short list of 4-6 cytokines. In addition, the majority of the studies regarding 
phagocytosis and cytokine production have been performed in macrophages, with the 
exception of De Simone and Fraser’s works (De Simone et al., 2003; Fraser et al., 2010), which 
were performed in rat primary microglia. Thus, our data suggest a more complex 
immunomodulatory effect of phagocytosis on microglia than previously thought. 
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7.3.2. Phagocytic microglia show alternative responses to inflammatory 
stimuli such as LPS 
The cytokine profile triggered in microglia after phagocytosis that we found in our in 
vitro assay shares similarities with the cytokine expression pattern associated to inflammation. 
Inflammatory stimuli such as LPS, peptidoglycan, or poly(I:C) also leads to the increased 
secretion of IL-1β, IL-6, TNF-α in culture. In addition, inflammatory microglia also release IFN-α, 
IFN-β, IL-10, IL12, IL-18, nitric oxide (NO), and chemokines such as macrophage-inflammaroty 
protein (MIP)-1a, monocyte chemotactic protein (MCP)-1, and chemokine ligand 5 (RANTES) 
(Lehnardt, 2010). Therefore, our phagocytic microglia shows a mixed expression profile of 
mRNA cytokines which holds some parallelism to the pro-inflammatory profile triggered upon 
inflammation and to the anti-inflammatory profile that was previously described after 
phagocytosis of apoptotic cells (section 7.1), rendering microglial phagocytosis an 
immunomodulatory process. 
 
To directly test this hypothesis, we challenged phagocytic microglia with LPS, and found 
that phagocytic microglia were overall very similar to naïve microglia, but one key difference 
was the mRNA expression of the pro-inflammatory TNF, which was reduced in phagocytic 
microglia compared to LPS-treated microglia. Our results are to some extent in disagreement 
with previous reports, possibly because of differences in the culture technique. De Simone and 
colleagues (De Simone et al., 2003) used a model of cultured rat microglia fed with apoptotic 
PC12 neurons in heat-inactivated serum and reported a reduced production of the pro-
inflammatory molecules NO (nitric oxyde) and TNF-α upon LPS stimulation. Moreover, Fraser 
and colleges showed that LPS-treated rat microglia increased pro-inflammatory cytokines IL-
1α, IL-1β, IL-6 and TNF-α after the phagocytosis of neuronal apoptotic cells. However, when 
the coverslips were coated with C1q prior to plating microglia, these pro-inflammatory 
cytokines were decreased (Fraser et al., 2010). Therefore, all these experimental differences 
are likely to contribute to the differences in the immunological outcome of phagocytosis that 
have been previously reported and thus, it could explain the fact that we observed several pro-
inflammatory cytokines (CSF3, IL-1β, IL-6, TNF-α) up-regulated after phagocytosis. 
 
In conclusion, we speculate that the immunological outcome of phagocytosis might not 
be ascribed to the reductionist dichotomy of pro- or anti-inflammatory, but that it is a rather 
more complex mechanism that merges molecules of different immunological nature. However, 
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the role of the majority of the immune molecules that we found to be released upon 
phagocytosis, have been studied in the concept of inflammation. 
 
7.4. MICROGLIAL PHAGOCYTOSIS TRIGGERS A NEUROMODULATORY 
PROGRAM 
 
7.4.1. Phagocytic microglia regulate the expression of 224 
neurocandidates 
Our transcriptional analysis also showed that phagocytosis initiated a coordinated 
transcriptional program in microglia. Using a strategy based on unbiased functional analyses 
(DAVID, ClueGO, and WGCNA/IPA) as well as a focused search using the neurogenesis-specific 
MANGO database, we identified up to 224 genes whose expression changed after 
phagocytosis, and potentially affect neurogenesis. Most of these molecules were peptides 
(such as VGF), trophic factors (IGF-1), matrix metalloproteases (MMP3), and cytokines (CSF3). 
Importantly, this neuromodulatory program was also triggered when a physiological model of 
phagocytosis was used (1:1 proportion of apoptotic cells to microglia). It is also interesting to 
note that many of the neurocandidate genes did not require full engulfment, as their 
expression in microglia was induced by the conditioned media from apoptotic cells. In the 
future, it would be interesting to determine which molecules (either released or membrane-
bound) are used by apoptotic cells to initiate and coordinate the neuromodulatory program in 
microglia.  
 
One interesting candidate is Hif-1α (Hypoxia-inducible factor-1-α), which is the 
major transcriptional regulator in response to hypoxia (Nizet and Johnson, 2009). Under 
hypoxic conditions, Hif-1α induces the transcription of several genes, including VEGF and 
erythropoietin, which are involved in biological processes such as angiogenesis,erythropoiesis 
(Lee et al., 2004a), and neurogenesis (Nowacka and Obuchowicz, 2012). In addition, Hif-1α also 
exerts hypoxia-independent functions by inducing transcription of genes involved in cell 
proliferation and survival, as well as glucose and iron metabolism (Weidemann and Johnson, 
2008). Hif-1α promotes glycolysis and inhibits Krebb’s cycle, similar to the metabolic changes 
suggested in our array data. Therefore, since phagocytic microglia presents an enhanced 
glycolysis and decreased Krebb’s cycle, and it also exerts a variety of functions that might 
regulate neurogenesis, we propose that Hif-1α might be a possible master regulator of the 
metabolic and neurogenic functions of phagocytic microglia. Nevertheless, the metabolic 
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switch and the role of Hif-1α in phagocytic microglia require further study and validation that 
will be performed in the future. 
 
7.4.2. The neuromodulatory program needs to be validated in vivo  
To validate in vivo this neuromodulatory program we have used different strategies. We 
first compared by RT-qPCR a population enriched in phagocytic microglia isolated from the 
dentate gyrus (DG), where neurogenesis occurs and apoptosis is abundant; with non-
phagocytic microglia isolated from the CA region of the hippocampus, where there is no 
neurogenesis and therefore no apoptosis. After four replicas of 10 mice each, we were only 
able to observe a tendency to find higher expression of neuromodulatory molecules. However, 
it must be noticed that the DG contains a highly heterogeneous population of microglia, 
including many non-phagocytic cells from the hilus and the molecular layer. For instance, in 
the SGZ proper, only 30% of microglia are engaged in phagocytosis (Sierra et al., 2010).  
 
Therefore, in order to overcome this limitation, we performed a single cell RNA-
sequencing of the same regions (CA and DG). Our purpose was to discriminate the expression 
profile of microglia population at different phagocytic stages using a new bioinformatics 
approach (the NBOR algorithm: ‘neighborhood-based ordering of single cells’; (Schlitzer et al., 
2015)). This approach can objectively determine the position of a given cell in a developmental 
continuum and calculate the similarity of each single cell’s gene-expression profile to a defined 
gene set of a particular cell population (landmark) and then order each cell according to such 
similarity score into a spatial continuum around those landmarks. The single-cell RNASeq was 
performed in a total of 192 cells from DG and 96 cells from CA in collaboration with Dr. Florent 
Ginhoux (A*Star, Singapore). However, we did not observed differences between the 
expression of CA and DG population, most likely because the DG is not sufficiently enriched in 
phagocytic microglia.  
 
Since none of these two approaches proved valuable for our validation, we also utilized 
alternative strategies in order to validate in vivo the phagocytic microglial neurogenic program. 
We hypothesized that if the apoptosis of newborn cells could be enhanced, consequently 
microglial phagocytosis would increase and therefore, we could obtain a DG population highly 
enriched in phagocytic microglia. We administered IGF-1 via osmotic pumps into the 
hippocampus of 1mo mice. IGF-1 is a neurogenic factor that increases neurogenesis and might 
subsequently increase apoptosis (Sierra et al., 2015). However, we could not find the exact 
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time point in which apoptosis was increased, probably due to an efficient phagocytosis (data 
not shown). Following a similar strategy, we also tried to induce an increase in apoptosis by 
the administration of temozolomide, an apoptotic inductor in proliferative cells (Garthe et al., 
2009). Nevertheless, as with IGF-1, we were not able to find the time point of increased 
apoptosis and phagocytosis (data not shown). An alternative model that we are planning to 
use to enrich phagocytosis is cranial irradiation. In a recent collaboration with Dr. Klas 
Blomgren (Karolinska Institute, Sweeden), our group had the opportunity to analyze microglial 
phagocytosis of irradiated mice and we have discovered that there is a large increase in 
apoptosis of DG newborn cells that is matched by increased microglial phagocytosis (Figure 34; 
data from Sol Beccari’s PhD Thesis). However, as large doses of irradiation have been reported 
to trigger microglial immune response (Monje et al., 2003), we will first determine the minimal 
irradiation dosage necessary to induce DG apoptosis and microglial phagocytosis to use this 
model to eventually confirm that phagocytosis of apoptotic cells triggers a neuromodulatory 
program in microglia in vivo. Another strategy that we are planning to pursue in order to 
validate the phagocytic microglial transcriptome in vivo is the analysis of the microglial 
ribosome associated mRNA by RiboTag procedure, which would allow the analysis of the active 
mRNA that is being translated (Haimon et al., 2018). RiboTag mice possess a modified RPL22 
protein (Ribosomal protein L22), which participates in the formation of the ribosome. The final 
exon of this gene is flanked by LoxP recombination sites followed by an identical exon that also 
encodes hemagglutinin (HA) epitope before the stop codon of the gene. When RiboTag mice 
are crossed with a Cre mouse of the cell of interest, the LoxP flanked RPL22 exon is removed, 
resulting in the expression of RPL22-HA protein. Thus, the mRNA that is being translated within 
the RPL22-HA ribosome can be purified and analyzed, which will allow us to selectively study 
the active mRNA of microglia. 
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Figure 34. Microglial phagocytosis efficiency after irradiation. [A] Representative confocal z-stack of 6h 
irradiated mice immunofluorescence in the mouse hippocampal DG. Microglia were labeled with fms 
CX3CR1-GFP (green) and apoptotic nuclei were detected by pyknosis/karyorrhexis (white, DAPI). [B] 
Quantification of apoptosis in control and after 6h of irradiation. [C] Percentage of apoptotic cells 
engulfed by microglia (Ph-index) in control and after 6h of irradiation. Data from Sol Beccari´s PhD 
Thesis. 
 
7.5. MICROGLIAL PHAGOCYTOSIS MODULATES NEUROGENESIS AND 
GLIOGENESIS  
In order to test the effect of our microglial phagocytosis-related neurocandidates on 
neurogenesis, we analyzed the effects of control and phagocytic CM both in vitro and in vivo. 
In vitro we cultured neuroprogenitor cells with CM obtained from either control or phagocytic 
microglia, whereas in vivo, we injected the CM from control and phagocytic microglia into 2mo 
fms-EGFP mice for 6d using osmotic pumps and assessed neurogenesis 2h and 28d after BrdU 
administration. We found that the regulation of the neurogenic niche by the secretome of 
phagocytic microglia might be exerted by the modulation of neurogenesis or gliogenesis, as we 
will discuss in the next sections. 
 
7.5.2. Phagocytosis triggers gliogenesis in vitro but not in vivo 
In vitro, naive microglia CM gave rise to a large proportion of astrocytes characterized by 
a stellate morphology and high expression of GFAP; and a small proportion of neuron-
commited cells (neuroblasts), ramified cells with high level of DCX. In contrast, neuroblasts 
were never observed in cultures treated with phagocytic microglia CM, which gave rise to 
astrocyte-committed cells. These cells presented a bipolar phenotype reminiscent of radial glia 
(Encinas and Enikolopov, 2008); expressed astrocyte markers, such as GFAP, and S100β 
(Encinas and Enikolopov, 2008; Raponi et al., 2007); and showed a strong increase in 
intracellular calcium in response to ATP, typical of astrocytes (De Melo Reis et al., 2011). 
However, bipolar cells also showed high levels of nestin, an intermediate filament that is 
typically expressed in neuroprogenitors and other mitotic cells (Lopez-Atalaya et al., 2017). To 
determine whether bipolar cells were neuroprogenitors, we performed a pluripotency assay 
by allowing them to differentiate in conventional media. We found that bipolar cells resulting 
from treatment with phagocytic CM gave rise to stellate cells and none neuroblasts suggesting 
that they are indeed committed to the astrocyte lineage. In order to further characterize the 
bipolar phenotype induced by phagocytic CM, we are currently performing Western Blot 
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analysis of different fate-committing transcription factor, REST (RE1 silencing transcription 
factor 1), Ascl (ASC1 like protein) and p-Smad (phospho-Smad) in the CM-treated cultures. 
REST is a repressor of neuronal genes and is highly expressed in astrocytes (Kohyama et al., 
2010); Ascl induces neuronal differentiation and therefore is elevated in neurons (Liu et al., 
2015); and p-Smad is highly expressed in astrocytes (Kohyama et al., 2010). The levels of these 
transcription factors in the CM-treated samples will be compared to those in neurospheres, 
astrocytes, and neurons in order to further elucidate the nature of the bipolar cells induced by 
phagocytic microglia. Therefore, these in vitro data suggest that microglial phagocytosis might 
modulate the neurogenic cascade by promoting the differentiation of neuroprogenitor cells 
into astrocytes. 
 
The potential gliogenic effect of phagocytic microglia was also suggested by our 
transcriptional assays, since we found the functions ‘gliogenesis’ and ‘glial cell differentiation’ 
significantly up-regulated in the ClueGo analysis. Nevertheless, the majority of the genes found 
under those categories were autologous, and therefore, their overexpression would only 
modulate the microglia cell expressing them. We were only able to find four genes within the 
‘gliogenesis’ and ‘glial cell differentiation’ categories that could exert heterologous functions: 
NLGN3 (neuroligin 3), NRG1 (neuregulin 1), S100a8 (S100 calcium binding protein A8), and 
S100a9 (S100 calcium binding protein A9). Both NLGN3 and NRG1 are post-synaptic adhesion 
molecules, mainly expressed in neurons, although glial expression has also been reported, and 
they promote maturation of functional synapses (Medina et al., 2018; Ting et al., 2011). NLGN3 
is cleaved in an activity dependent manner and the soluble form mediates glioblastoma 
growth (Jeong et al., 2017). In addition, NRG1 can drive microglial proliferation after nerve 
injury (Calvo et al., 2011) and NRG1 signaling downregulation can trigger the stem cell 
transformation into astrocytes (Schmid et al., 2003). The mechanism by which these two 
molecules cleave in non-neuronal cells has not been studied, and therefore, whether their 
overexpression in phagocytic microglia could also consequently lead to an enhancement of 
their soluble forms is yet to be determined. If the soluble forms of NLGN3 or NRG1 were to be 
detected in the conditioned media from phagocytic microglia, NLGN3 might act as a mitogen 
and contribute to the expansion of astrocytes in culture. However, the overexpression of NRG1 
should not drive neuroprogenitor cells towards astrocytes, and therefore, none of these two 
molecules could explain the development of neuroprogenitor cells into the bipolar astrocytes 
that we observed after phagocytic CM treatment. On the other hand, S100a8 and S100a9 are 
calcium binding proteins usually localized within the cell cytoplasm, but they can also be 
released. These two molecules can form a heterodimer (S100a8/a9) and its release has been 
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related to the priming of microglia after a neuroinflammatory stimulus (Denstaedt et al., 
2018). Therefore, none of these four candidate molecules are likely to promote the 
neuroprogenitor differentiation towards astrocytes that we found in the in vitro differentiation 
assay.  
 
In addition, in vivo, astrocytes are produced directly from the NSCs, after they have 
exhausted their mitotic potential (Encinas et al., 2011). However, CM from phagocytic 
microglia administration did not increase newborn astrocytes in the 28d experiment, highly 
suggesting that phagocytic microglia does not promote the direct conversion of NSC into 
astrocytes. Therefore, the gliogenesis observed in the in vitro studies might occur as an 
indirect consequence of the modulation of neurogenesis by phagocytic microglia, as we will 
discuss in the next section. 
 
7.5.2. Phagocytosis limits neurogenesis in vivo by the regulation of the 
survival of the neuronal-committed cells 
The idea that microglia could exert beneficial functions on neurogenesis in physiological 
conditions is not new. There are some evidences in the literature suggesting that macrophages 
are able to produce different trophic factors upon phagocytosis. For instance, phagocytic 
microglia in culture produce TGF-β and NGF (De Simone et al., 2003) and, similarly, phagocytic 
hepatic macrophages produce VEGF (Golpon et al., 2004). These three factors are regulators of 
hippocampal neurogenesis in vivo (Buckwalter et al., 2006; Cao et al., 2004). In addition, upon 
IL-4 or IFNγ administration, cultured microglia decrease levels of TNFα and produce IGF-1, 
which help to maintain critical functions such as neurogenesis or oligodendrogenesis (Butovsky 
et al., 2006). Thus, trophic factors released from phagocytic microglia may contribute to the 
regulation of neurogenesis (Sierra et al., 2014). Therefore, since our data suggest that it is 
unlikely that phagocytic microglia regulates the neurogenic niche by an induction of 
gliogenesis, we also focused on the possibility that this modulation is mediated by the 
regulation of neurogenesis by affecting different steps of the cascade such as proliferation or 
survival of the newborn cells. 
 
Although we have not directly assessed neuroprogenitor proliferation, the cell density 
between 3 and 5d increases in both naïve microglia CM and DMEM, suggesting that there is an 
intrinsic continuous proliferation of the culture. On the contrary, in phagocytic microglia CM 
the cell density between 3 and 5d decreases. However, we cannot discard that the bipolar cell 
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culture does not divide because any virtual proliferation would be masked by the excess of 
apoptosis unless the proliferation matched the apoptosis observed in this culture. In addition, 
in vivo experiments showed no differences in proliferation at 2h after BrdU (although there is a 
tendency to find fewer BrdU cells, which will be further validated by increasing the ‘n’ in order 
to obtain a higher statistical power) and a decrease of BrdU cells after 28d, suggesting that 
microglial phagocytosis might not be modulating proliferation, but rather the survival of the 
the neuronal-committed cells.  
 
Indeed, one important effect of the phagocytic microglia CM in vitro is that it resulted in 
the death of up to 50% of neuroprogenitors in early differentiation assays. In contrast, naïve 
microglia have been shown to promote survival of cultured neuroprogenitors. Microglia CM 
from primary rat cultures promoted neuronal survival after 7d in culture compared to non-
treated neurons (Morgan et al., 2004). Similarly, neuroblast production in a SVZ-derived 
culture was increased when culturing with microglia CM (Walton et al., 2006). However, 
several lines of evidence argue against a toxic effect of phagocytic microglia CM. First, the 
majority of the pro-apoptotic genes that were up-regulated in phagocytic microglia were 
autologous, with the exception of pro-inflammatory cytokines. However, as we discussed 
above, inflammatory microglia CM not only did not induce cell death, but it also increased 
neuroblast population in vitro, suggesting that pro-inflammatory cytokines do not promote 
apoptosis in our in vitro model. Second, in vivo administration of phagocytic microglia CM does 
not increase the total number of apoptotic cells. However, it must be noted that in vivo in 
physiological conditions, microglial phagocytosis is a fast process that lasts around 1.5h (Sierra 
et al., 2010), and therefore increases in apoptosis might be masked by the high efficiency of 
removal. And third, in the in vitro late survival neurogenesis assay the phagocytic microglia CM 
did not induced cell death. Therefore, the phagocytic microglia CM is unlikely to be toxic per se 
but rather seems to affect the survival/differentiation of early neuroprogenitor cells. 
 
Thus, we studied those molecules of our neurocandidates that could potentially alter 
the survival/differentiation of the neurogenic cascade. We focused on the up-regulated 
neurocandidates because this was the only gene group in which the term neurogenesis 
showed up. Among the up-regulated neurocandidates, we found that IL-1β, IL-6 and TNFα 
have been reported to decrease survival of neuroprogenitor cells in vitro (IL-1β, TNFα) and in 
vivo (IL-6) (Breton and Mao-Draayer, 2011), which results in an inhibition of adult 
neurogenesis. However, in our hands inflammatory microglia CM did not trigger a reduction in 
the survival of neuroprogenitor cells, and thus the effects of these candidates on the 
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neuroprogenitor cell culture should be extensively studied in the future. Next, we 
hypothesized that the lack of an essential factor in the media obtained from phagocytic 
microglia could also be responsible for the reduction in survival. IGF-1, for example, enhances 
proliferation and survival of stem cells (Huat et al., 2014) and is down-regulated upon 
phagocytosis, therefore it is likely that the absence or reduction of key molecules could also 
mediate the phagocytic microglial effects on the modulation of neurogenesis. 
 
Since both in vitro and in vivo experiments support the hypothesis that the regulation of 
neurogenesis by phagocytic microglia might be mediated by the modulation of the 
survival/differentiation of newborn cells, we next focused on analyzing whether the identity of 
the cells in the neurogenic cascade were being affected (NSCs, ANPs, or neuroblasts). In vivo 
experiments showed no changes in NSCs between CM from naïve and phagocytic microglia 
suggesting that they are not the target cells of the neuromodulatory program. Nevertheless, 
both at 6d and 4w, NSCs presented a tendency to decline, which needs to be further studied in 
order to validate any differences in these cells. Moreover, ANPs are unlikely to have been 
affected by the CM microPH treatment because their immediate product, the AB neuroblasts, 
are not altered at 6d. Finally, in vivo experiments showed a decreased in the most mature 
neuroblasts (EF) at 28d, suggesting that neuroblasts are the cell population that is mostly 
affected by the phagocytic microglia CM. Overall, these results suggest that phagocytic 
microglia modulates neurogenesis via the reduction in the survival of neural-committed cells. 
 
It is important to note that in order to understand the relevance of this 
neuromodulatory program, as well as the discrepancies between in vitro and in vivo data, first, 
we must take into account that our in vitro analysis is a reductionist approach of what can be 
observed in vivo. During adult neurogenesis, microglia phagocytose the excess of newborn 
cells that are generated (Sierra et al., 2010). The peak of neurogenesis, and consequently 
apoptosis and phagocytosis is reached at 1mo, in which at most, around 30% of phagocytic 
microglia (containing a phagocytic pouch) can be observed in the subgranular layer of the DG. 
This means that there are a great number of non-phagocytic microglia merged in the 
neurogenic cascade, which are in the subgranular layer, molecular layer and the hilus. 
Therefore, in vivo neuromodulatory molecules released by phagocytic microglia would have a 
localized effect on neurogenesis since only cells in close proximity to a phagocytic site would 
be affected. On the contrary, in vitro we have generated an exaggerated model in which 
almost every single microglia is phagocytic, therefore all of them produce the different factors 
that might modulate neurogenesis; and every single neuroprogenitor cell in the culture is 
  DISCUSSION 
193 
 
affected by the conditioned media. Thus, what in physiological conditions might be a more 
localized action, in the in vitro study gets completely exacerbated in the culture, leading to the 
idea of a detrimental effect of the phagocytic conditioned media if it is not put into context.  
 
7.6. POTENTIAL MECHANISMS UNDERLYING THE EFFECT OF 
PHAGOCYTOSIS ON NEUROGENESIS 
In order to find the possible mechanism that exerts neuromodulatory function of 
phagocytic microglia, we searched among the 224 neurocandidates identified in our 
transcriptional assay. We will focus on three main mechanisms: inflammatory cytokines; the 
metabolite lactate; and the neuropeptide VGF.  
 
7.6.1. Inflammatory cytokines are unlikely to mediate the effect of 
phagocytic microglia CM on neurogenesis in vitro 
Inflammation is a crucial mechanism triggered in response to stimuli that are recognized 
as noxious, such as pathogens, cell death or injury. In the presence of an inflammatory insults, 
microglia release different inflammatory mediators such as cytokines, proteins of the 
complement cascade or chemokines (Nayak et al., 2014). The majority of the molecules 
released upon inflammation are almost undetectable in physiological CNS; nevertheless, these 
molecules are rapidly produced in response to an inflammatory stimulus. An excessive and 
chronic release of these cytokines results in detrimental consequences for the tissue, which 
have been demonstrated to contribute to tissue damage in several neurodegenerative 
diseases such as AD, Parkinson’s, stroke, MS, epilepsy (Amor et al., 2010; Vezzani et al., 2011).  
 
Inflammatory microglia have previously been reported to modulate neurogenesis in 
vivo. As stated above, microglial activation upon inflammatory stimuli has considered to 
trigger deleterious consequences for adult neurogenesis. Cranial irradiation therapy results in 
cognitive decline and chronic inflammation and it has been associated to adult neurogenesis 
impairment in vivo, which was reestablished after the blockade of neuroinflammation by 
indomethacin, which inhibits the synthesis of proinflammatory prostaglandin (Monje et al., 
2003). Moreover, upon inhibition of microglial activation by the administration of the 
antibiotic minocycline neurogenesis was restored in epileptic rodents (Ekdahl et al., 2003). This 
data linked microglia to a detrimental effect on neurogenesis, however, our data suggests that 
the relationship between inflammation and neurogenesis is more complex. 
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To test whether the immunodulatory effects of phagocytosis were responsible for the in 
vitro effects we observed on neurogenesis after treatment with phagocytic microglia CM, we 
performed a neurogenesis assay in which we compared the neuroprogenitor cell 
differentiation when cultured with phagocytic and LPS-treated microglial conditioned media, 
using LPS as control. To our surprise, not only did we not observe a reduction in neuroblast 
cells upon LPS-treated microglia CM or LPS culturing, but we found an increase in neuroblasts, 
in disagreement with influential papers such as (Monje et al., 2003), where they showed that 
CM from LPS-treated microglia (BV2 cells) reduced neuroblast survival, an effect that was 
mediated by IL-6. In order to confirm these results we mimicked Monje´s protocol (BV2 cells, 
high LPS dose), but we still found an increase in the neuroblast population. Thus, our results 
suggest that inflammation may not be as detrimental for neurogenesis as previously thought.  
 
Interestingly, LPS per se increased the number of neuroblasts in the culture. An increase 
in neurogenesis 28d after LPS administration in vivo was reported by (Bland et al., 2010), 
which might be the result of a compensatory boost in neurogenesis after an initial decrease of 
the neural progenitor cell population (Valero et al., 2014). Moreover, neural progenitor cells 
also express TLR receptors (Toll like receptor), which recognize the conserved structural motifs 
(so called PAMPs, pathogen-associated molecular patterns) in pathogens and trigger the 
inflammatory response in microglia and macrophages (Rolls et al., 2007). TLRs are activated by 
LPS, and therefore, the augmented neuroblast cell population in our LPS-treated control group 
could be due to the direct effect of LPS on the neuroprogenitor cells rather than being 
mediated by cytokines. In addition, the neuroblasts that we observed in both LPS-treated 
microglia CM and LPS neuroprogenitor cultures, showed a shorter and thicker morphology 
than those grown in the naïve microglia CM, which suggests that, although abundant, these 
neuroblasts might be somehow aberrant and might not develop a correct function and 
connectivity.  
 
In order to discard the possibility that the neuroblast increase that we observed in LPS-
treated microglia CM and LPS neuroprogenitor cultures was due to a direct effect of any 
remaining LPS on neuroprogenitor cells, we developed another paradigm in which we treated 
primary microglia with LPS for 6h in order to trigger the inflammatory response and then 
change to fresh media for another 18h, which would not contain any LPS. Next, we treated 
neuroprogenitor cells with either LPS or CM microLPS 6h + 18h. Similar to the previous LPS 
paradigm, we found an increase in neuroblast cell population, although this time, LPS-treated 
microglia CM triggered neuroblasts presented a more immature phenotype that the LPS 
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treated cultured, as shown by an increase levels of nestin cell marker in LPS-treated microglia 
CM culture. Overall, these data suggested that our primary microglia enhanced the production 
of neuroblast cell population. The discrepancies of these results with the already published 
literature might reside on our strategies for culturing microglia detailed in section 7.1. In 
addition, the observed enhancement of neuroblast population does not ensure the correct 
function and connectivity of the cells, and therefore, it would not necessarily translate into an 
increase in neurogenesis. Thus, further research is necessary in order to unravel the role of 
microglial produced cytokines in the modulation of neurogenesis. 
 
7.6.2. The metabolite lactate does not mediate the effect of phagocytic 
microglia CM on neurogenesis in vitro 
Another possible mechanism driving the modulation of neurogenesis by phagocytic 
microglia is the metabolite lactate, which is a product of glycolysis. As we have discussed in the 
section 7.2, phagocytic microglia showed major transcriptional changes in metabolism; 
mitochondrial processes such as Krebb’s cycle and oxidative phosphorylation were 
downregulated, whereas glycolysis was increased. These alterations in metabolism could lead 
to the production of lactate by phagocytic microglia. Lactate has been described to exert 
hormone functions and it has been related to memory formation and neuroprotection (Proia 
et al., 2016) and it might also support neurogenesis in vivo (Alvarez et al., 2014). Therefore, we 
studied the production and release of this metabolite in the CM form naïve, phagocytic, and 
LPS-treated microglia. There were no differences between the lactate concentration produced 
by naïve and phagocytic microglia, suggesting that lactate was unlikely responsible to mediate 
the neuromodulatory effects triggered by phagocytosis. Interestingly, lactate production was 
enhanced in LPS-treated microglia. As mentioned in section 7.2, the Warburg effect, which is 
characterized by an enhancement in glycolysis and a reduction in Krebb’s cycle (Tannahill et 
al., 2013), has been observed in LPS-stimulated macrophages (Palsson-McDermott et al., 
2015). Therefore, an increased in lactate production suggests that our LPS-treated microglia 
might have undergone the metabolic switch towards glycolysis and it could be related to a 
microglial priming induced by LPS in order to trigger an enhanced response upon reiterative 
inflammatory stimuli. 
 
7.6.3. The peptide VGF is overexpressed in phagocytic microglia in vitro 
Finally, we studied the role of the neurocandidate that showed the highest FC changes 
in both the arrays and RT-qPCR, the neuropeptide VGF. VGF is a neuropeptide that has been 
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implicated in metabolism and neurogenesis (Foglesong et al., 2016; Thakker-Varia et al., 2014), 
and to our knowledge, we are the first group who shows that microglia express VGF and that 
this expression is enhanced upon phagocytosis. In addition, we are currently validating VGF 
protein expression in phagocytic microglia both in vivo and in vitro. Nonetheless, we have not 
been able to identify yet the exact mechanism underlying microglial phagocytosis effects on 
neurogenesis.  
 
In addition, it is possible that the driving mechanism of phagocytic microglia is not 
merely a single molecule alone, but the result of the combination of several neuromodulatory 
molecules. We would like to narrow down the search by characterizing the exact proteins that 
have been released by phagocytic microglia in the CM media. Since we have identified 224 
virtual candidates, the study of all of them by single ELISA is not plausible. In addition, the 
available commercial ELISA multiplex kits offer the possibility to study fixed groups of proteins, 
such as angiogenic or immune proteins, and there are no offers available for the vast majority 
of our candidates. Moreover, personalized assays or full murine proteome ELISA are extremely 
expensive techniques. Furthermore, we had to discard the option of performing Liquid 
Chromatography followed by Mass Spectrometry due to the presence of serum proteins in our 
media, since it could mask the results of lower expressed proteins. In future experiments, we 
will add or block our candidates of interest in the CM in order to test whether they are 
responsible of the phenotypes we observed in phagocytic CM. In this task we will either try to 
modulate single molecules by addition or deprivation or we will use Seppro protein depletion 
resins (Sigma Aldrich) in order to remove several neuromodulatory molecules at the same time 
from the CMs.  
 
7.6.4. Alternative approaches to validate the role of phagocytosis on 
neurogenesis in vivo 
We are currently developing alternative strategies to demonstrate the role of microglial 
phagocytosis on neurogenesis in vivo, based on the genetic knock-down or pharmacological 
manipulation of key phagocytic receptors. To identify suitable targets, we have focused on a 
model of microglial phagocytosis impairment, a mouse model of epilepsy by intrahippocampal 
injection of the glutamate agonist kainic acid (Abiega et al., 2016). We first focused on 
glutamate receptors, whose expression in microglia had been shown in vitro (Beppu et al., 
2013; Domercq et al., 2013). Thus, we studied the expression of both ionotropic (AMPA, KA, 
and NMDA) and metabotropic (Grm1-8) in acutely purified microglia from the hippocampus 
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and cortex of 2mo fms-EGFP mice. We detected a residual expression of mRNA of all subunits 
in hippocampal and cortical microglia by RTqPCR, however, this poor expression was unlikely 
to lead to the formation of functional receptors. Therefore, it is unlikely that microglia 
interacts with the neurogenic niche via glutamate signaling. 
 
In addition, we focused on phagocytic and purinergic receptors involved in finding and 
tethering apoptotic cells, and characterized their expression on acutely purified microglia from 
the hippocampus of control and kainic mice. Purinergic receptors (P2X4, P2Y6, and P2Y12) 
were significantly increased, while the apoptotic cell recognition receptors (Trem2, MerTK, 
CR3, and GPR34) were significantly decreased in microglia from KA mice. Furthermore, some 
microglial purinergic receptors have been described to modulate neurogenesis. For example, 
the reduction of microglial P2Y13 receptor has been recently shown to enhance neurogenesis 
in P2Y13 KO mice (Stefani et al., 2018). Interestingly, our arrays showed a downregulation of 
P2Y13 receptor upon phagocytosis, suggesting that phagocytosis might regulate purinergic 
receptors in turn impacting on neurogenesis. These results suggest that modulating the 
expression or function of purinergic and recognition receptors may alter microglial 
phagocytosis and allow us to further test its impact on neurogenesis. 
 
We have analyzed three different constitutive KO mice, for P2Y12, GPR34 and a double 
transgenic KO for MerTK and Axl (Figure 35; data from Victor Sanchez-Zafra and Iñaki Paris 
PhD Theses). All these receptors have been described to actively participate in the phagocytic 
process (Preissler et al., 2015; Scott et al., 2001). We first demonstrated by RT-qPCR that 
except for Axl, these receptors are selectively expressed in microglia. Second, we confirmed 
that the absence of these receptors resulted in an impairment in microglia phagocytosis. 
Lastly, we studied neurogenesis in these phagocytosis impaired KO models. We found that at 
1mo, P2Y12 KO mice presented a decrease in both neuroblast and neuroblast proliferation, 
MerTK/Axl KO showed a reduction in neuroblast numbers and GPR34 did not show differences 
until 3mo, in which DCX+ cells were decreased. In addition, in P2Y12 KO mice, BrdU+ cells and 
newborn neurons (NeuN/BrdU) were diminished. Constitutive KO mice present several 
limitations, since the reduction in neurogenesis is the result of a continuous decrement in 
phagocytosis and many compensatory mechanisms may have played a role before the analysis 
at 1mo. However, this data highlights the importance of microglial phagocytosis for the correct 
long-term maintenance of the neurogenic cascade. 
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Figure 35. Microglial phagocytosis impairment reduces adult hippocampal neurogenesis. [A]Schematic 
representation of the interactions of P2Y12, GPR34 and MerTK/AXL receptors with apoptotic cells. [B] 
Experimental design used to isolate microglia (GFP+) vs non-microglial cells (GFP-) from 1 mo fms-EGFP 
mice. Flow cytometry analysis of the expression of C1q subunits in hippocampal cells. First, debris was 
excluded using the P1 gate in FSC versus SSC (left panel). Next, gates for GFP
+
 microglia cells (P3) and 
GFP
-
 non-microglial cells (P2) were defined based on the distribution of the fms-EGFP
+
 cells in EGFP vs 
FSC (right panel). [C] Expression of P2Y12, MerTK, AXL and GPR34 in microglia (GFP+) vs non-microglial 
cells (GFP-) by RTqPCR in FACS-sorted cells from fms-EGFP mice hippocampi (n = 3, each from 8 pooled 
hippocampi). OAZ1 was selected as a reference gene. [D] Representative confocal z-stack of P2Y12, 
MerTK/AXL and GPR34 KO mice immunofluorescence in the mouse hippocampal DG in physiological 
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conditions at 1 month. Microglia were labeled with fms EGFP+ (cyan), C1q (red) and apoptotic nuclei 
were detected by pyknosis/karyorrhexis (white, DAPI). [E] Percentage of apoptotic cells engulfed (Ph-
index) in P2Y12 KO mice. [F] Percentage of apoptotic cells engulfed (Ph-index) in MerTK/AXL KO mice. [G] 
Percentage of apoptotic cells engulfed (Ph-index) in GPR34 KO mice. [H] Representative confocal z-stack 
of P2Y12, MerTK/AXL and GPR34 KO mice immunofluorescence in the mouse hippocampal DG in 
physiological conditions at 1 month. Neuroblasts were labeled with DCX (green) and proliferation was 
labeled with either BrdU or Ki67 (magenta). [I] Quantifications of neuroblast and neuroblast proliferation 
in 1mo P2Y12 KO mice. [J] Quantifications of neuroblast and neuroblast proliferation in 1mo MerTK/AXL 
KO mice. [K] Quantification of neuroblast and mature neuroblast cell population in 3mo GPR34 KO mice. 
Data from Victor Sanchez-Zafra and Iñaki Paris PhD Theses. 
 
 In parallel, we are developing an alternative strategy based on inhibiting microglial 
phagocytosis in adult mice by injection of a lentiviral vector encoding a truncated dominant 
form of MGF-E8, an opsonizing molecule that binds to PS of apoptotic cells in order to facilitate 
phagocytosis (Akakura et al., 2004; Hanayama et al., 2002). The truncated dominant form 
would be overexpressed by neurons and might prevent microglia from recognizing apoptotic 
cells. We have some preliminary data in organotypic cultures in which we have observed a 
diminished microglial phagocytosis. In the future, we will use this strategy to inhibit microglial 
phagocytosis in vivo and study the effects of microglial phagocytosis impairment in 
neurogenesis. 
 
7.7. MICROGLIAL PHAGOCYTOSIS ACTS AS THE BRAKE OF NEUROGENESIS 
Overall, our data suggest that in physiological conditions, microglial phagocytosis acutely 
acts as the break of neurogenesis by releasing several neuromodulatory factors. These 
neuromodulatory factors are likely to aim at reducing the survival of neuronal-committed cells, 
and therefore, prevent an excessive production of new neurons. Moreover, the effects exerted 
by phagocytic microglia would be local since only cells from the neurogenic niche in close 
proximity to an apoptotic cell and, consequently to a phagocytic microglia, might be affected. 
However, upon microglial phagocytosis impairment, the break exerted on neurogenesis would 
disappear, allowing the uncontrolled survival of many neural-committed cells, which in turn, 
would proliferate and differentiate resulting in an increase in neuroblast cell population which 
could lead to aberrant connections with the hippocampal circuitry and thus, to the disruption 
of the balance of the neurogenic cascade. Therefore, in phagocytosis impairment conditions, 
such as epilepsy (Abiega et al., 2016), the phagocytosis impairment could contribute to the 
disease not only by the lack of clearance of apoptotic cells, but also by the absence of a 
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neuromodulatory brake. In addition, because the KO models in which microglial phagocytosis 
is impaired have shown that a decrease in phagocytosis results in a reduced neurogenesis, our 
data confirm that this regulation is essential for the correct long-term maintenance and 
functioning of the neurogenic cascade (Figure 36). 
 
 
Figure 36. Microglial phagocytosis imposes a brake on neurogenesis. In physiological conditions, 
microglial phagocytosis of apoptotic cells triggers the production of neuromodulatory molecules that 
contribute to the maintenance of the neurogenic cascade. However, upon microglial phagocytosis 
impairment, the balance of the neurogenic cascade is disrupted. 
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8. CONCLUSIONS 
 
1. REFINEMENT OF AN IN VITRO MODEL OF PHAGOCYTOSIS OF APOPTOTIC CELLS 
- We have developed an in vitro model of phagocytosis using primary microglia cultures 
from fms-EGFP mice fed with apoptotic murine NE-4C neuroprogenitors or human SH-
SY5Y neurons that mimics many features of in vivo phagocytosis. 
- The opsonizing molecule C1q must be present in the in vitro phagocytosis assay 
because in the adult hippocampus C1q mRNA is highly enriched in microglia and its 
protein is present in all phagocytic pouches, suggesting its involvement in 
phagocytosis.  
- We performed a direct quantification of phagocytic pouches using confocal z-stacks 
and orthogonal projections, a critical procedure to confirm the presence of the cargo 
within the microglial pouch.  
- Similar to phagocytosis in the adult hippocampus, microglial phagocytosis of mouse 
and human apoptotic cells (NE-4C and SH-SY5Y) is very fast and efficient in vitro. 
 
2. PHAGOCYTOSIS ALTERS GENES INVOLVED IN MICROGLIAL PHYSIOLOGY, INCLUDING 
METABOLISM AND APOPTOSIS 
- Whole genome transcriptome of phagocytic microglia reveals changes in microglial 
physiology, including cell metabolism and apoptosis. 
- Human SH-SY5Y apoptotic cells do not have active transcription sites, their mRNA is 
degraded, and the gene arrays probes and qPCR primers used are mouse-specific, 
suggesting that phagocytosis-related transcripts are specific to microglia.  
- Phagocytic microglia show expression changes in apoptosis-related genes which might 
exert pro-apoptotic actions within microglia (autologous genes) and anti-apoptotic 
actions in the surrounding cells (heterologous genes). 
- A small percentage of microglia dies after phagocytosis in vitro, which is unrelated to 
the amount or type of phagocytosed apoptotic cells. 
- Phagocytic microglial show expression changes in genes related to metabolism, which 
might be related to an enhanced glycolysis, a decreased Krebb’s cycle, and a shutdown 
oxidative phosphorylation.  
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- Phagocytic microglia show expression changes in genes related to chromatin 
modification and transcription factors, which would provide microglia with the 
capacity to maintain long-term expression and functional changes. 
 
3. PHAGOCYTOSIS TRIGGERS AN IMMUNOMODULATORY PROGRAM IN MICROGLIA 
- Phagocytic microglia present an enhanced expression of several both pro- and anti-
inflammatory cytokine genes, suggesting that it is a complex mechanism that 
combines molecules of different immunological nature. 
- Phagocytic microglia show alternative responses to inflammatory stimuli such as LPS. 
 
4. PHAGOCYTOSIS TRIGGERS A NEUROMODULATORY PROGRAM IN MICROGLIA 
- Phagocytic microglia express a coordinated neuromodulatory program that encompass 
up to 224 heterologous genes previously shown to modulate neurogenesis 
(neurocandidates), including peptides, trophic factors, matrix metalloproteases, and 
cytokines. 
- The neuromodulatory program is independent on the amount of cells engulfed by 
microglia. 
- The expression of some neurocandidates requires actual engulfment, whereas others 
depend on the apoptotic cell conditioned media. 
- Comparative RTqPCR or single cell RNASeq of microglia acutely purified from CA and 
the DG was not sufficient to validate the neuromodulatory program in vivo. 
 
5. PHAGOCYTOSIS TRIGGERS GLIOGENESIS IN VITRO BUT NOT IN VIVO 
- Conditioned media from phagocytic microglia and naïve microglia differentiate 
neuroprogenitor cells into different phenotypes in vitro.  
- Naïve microglia drive neuroprogenitor cells towards astrocytes and neuron-committed 
cells. 
- Phagocytic microglia drive neuroprogenitor cells towards a bipolar phenotype of 
astrocytic lineage characterized by high expression of astrocytic markers such as 
nestin, GFAP and S100their calcium responses to different stimuli; and their ability 
to differentiate into astrocytes . 
- Heterologous gliogenic genes expressed in phagocytic microglia are few and likely not 
involved in promoting astrocyte differentiation. 
- In vivo, phagocytic microglia CM does not induce astrogenesis. 
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6. PHAGOCYTOSIS LIMITS NEUROGENESIS IN VIVO BY THE REGULATION OF THE SURVIVAL OF 
THE NEURONAL-COMMITTED CELLS 
- Phagocytic microglia conditioned media induces apoptosis of neuroprogenitors in vitro 
but not in vivo. 
- Phagocytic microglia CM reduces differentiation into neuron-committed cells 
compared with control CM in vitro. 
- There is a tendency to find a decrease in stem cells and proliferation of stem cells at 2h 
in mice injected with phagocytic CM. 
- Phagocytic microglia CM does not induce changes in proliferation at 2h, but 
proliferative cells are diminished after 28d of treatment, suggesting that phagocytosis 
regulates the survival of neuronal-committed cells.. 
- Phagocytic microglia CM reduces the most mature neuroblast subpopulation (EF) at 
28d. 
 
7. POTENTIAL MECHANISMS UNDERLYING THE MODULATION OF NEUROGENESIS BY 
MICROGLIAL PHAGOCYTOSIS  
- Cytokines are unlikely to give rise to the bipolar cell phenotype observed in phagocytic 
conditioned media because they are not observed in LPS-treated microglial 
conditioned media. 
- Both LPS and CM from LPS-treated microglia induce an increase of neuroblasts 
compared to CM from naïve microglia. 
- Lactate is not increased in phagocytic microglia, but is enhanced in LPS, which renders 
lactate unlikely to mediate the modulation of neurogenesis by phagocytic microglia. 
- The neuropeptide VGF is highly increased in phagocytic microglia in vitro. 
- Glutamatergic receptors are residually expressed in microglia and therefore they are 
unlikely to form functional receptors and drive the communication between microglia 
and the neurogenic niche. 
- Phagocytic receptors are down-regulated and purinergic receptors are up-regulated in 
microglia upon microglial phagocytosis impairment after the intrahippocampal 
injection of Kainic acid, suggesting novel targets to manipulate microglial phagocytosis 
in vivo. 
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